{"title":"All","description":"","products":[{"product_id":"how-to-have-healthy-pregnancy-1","title":"How to have healthy pregnancy? 1","description":"\u003ch1\u003eEssential Steps for a Healthy Pregnancy and Baby: Expert Obstetric Advice\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#optimal-age-for-pregnancy\"\u003eOptimal Age for Pregnancy\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#avoiding-alcohol-smoking-and-toxins\"\u003eAvoiding Alcohol, Smoking, and Toxins\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#importance-of-early-prenatal-care\"\u003eImportance of Early Prenatal Care\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#genetic-testing-and-risk-assessment\"\u003eGenetic Testing and Risk Assessment\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#sharing-family-medical-history\"\u003eSharing Family Medical History\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#managing-gestational-diabetes\"\u003eManaging Gestational Diabetes\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#being-proactive-in-pregnancy-monitoring\"\u003eBeing Proactive in Pregnancy Monitoring\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"optimal-age-for-pregnancy\"\u003eOptimal Age for Pregnancy\u003c\/h2\u003e\n\u003cp\u003eDr. Philip Darney, MD, stresses that maternal age significantly impacts pregnancy outcomes. Teen pregnancies carry higher risks of labor complications, while pregnancies after age 35 increase difficulties with conception and pregnancy-related complications. The UCSF obstetrician recommends planning pregnancies during the biologically optimal window of early 20s to mid-30s.\u003c\/p\u003e\n\n\u003ch2 id=\"avoiding-alcohol-smoking-and-toxins\"\u003eAvoiding Alcohol, Smoking, and Toxins\u003c\/h2\u003e\n\u003cp\u003e\"These aspects are completely within the woman's control,\" emphasizes Dr. Darney. Eliminating alcohol, tobacco, and environmental toxins dramatically improves fetal development outcomes. Research shows these substances can cause low birth weight, developmental delays, and birth defects - all preventable through conscious avoidance during pregnancy.\u003c\/p\u003e\n\n\u003ch2 id=\"importance-of-early-prenatal-care\"\u003eImportance of Early Prenatal Care\u003c\/h2\u003e\n\u003cp\u003eDr. Philip Darney, MD, advises scheduling the first prenatal visit immediately after a positive pregnancy test. Early medical supervision allows detection of conditions like gestational diabetes or preeclampsia when most treatable. Statistics show women receiving prenatal care in the first trimester have 50% lower risk of pregnancy complications.\u003c\/p\u003e\n\n\u003ch2 id=\"genetic-testing-and-risk-assessment\"\u003eGenetic Testing and Risk Assessment\u003c\/h2\u003e\n\u003cp\u003eThe triple test and newer genetic screenings help identify fetal abnormalities, particularly important for women over 35. Dr. Philip Darney, MD, explains these non-invasive tests analyze maternal blood for markers indicating potential chromosomal conditions, with 85-90% detection rates for Down syndrome when performed between 15-20 weeks.\u003c\/p\u003e\n\n\u003ch2 id=\"sharing-family-medical-history\"\u003eSharing Family Medical History\u003c\/h2\u003e\n\u003cp\u003e\"Disclose any family history of genetic disorders during your first visit,\" urges Dr. Darney. Inherited conditions like cystic fibrosis or congenital heart defects warrant specialized monitoring. The UCSF expert notes that 3-4% of pregnancies involve birth defects, many preventable or manageable with early intervention.\u003c\/p\u003e\n\n\u003ch2 id=\"managing-gestational-diabetes\"\u003eManaging Gestational Diabetes\u003c\/h2\u003e\n\u003cp\u003eDr. Philip Darney, MD, highlights the value of second opinions for gestational diabetes diagnosis and treatment plans. This condition affects 2-10% of pregnancies and requires careful blood sugar control through diet, exercise, and sometimes medication to prevent complications like macrosomia (excessive fetal growth).\u003c\/p\u003e\n\n\u003ch2 id=\"being-proactive-in-pregnancy-monitoring\"\u003eBeing Proactive in Pregnancy Monitoring\u003c\/h2\u003e\n\u003cp\u003eWhile trusting medical professionals is essential, Dr. Darney encourages women to actively track pregnancy progress. Noticing changes in fetal movement, unusual symptoms, or test results allows timely intervention. The obstetrician concludes, \"A mother's vigilance combined with expert care creates the healthiest outcomes.\"\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e How to have a healthy pregnancy and give birth to a healthy baby?\u003c\/p\u003e\n\n\u003cp\u003eIt is important to visit a doctor as soon as you learn that you are pregnant. Early medical care can find signs of any potential problems during pregnancy. Many factors of a healthy pregnancy are under a woman's control.\u003c\/p\u003e\n\n\u003cp\u003ePregnancy brings not only excitement but also anxiety, especially during a first pregnancy. There are more contacts with medical professionals and more diagnostic tests. Women often fully entrust the management of pregnancy to medical professionals, as they should. But sometimes it is worth being proactive. A woman must be vigilant about how the pregnancy progresses.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e You have enormous international experience in women's health. What can a woman do to ensure that her pregnancy goes well?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Philip Darney, MD:\u003c\/strong\u003e There's a lot women and families can do to ensure that pregnancy goes well. First is probably to avoid pregnancy at too young or too old an age. For example, women in their early teen years have more pregnancy complications, particularly in labor and delivery. Women beyond age 35 or 40 have more difficulty becoming pregnant and more complications with the pregnancy itself.\u003c\/p\u003e\n\n\u003cp\u003eAnother important aspect of protecting pregnancy is to avoid alcohol, smoking, and chemicals or toxins that could negatively influence pregnancy outcomes. Those aspects are completely within the control of the woman herself.\u003c\/p\u003e\n\n\u003cp\u003eSometimes complications develop that require medical intervention. The best method to identify complications is to seek prenatal care early in pregnancy. If complications occur, they are identified early.\u003c\/p\u003e\n\n\u003cp\u003eFor example, a woman's risk of genetic abnormalities in pregnancy increases with age. Pregnancy risks can be tested for and predicted. The genetic test widely used is called the triple test. There are more modern iterations of these diagnostic tests.\u003c\/p\u003e\n\n\u003cp\u003eFrom simple pregnancy complication diagnostic tests, a woman can proceed to more complex investigations of the genetic makeup of the fetus.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Yes, that's a good example. A family history of genetic abnormalities would be important to tell a physician about. Share any family history of congenital malformations during an early prenatal visit.\u003c\/p\u003e\n\n\u003cp\u003eMother's health and early prenatal care are key to the health of the child.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852067807388,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"how-to-give-birth-to-healthy-child","title":"How to give birth to healthy child? 2","description":"\u003ch1\u003eEssential Steps for a Healthy Pregnancy and Safe Delivery\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#planning-pregnancy-for-better-outcomes\"\u003ePlanning Pregnancy for Better Outcomes\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#avoiding-toxins-during-pregnancy\"\u003eAvoiding Toxins During Pregnancy\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#the-critical-role-of-prenatal-care\"\u003eThe Critical Role of Prenatal Care\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#recognizing-signs-of-preeclampsia\"\u003eRecognizing Signs of Preeclampsia\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#managing-gestational-diabetes-risks\"\u003eManaging Gestational Diabetes Risks\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#breastfeeding-for-newborn-health\"\u003eBreastfeeding for Newborn Health\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#when-hospital-care-becomes-essential\"\u003eWhen Hospital Care Becomes Essential\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"planning-pregnancy-for-better-outcomes\"\u003ePlanning Pregnancy for Better Outcomes\u003c\/h2\u003e\n\u003cp\u003eDr. Philip Darney, MD, stresses that planned pregnancies significantly reduce risks of prematurity, the leading global cause of early neonatal death and pregnancy loss. Contraception use allows conception when maternal health is optimized. Planned pregnancies enable women to address chronic conditions, nutritional status, and lifestyle factors before conception, creating the best possible environment for fetal development.\u003c\/p\u003e\n\n\u003ch2 id=\"avoiding-toxins-during-pregnancy\"\u003eAvoiding Toxins During Pregnancy\u003c\/h2\u003e\n\u003cp\u003eEliminating alcohol, tobacco, and environmental toxins is crucial for fetal health, explains Dr. Darney. These substances can disrupt organ development and lead to birth defects or growth restrictions. Even moderate alcohol consumption increases risks of fetal alcohol spectrum disorders, while smoking raises chances of low birth weight by nearly 50% according to CDC data.\u003c\/p\u003e\n\n\u003ch2 id=\"the-critical-role-of-prenatal-care\"\u003eThe Critical Role of Prenatal Care\u003c\/h2\u003e\n\u003cp\u003eRegular prenatal visits allow early detection of complications, with Dr. Darney noting they should begin as soon as pregnancy is confirmed. Monitoring includes blood pressure checks (critical for catching preeclampsia), weight tracking, and fetal growth assessments. The American College of Obstetricians recommends at least 14 prenatal visits for low-risk pregnancies, with more frequent monitoring for high-risk cases.\u003c\/p\u003e\n\n\u003ch2 id=\"recognizing-signs-of-preeclampsia\"\u003eRecognizing Signs of Preeclampsia\u003c\/h2\u003e\n\u003cp\u003eDr. Philip Darney, MD, identifies rising blood pressure and protein in urine as key preeclampsia warning signs, typically emerging in late second or third trimester. This dangerous condition affects 5-8% of pregnancies globally. Regular blood pressure monitoring can detect concerning trends before symptoms appear, allowing early intervention to prevent eclampsia (seizures) or HELLP syndrome.\u003c\/p\u003e\n\n\u003ch2 id=\"managing-gestational-diabetes-risks\"\u003eManaging Gestational Diabetes Risks\u003c\/h2\u003e\n\u003cp\u003eScreening for gestational diabetes between 24-28 weeks is vital, notes Dr. Darney. This temporary condition affects up to 10% of pregnancies and can cause excessive fetal growth. Tight glucose control through diet, exercise, and sometimes medication prevents complications like birth injuries from macrosomia (oversized babies) and reduces future type 2 diabetes risks for both mother and child.\u003c\/p\u003e\n\n\u003ch2 id=\"breastfeeding-for-newborn-health\"\u003eBreastfeeding for Newborn Health\u003c\/h2\u003e\n\u003cp\u003eDr. Philip Darney, MD, emphasizes breastfeeding's proven benefits, including stronger immunity and reduced infection risks. WHO recommends exclusive breastfeeding for six months, with continued breastfeeding alongside solids for two years or more. Breast milk provides ideal nutrition and antibodies while reducing risks of obesity, asthma, and SIDS (sudden infant death syndrome).\u003c\/p\u003e\n\n\u003ch2 id=\"when-hospital-care-becomes-essential\"\u003eWhen Hospital Care Becomes Essential\u003c\/h2\u003e\n\u003cp\u003eCertain pregnancy complications require hospital-based management, explains Dr. Philip Darney, MD. Severe preeclampsia may need magnesium sulfate to prevent seizures and early delivery. Preterm labor might require corticosteroids to accelerate fetal lung development. Having a high-risk pregnancy care plan ensures rapid response to emerging complications that threaten maternal or fetal wellbeing.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e What can a woman do to ensure that her child is born healthy? What can a woman do to make sure her baby stays healthy in early infancy and beyond?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Philip Darney, MD:\u003c\/strong\u003e The health of the baby is determined in large part by the health of the woman herself. We mentioned some of the things a woman can do to be healthy for her pregnancy. Perhaps the most important health advice is to plan the pregnancy.\u003c\/p\u003e\n\n\u003cp\u003eAll around the world, the principal cause of early neonatal death and pregnancy loss is prematurity. Planned pregnancies are less likely to be born premature. So the use of contraception in order to plan a pregnancy is important. Then the pregnancy comes when the woman wants it to come.\u003c\/p\u003e\n\n\u003cp\u003eThe avoidance of toxins is important. Do not use alcohol or tobacco. Exposure to environmental toxins is important to avoid. A woman must preserve the health of the newborn.\u003c\/p\u003e\n\n\u003cp\u003eSeeking prenatal care is important. Breast-feeding has been shown to result in babies who are more resistant to infection. Breast-fed babies grow up healthier. So breastfeeding for as long as possible is an important aspect of good care for the newborn baby.\u003c\/p\u003e\n\n\u003cp\u003eThen there are special situations where hospital care is required. The type of care received only in the hospital might be important. For example, the development of preeclampsia can be treated. Preeclampsia is high blood pressure that develops during the later stages of pregnancy.\u003c\/p\u003e\n\n\u003cp\u003eScreening for diabetes is important. A woman who develops diabetes during pregnancy receives treatment to avoid excessive weight gain in herself and in the fetus. That can be an important aspect in pregnancy management.\u003c\/p\u003e\n\n\u003cp\u003eI would say there are several critical factors for a healthy pregnancy. It is important to plan a pregnancy and avoid outside toxins. They can adversely affect the development of the baby.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e You mentioned preeclampsia. It is a very important risk factor for the health of pregnant women. What are the signs of preeclampsia that the woman should know and recognize?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Philip Darney, MD:\u003c\/strong\u003e That's why prenatal care is important. Because rising blood pressure is the critical problem during pregnancy. Protein in the urine and excessive weight gain may happen toward the latter part of the second trimester of pregnancy.\u003c\/p\u003e\n\n\u003cp\u003eRegular prenatal visits and documentation of expected fetal growth during pregnancy are both important.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e This is a very important point, because some of the symptoms could develop quite late in the pregnancy. But high blood pressure can be caught by health professionals before it develops into such a significant problem as preeclampsia.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Philip Darney, MD:\u003c\/strong\u003e Yes. Two good examples are hypertension during pregnancy and the development of gestational diabetes.\u003c\/p\u003e\n\n\u003cp\u003eHow to give birth to a healthy child? What are signs of high-risk pregnancy, preeclampsia, gestational diabetes? Regular prenatal visits find early warning.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852067840156,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"cesarean-section-or-natural-birth-how-to-choose","title":"Cesarean section or natural birth. How to choose? 3","description":"\u003ch1\u003eChoosing Between Cesarean Section and Natural Birth: Safety and Considerations\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#safety-considerations-for-cesarean-and-natural-birth\"\u003eSafety Considerations for Cesarean and Natural Birth\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#medical-indications-for-cesarean-section\"\u003eMedical Indications for Cesarean Section\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#risks-of-unnecessary-cesarean-section\"\u003eRisks of Unnecessary Cesarean Section\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#impact-on-future-pregnancies\"\u003eImpact on Future Pregnancies\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#global-trends-and-concerns-in-cesarean-rates\"\u003eGlobal Trends and Concerns in Cesarean Rates\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#hospital-practices-and-birth-outcomes\"\u003eHospital Practices and Birth Outcomes\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"safety-considerations-for-cesarean-and-natural-birth\"\u003eSafety Considerations for Cesarean and Natural Birth\u003c\/h2\u003e\n\u003cp\u003eDr. Philip Darney, MD, emphasizes that vaginal delivery is generally the safest method for both mother and baby. He notes that natural birth minimizes complications and supports better outcomes in future pregnancies. Dr. Anton Titov, MD, concurs, highlighting that natural birth should be prioritized unless specific medical conditions necessitate a cesarean section.\u003c\/p\u003e\n\n\u003ch2 id=\"medical-indications-for-cesarean-section\"\u003eMedical Indications for Cesarean Section\u003c\/h2\u003e\n\u003cp\u003eDr. Darney explains that cesarean sections should only be performed when there are clear medical indications, such as breech presentation or placenta previa. He stresses the importance of a medical second opinion to confirm the necessity of a C-section, ensuring the best treatment plan for both mother and child.\u003c\/p\u003e\n\n\u003ch2 id=\"risks-of-unnecessary-cesarean-section\"\u003eRisks of Unnecessary Cesarean Section\u003c\/h2\u003e\n\u003cp\u003eUnnecessary cesarean sections can lead to complications for both mother and baby, Dr. Darney warns. He points out that cesarean deliveries without medical need can result in increased risks during subsequent pregnancies and potential complications that are difficult to predict.\u003c\/p\u003e\n\n\u003ch2 id=\"impact-on-future-pregnancies\"\u003eImpact on Future Pregnancies\u003c\/h2\u003e\n\u003cp\u003eDr. Darney highlights that a first cesarean section often necessitates C-sections in future pregnancies, which can increase risks for both mother and child. He advises that vaginal delivery, when possible, is preferable to avoid these complications and support healthier future pregnancies.\u003c\/p\u003e\n\n\u003ch2 id=\"global-trends-and-concerns-in-cesarean-rates\"\u003eGlobal Trends and Concerns in Cesarean Rates\u003c\/h2\u003e\n\u003cp\u003eDr. Darney expresses concern over the rising rates of cesarean sections worldwide. He notes that this trend poses significant risks to maternal and neonatal health, emphasizing the need for careful consideration and medical justification for each C-section performed.\u003c\/p\u003e\n\n\u003ch2 id=\"hospital-practices-and-birth-outcomes\"\u003eHospital Practices and Birth Outcomes\u003c\/h2\u003e\n\u003cp\u003eDr. Anton Titov, MD, discusses how hospital practices can influence birth outcomes. He mentions that some hospitals may prioritize convenience over patient safety, leading to higher rates of cesarean deliveries. Dr. Darney cites San Francisco General Hospital as an example of a facility with low cesarean rates and excellent maternal and neonatal outcomes, underscoring the importance of prioritizing natural birth whenever possible.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e How to decide to deliver a baby by Cesarean section or natural birth? What is safer? C-section or natural delivery?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Philip Darney, MD:\u003c\/strong\u003e Induction of labor and cesarean section have to be done only when medical indications exist. Vaginal delivery is the safest method for both baby and mother. Natural birth is also better for future pregnancies. The first cesarean section often requires C-sections in subsequent pregnancies.\u003c\/p\u003e\n\n\u003cp\u003eMedical second opinion confirms that breech presentation and placenta previa diagnosis is correct and complete. Medical second opinion also confirms that cesarean section is required. Medical second opinion helps to choose the best treatment for placenta previa and breech presentation. Get a medical second opinion on placenta previa and be confident that your treatment is the best.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Is it a question of a woman's choice if there are no medical indications for a C-section? How to decide whether vaginal birth or cesarean section is better? How to deliver a baby after an uncomplicated pregnancy?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Philip Darney, MD:\u003c\/strong\u003e Cesarean section delivery should only be done when it is medically necessary. Induction of labor for a vaginal delivery should be done only when it is medically necessary. Cesarean delivery and induction of labor in vaginal delivery can be done too early, which is dangerous. The baby should be delivered when it's ready to be delivered. Pregnancy becomes full term at forty weeks.\u003c\/p\u003e\n\n\u003cp\u003eCesarean delivery without medical indications is harmful to both the mother and the baby. Rising rates of cesarean section delivery all around the world are of concern. Higher rates of cesarean delivery increase the risk to both mother and baby in subsequent pregnancies.\u003c\/p\u003e\n\n\u003cp\u003eCesarean delivery itself can result in complications for both mother and child. It is difficult to anticipate some complications of C-section. So vaginal delivery whenever possible is the best course of action.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e This is very important because frequently a scheduled cesarean section delivery is convenient for the hospital and for doctors. Maybe this convenience of C-section delivery accounts for the growth in cesarean sections around the world. But natural vaginal birth is the safest. It is the best for both mother and child.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Philip Darney, MD:\u003c\/strong\u003e Yes. I will give an example. We are now in San Francisco General Hospital. There was an article in the New York Times about San Francisco General Hospital. It is the safest place for mother and baby in California. Why was this hospital the safest for baby delivery? It was mostly because we have a very low rate of cesarean section deliveries.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e How to decide? What is safer for mother and best for child? The best method to deliver a child is a natural vaginal delivery.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852067905692,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"high-risk-pregnancy-pregnancy-with-complications","title":"High risk pregnancy. Pregnancy with complications. 4","description":"\u003ch1\u003eHigh-Risk Pregnancy: Key Warning Signs and Essential Prenatal Care\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#high-risk-pregnancy-factors\"\u003eHigh-Risk Pregnancy Factors\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#pre-existing-conditions-that-increase-risk\"\u003ePre-Existing Conditions That Increase Risk\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#lifestyle-risk-factors\"\u003eLifestyle Risk Factors\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#genetic-anomalies-and-pregnancy-risks\"\u003eGenetic Anomalies and Pregnancy Risks\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#importance-of-pregnancy-timing\"\u003eImportance of Pregnancy Timing\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#prenatal-care-strategies-for-high-risk-pregnancies\"\u003ePrenatal Care Strategies for High-Risk Pregnancies\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"high-risk-pregnancy-factors\"\u003eHigh-Risk Pregnancy Factors\u003c\/h2\u003e\n\u003cp\u003eDr. Philip Darney, MD, identifies hypertension, diabetes, and obesity as primary indicators of high-risk pregnancy. These conditions require close monitoring from conception through delivery. Women with chronic illnesses should disclose their full medical history during the first prenatal visit to assess pregnancy risks accurately.\u003c\/p\u003e\n\n\u003ch2 id=\"pre-existing-conditions-that-increase-risk\"\u003ePre-Existing Conditions That Increase Risk\u003c\/h2\u003e\n\u003cp\u003ePre-pregnancy health significantly impacts pregnancy outcomes, according to Dr. Darney. Chronic conditions like type 2 diabetes or essential hypertension elevate risks for complications such as preeclampsia. Unlike gestational diabetes that develops during pregnancy, pre-existing diabetes carries higher risks for birth complications and requires specialized care protocols.\u003c\/p\u003e\n\n\u003ch2 id=\"lifestyle-risk-factors\"\u003eLifestyle Risk Factors\u003c\/h2\u003e\n\u003cp\u003eSmoking and heavy alcohol consumption dramatically increase pregnancy risks, notes Dr. Philip Darney, MD. These behaviors can lead to fetal alcohol syndrome, low birth weight, and preterm labor. Obstetricians recommend complete cessation of these substances before conception to mitigate high-risk pregnancy complications.\u003c\/p\u003e\n\n\u003ch2 id=\"genetic-anomalies-and-pregnancy-risks\"\u003eGenetic Anomalies and Pregnancy Risks\u003c\/h2\u003e\n\u003cp\u003eDr. Philip Darney, MD, emphasizes that family history of genetic disorders or advanced maternal age (over 35) warrants genetic counseling. Screening tests like amniocentesis or NIPT (non-invasive prenatal testing) become crucial for early detection of chromosomal abnormalities in high-risk pregnancies.\u003c\/p\u003e\n\n\u003ch2 id=\"importance-of-pregnancy-timing\"\u003eImportance of Pregnancy Timing\u003c\/h2\u003e\n\u003cp\u003eThe UCSF specialist advises optimal pregnancy timing between ages 20-35 to reduce risks. Dr. Philip Darney, MD, explains that very young or advanced maternal age increases chances of complications like gestational diabetes or chromosomal disorders. Preconception planning helps address modifiable risk factors before pregnancy begins.\u003c\/p\u003e\n\n\u003ch2 id=\"prenatal-care-strategies-for-high-risk-pregnancies\"\u003ePrenatal Care Strategies for High-Risk Pregnancies\u003c\/h2\u003e\n\u003cp\u003eFrequent prenatal visits form the cornerstone of managing high-risk pregnancies, according to Dr. Darney. These allow early detection and intervention for complications like gestational hypertension. Specialized monitoring may include more frequent ultrasounds, glucose tolerance tests, and blood pressure tracking to ensure maternal and fetal wellbeing throughout pregnancy.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003eWhat to expect in high risk pregnancy. How do you know if your pregnancy is high risk? Leading expert in obstetrics and gynecology explains key health implications of high-risk pregnancy.\u003c\/p\u003e\n\n\u003cp\u003eHigh risk pregnancy - what to expect?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e How do you know if you are a high risk pregnancy?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Philip Darney, MD:\u003c\/strong\u003e High blood pressure and diabetes are risk factors present before pregnancy. A woman with hypertension, diabetes, or obesity should ask \"am I considered high risk pregnancy?\" Her health should be monitored very closely.\u003c\/p\u003e\n\n\u003cp\u003eHow do you know if your pregnancy is high risk? Get a visit to doctor early in the pregnancy and share all your medical history. What are the factors that put a pregnancy at risk? They are high blood pressure, diabetes, clotting disorders or history of any significant chronic medical illness.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e High-risk pregnancy - what to expect. What makes high-risk pregnancy? What are symptoms of high-risk pregnancy?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e What signs should a pregnant woman pay attention to that can signal her pregnancy is \"high risk\"? What should a pregnant woman do if a doctor or nurse tells her she has reasons for high-risk pregnancy?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Philip Darney, MD:\u003c\/strong\u003e The most important factors in predicting a high risk pregnancy would be the health of the woman herself. Factors that predict high-risk pregnancy would be diabetes or high blood pressure before the pregnancy.\u003c\/p\u003e\n\n\u003cp\u003eHigh-risk pregnancy risk factors do not include hypertension or gestational diabetes that develop during the pregnancy. Heavy drinking and smoking during pregnancy would predict high-risk pregnancy. Pregnant women should discuss these important issues with their obstetrician.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Philip Darney, MD:\u003c\/strong\u003e Genetic anomalies or factors that increase risk for genetic anomalies in the developing child are important predictors of pregnancy outcome. These risk factors can put a woman into high-risk pregnancy category.\u003c\/p\u003e\n\n\u003cp\u003eMedical history during the first prenatal visit is important. It should reveal all these risk factors for high-risk pregnancy. A woman should be properly immunized prior to pregnancy.\u003c\/p\u003e\n\n\u003cp\u003eI have already mentioned the importance of having the pregnancy come at the time when a woman is ready to be a mother. Woman should be not too young and not too old. This helps to avoid high-risk pregnancy problems.\u003c\/p\u003e\n\n\u003cp\u003eFor problems that develop during high-risk pregnancy, regular prenatal visits are the best method. They help to determine the severity of complications and initiate early treatment. Sometimes gestational diabetes is a complication of high-risk pregnancy.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e High risk pregnancy - what to expect? Hypertension, diabetes, obesity, history of chronic disease before pregnancy are warning signs. Seek prenatal care early.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068069532,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"birth-control-and-population-control","title":"Birth control and population control. 5","description":"\u003ch1\u003eBirth Control's Role in Global Population Growth\u003c\/h1\u003e\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#birth-control-and-womens-prosperity\"\u003eBirth Control and Women's Prosperity\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#population-growth-and-socioeconomic-tensions\"\u003ePopulation Growth and Socioeconomic Tensions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#access-to-family-planning\"\u003eAccess to Family Planning\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#successful-interventions-in-fertility-reduction\"\u003eSuccessful Interventions in Fertility Reduction\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#cost-effectiveness-of-birth-control\"\u003eCost-Effectiveness of Birth Control\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 id=\"birth-control-and-womens-prosperity\"\u003eBirth Control and Women's Prosperity\u003c\/h2\u003e\n\u003cp\u003eDr. Philip Darney, MD, highlights the significant role of birth control in enhancing women's prosperity worldwide. By providing effective and affordable contraception, women can plan their families better, leading to improved health outcomes and economic opportunities. Birth control reduces the burden on healthcare systems by preventing unplanned pregnancies, allowing women to pursue education and careers.\u003c\/p\u003e\n\u003ch2 id=\"population-growth-and-socioeconomic-tensions\"\u003ePopulation Growth and Socioeconomic Tensions\u003c\/h2\u003e\n\u003cp\u003eDr. Anton Titov, MD, discusses the challenges posed by population growth, particularly in economically underdeveloped regions. With the global population nearing 7 billion, the disparity between developed and developing countries creates socioeconomic tensions. High population growth in less developed areas contrasts with declining populations in industrialized nations, leading to skill mismatches in the global market.\u003c\/p\u003e\n\u003ch2 id=\"access-to-family-planning\"\u003eAccess to Family Planning\u003c\/h2\u003e\n\u003cp\u003eDr. Philip Darney, MD, emphasizes the importance of access to family planning services. Many women worldwide express a desire for fewer children than they currently have, often due to limited access to contraception and safe abortion. By providing these services, women can make informed choices about their reproductive health, leading to a natural decline in population growth.\u003c\/p\u003e\n\u003ch2 id=\"successful-interventions-in-fertility-reduction\"\u003eSuccessful Interventions in Fertility Reduction\u003c\/h2\u003e\n\u003cp\u003eDr. Darney points to successful interventions in countries like Bangladesh and Mexico, where fertility rates have declined despite economic and political challenges. These interventions include family planning, safe abortion, and early prenatal care. Such measures have proven effective in reducing maternal mortality and improving overall health outcomes.\u003c\/p\u003e\n\u003ch2 id=\"cost-effectiveness-of-birth-control\"\u003eCost-Effectiveness of Birth Control\u003c\/h2\u003e\n\u003cp\u003eDr. Anton Titov, MD, and Dr. Philip Darney, MD, agree on the cost-effectiveness of birth control as a method to improve maternal and child health globally. Compared to other government expenditures, investing in family planning and reproductive health services offers significant returns in terms of health and economic benefits. These interventions are inexpensive yet powerful tools for enhancing global health and prosperity.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Do women around the world want to have fewer babies than they actually have? What does effective and cheap birth control mean for the prosperity of women?\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Philip Darney, MD:\u003c\/strong\u003e Birth control for population control is an effective method to improve the lives of women in many countries. It's an important social and health topic. A healthy pregnancy is a planned pregnancy. Human population control methods are effective in improving standards of living. Birth control is also not expensive and reduces the burden on healthcare systems that unplanned pregnancies can create.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e There are 7 billion people on the planet today, almost triple the number about sixty years ago. Most of the population growth will come from the countries that are least economically developed. This growth, combined with a decline in population in the industrialized world, creates a lot of social and socioeconomic tensions. The problem is that the skills required in the modern market are very high-level skills, which people from the most populous countries often do not have.\u003c\/p\u003e\n\u003cp\u003eIn traditional societies, having more children serves as a bit of insurance for older age for the parents. Some children will tend the farm or do some family business. Even if only one of several children \"makes it,\" that child would take care of the entire family. So, population growth and control are very difficult subjects to approach.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Can the population be controlled around the world? Is it worth doing so?\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Philip Darney, MD:\u003c\/strong\u003e As you point out, this is a complicated issue—economically, politically, and socially. It has traditional and religious implications. The most direct answer to your question is: Yes, and the mechanism is simple. When we ask women all around the world how many children they want to have, they tell us they want fewer children than they actually do have. Why is that? They didn't have access to family planning.\u003c\/p\u003e\n\u003cp\u003eIn healthcare systems worldwide, the number of children women have is far higher than they want. This is true even in sub-Saharan Africa, where the number of children desired is higher than in the rest of the world. Women say: I want to have fewer children than I'm likely to have. Please give me contraception and safe abortion.\u003c\/p\u003e\n\u003cp\u003eSometimes, if we simply gave all women the opportunity to have as many children as they want, they would have many fewer than they do. Population growth would gradually decline. We see those declines in societies where there hasn't been much economic growth and where there's been political chaos for much of the past 20 years. Great examples are countries like Bangladesh and Nepal. In Mexico, fertility rates have declined dramatically.\u003c\/p\u003e\n\u003cp\u003eThe interventions that make this possible for women and families are clear. A report from the Global Health Policy Summit in 2012 showed that seven simple interventions decreased maternal mortality around the world dramatically. Those interventions were family planning, safe abortion, and early prenatal care. They are very inexpensive compared to other ways governments spend money. That's a long answer, but it's a complicated question. However, I think the answers aren't as complex as you might think.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Is birth control a cheap method to improve maternal and child health around the world? Does population growth control make sense?\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068102300,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"best-birth-control-methods","title":"Best birth control methods. Contraceptive implants. 6","description":"\u003ch1\u003eTop Long-Acting Birth Control Options\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"#importance-of-effective-birth-control\"\u003eImportance of Effective Birth Control\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#contraceptive-implants\"\u003eContraceptive Implants\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#intrauterine-devices\"\u003eIntrauterine Devices\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#safety-and-reversibility\"\u003eSafety and Reversibility\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#comparing-to-other-methods\"\u003eComparing to Other Methods\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#global-impact\"\u003eGlobal Impact\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"importance-of-effective-birth-control\"\u003eImportance of Effective Birth Control\u003c\/h2\u003e\n\u003cp\u003eEffective birth control is vital for family planning and reducing unintended pregnancies. Professor Darney highlights that around 40% to 50% of pregnancies worldwide are unintended, which can lead to complications and affect maternal and infant health. Access to reliable contraception helps women plan pregnancies, improving health outcomes.\u003c\/p\u003e\n\n\u003ch2 id=\"contraceptive-implants\"\u003eContraceptive Implants\u003c\/h2\u003e\n\u003cp\u003eContraceptive implants are a highly effective long-term birth control option. They are inserted under the skin and can prevent pregnancy for up to five years. Professor Darney notes their cost-effectiveness and ease of use, as they eliminate the need for daily attention, unlike pills or condoms.\u003c\/p\u003e\n\n\u003ch2 id=\"intrauterine-devices\"\u003eIntrauterine Devices\u003c\/h2\u003e\n\u003cp\u003eIntrauterine devices (IUDs) are another long-acting contraceptive method. They can last even longer than implants and are praised for their high efficacy. According to Professor Darney, IUDs are a practical choice as they require minimal maintenance and are cost-effective over time.\u003c\/p\u003e\n\n\u003ch2 id=\"safety-and-reversibility\"\u003eSafety and Reversibility\u003c\/h2\u003e\n\u003cp\u003eBoth contraceptive implants and IUDs are safe and their effects are reversible. Professor Darney assures that these methods do not affect long-term fertility, allowing women to conceive after removal. There is no evidence linking IUDs to pelvic infections, making them a safe choice for many women.\u003c\/p\u003e\n\n\u003ch2 id=\"comparing-to-other-methods\"\u003eComparing to Other Methods\u003c\/h2\u003e\n\u003cp\u003eWhile birth control pills are widely used, they are not as effective as implants or IUDs. Professor Darney points out that pills carry a risk of venous thrombosis for some women. Condoms and vaginal methods require consistent effort, whereas long-acting methods offer convenience and reliability.\u003c\/p\u003e\n\n\u003ch2 id=\"global-impact\"\u003eGlobal Impact\u003c\/h2\u003e\n\u003cp\u003eLong-acting contraceptives like implants and IUDs have a significant impact globally. They help reduce unintended pregnancies and support planned pregnancies, which is crucial for women's health. Professor Darney emphasizes their growing popularity due to their effectiveness and safety, contributing to better health outcomes worldwide.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Philip Darney, MD:\u003c\/strong\u003e The best birth control methods are not birth control pills. However, \"the pill\" remains the most popular contraception method. Intrauterine devices and hormonal implants are the most effective and safe birth control methods. They are also cost-effective for long-term use. Both methods are completely reversible, allowing a woman to become pregnant after removal.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Darney:\u003c\/strong\u003e As you mentioned earlier, the desired pregnancy is a crucial indicator of a woman's health and the future child's health. Access to safe and effective birth control methods is vital in family planning. Oral contraceptives have been popular, but I have published extensively on the safety and efficacy of intrauterine devices and implantable contraception. The most effective contraceptives today are long-acting methods like contraceptive implants and intrauterine devices, which are more effective than surgical sterilization.\u003c\/p\u003e\n\n\u003cp\u003eBecause of their efficacy and safety, the popularity of these methods is increasing worldwide. While birth control pills have been a principal method of contraception, they are not as effective as long-acting methods. Oral contraceptives carry a risk of venous thrombosis, particularly for women already at risk, which has been a controversial issue in Western Europe.\u003c\/p\u003e\n\n\u003cp\u003eCondoms can be effective but require effort from the couple each time they are used. The same applies to vaginal methods of contraception. Long-acting contraceptives like intrauterine devices and hormonal implants offer significant advantages. Clinical trials have shown that contraceptive implants prevent teenage pregnancy and encourage planned pregnancies. Globally, 40% to 50% of pregnancies are unintended, including in the United States, but not in Western Europe.\u003c\/p\u003e\n\n\u003cp\u003eSome women experience complications or die from pregnancies they did not want, leading to premature births and neonatal mortality. Helping women plan pregnancies is crucial for women's and infant health. Intrauterine devices and hormonal implants reduce the human factor, eliminating the need to remember daily pills or condoms, thus increasing their practical efficacy.\u003c\/p\u003e\n\n\u003cp\u003eWith a contraceptive implant, you are protected from unintended pregnancy for five years without needing to do anything. Intrauterine contraceptives last even longer and are highly effective due to their mechanisms of action. They are cost-effective in the long term, despite a higher upfront cost for insertion.\u003c\/p\u003e\n\n\u003cp\u003eWhen a woman decides to have a planned pregnancy, the effects of intrauterine devices and hormonal implants are reversible. There is no evidence that intrauterine contraceptives cause pelvic infections or affect fertility. We are happy to provide teenagers who wish to avoid pregnancy with an intrauterine contraceptive if they choose.\u003c\/p\u003e\n\n\u003cp\u003eThank you for this fascinating and important conversation. The topic of reproductive health and family planning is crucial for women and families worldwide. I'm grateful for the opportunity to speak with you today.\u003c\/p\u003e\n\n\u003cp\u003eIt's been my pleasure. Thank you for your good questions.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068167836,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"aortic-valve-replacement-how-to-choose-correct-method","title":"Aortic valve replacement. How to choose correct method? 1","description":"\u003ch1\u003eChoosing the Optimal Aortic Valve Replacement Method\u003c\/h1\u003e\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#understanding-aortic-valve-replacement\"\u003eUnderstanding Aortic Valve Replacement\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#risk-factors-in-aortic-valve-surgery\"\u003eRisk Factors in Aortic Valve Surgery\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#advantages-of-the-medtronic-freestyle-valve\"\u003eAdvantages of the Medtronic Freestyle Valve\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#patient-prosthesis-mismatch-solutions\"\u003ePatient-Prosthesis Mismatch Solutions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#using-risk-scores-for-surgical-decisions\"\u003eUsing Risk Scores for Surgical Decisions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 id=\"understanding-aortic-valve-replacement\"\u003eUnderstanding Aortic Valve Replacement\u003c\/h2\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003eDr. Jürgen Ennker, MD, explains that aortic valve replacement is a critical procedure for patients with severe valve disease. The choice of surgical technique depends on the patient's specific anatomical and health conditions. Surgeons aim to replace the diseased valve with one that has a large valvular orifice to ensure optimal blood flow and recovery.\u003c\/p\u003e\n\u003ch2 id=\"risk-factors-in-aortic-valve-surgery\"\u003eRisk Factors in Aortic Valve Surgery\u003c\/h2\u003e\n\u003cp\u003eDr. Jürgen Ennker, MD, highlights that patient-specific factors, such as age, renal and pulmonary diseases, and previous heart conditions, significantly influence the risks associated with aortic valve surgery. Understanding these factors helps in tailoring the surgical approach to minimize risks and improve outcomes.\u003c\/p\u003e\n\u003ch2 id=\"advantages-of-the-medtronic-freestyle-valve\"\u003eAdvantages of the Medtronic Freestyle Valve\u003c\/h2\u003e\n\u003cp\u003eThe Medtronic Freestyle valve, discussed by Dr. Jürgen Ennker, MD, is a stentless heart valve that offers a larger internal diameter and better recovery outcomes. Its design allows for use in aortic root replacement, particularly beneficial for patients with aortic root aneurysms, enhancing patient recovery and survival rates.\u003c\/p\u003e\n\u003ch2 id=\"patient-prosthesis-mismatch-solutions\"\u003ePatient-Prosthesis Mismatch Solutions\u003c\/h2\u003e\n\u003cp\u003eFor patients with small annular diameters, Dr. Ennker recommends the Freestyle valve for its ability to accommodate aortic root enlargement. This approach reduces the risk of patient-prosthesis mismatch, leading to improved surgical outcomes compared to traditional stented valves.\u003c\/p\u003e\n\u003ch2 id=\"using-risk-scores-for-surgical-decisions\"\u003eUsing Risk Scores for Surgical Decisions\u003c\/h2\u003e\n\u003cp\u003eDr. Jürgen Ennker, MD, emphasizes the use of risk scores, such as the euroSCORE and Parsonnet score, to evaluate patient-specific risks before surgery. These scores help patients and surgeons make informed decisions about the feasibility and safety of undergoing aortic valve replacement surgery.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Let's start our conversation with aortic valve replacements. Let’s discuss the risks of aortic valve replacement surgical operation. You have done thousands of aortic valve replacement surgeries. You used several techniques of aortic valve replacement. You also carefully match the patients to the best surgical technique. There are several aortic valve replacement methods. What are the risk factors for aortic valve replacement operation? How do you match patients with a method of surgical operation? How do you minimize surgical risks for the patient?\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Jürgen Ennker, MD:\u003c\/strong\u003e Yes, it’s very important! The patient, of course, is the most important risk factor. The anatomical situation of the aortic valve is important for the surgeon to understand. Are there substantial calcifications of the heart valve? Is there only the aortic valve insufficiency? The aim is to replace the diseased valve with a valve with a very large valvular orifice.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Jürgen Ennker, MD:\u003c\/strong\u003e I found the Medtronic Freestyle aortic valve. It came on the market in 1994. Two years later, in 1996, I started to implant this aortic valve. This is a stentless heart valve. It is actually just a root of the pig valve. It has a heart valve surface treatment, so it's not antigenic. You don't need a stent. This saves you an internal diameter. A patient receives a Freestyle aortic valve. It has a larger internal diameter and a bigger intraannular space. This means less gradients and more rapid recovery of the diseased myocardium. Faster recovery of the patient after aortic valve implantation. So this is very important.\u003c\/p\u003e\n\u003cp\u003eIn addition to this, a unique feature of the Freestyle valve is that it comes as a total aortic root. So you can use it for a root replacement in patients with aortic root aneurysm. You can get rid of aortic root aneurysm by two techniques. The first one is total aortic root replacement. You resect the native aortic root of the patient. Then you have to implant again the coronary ostia. The other technique is the so-called aortic root inclusion. You implant the Freestyle heart valve inside the patient's aortic root. Of course, you have to re-implant the coronary ostia as well. So this is one indication.\u003c\/p\u003e\n\u003cp\u003eAnother indication for aortic stenosis heart surgery is this. The patient may suffer from patient-prosthesis mismatch. Patients who have a very small annular aortic valve surface (annular diameter) need an aortic root enlargement. Freestyle heart valve is excellent. It is adapted for this enlargement of the aortic root. Because you can cut into the noncoronary sinus. Then you can implant a larger Freestyle valve. It is better in comparison to a typical stented valve.\u003c\/p\u003e\n\u003cp\u003eYou can use a noncoronary sinus of the Freestyle valve as a replacement of the noncoronary sinus of the patient. Then you have enlargement by one of two grades larger than with typical normal stented heart valves. So this is a big advantage. Again, this contributes to better patient survival. Because the patient does much better after implantation of this heart valve in comparison to a routine stented aortic valve surgery.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Thank you for this very good review of the technologies to replace the aortic valve. You reviewed important heart valves that are used in aortic valve replacements. You have also identified a number of patient-side risk factors. They predict the risks of aortic valve replacement operations. In particular, the patient's age predicts the success of heart surgery. You also studied and published it extensively. What are the patient-side risk factors for aortic valve replacement surgical operation?\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Jürgen Ennker, MD:\u003c\/strong\u003e For patient risk factors, we have risk factor scores. In Europe, we are using the euroSCORE. In the United States, you are using the Parsonnet score. There are several patient-related risk factor variables. This is age, renal disease, pulmonary disease, reoperation, the state of their heart as graded by the New York Heart Association, Class 2, 3, or 4.\u003c\/p\u003e\n\u003cp\u003eAre there previous myocardial infarctions? You have a number of different variables. So you can calculate the risk score. I started working in Lahr clinic. We started to calculate the patients' risk factors for heart surgery. We are able to give a patient a risk score as a number. This score reflects a risk that the patient will have in our hospital. It is based on the experience of more than 15,000 cardiac operations. So everybody could make a decision about surgical operation. This decision is based on the patient's personal risk. It is due to the patient's personal risk factors. This is what we should tell our heart surgery patients. So that every patient can make an adequate decision whether to undergo heart surgery or not.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068200604,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"aortic-valve-replacement-in-elderly-patients","title":"Aortic valve replacement in elderly patients. How to calculate risks of surgery. 2","description":"\u003ch1\u003eAortic Valve Replacement Options for Elderly Patients\u003c\/h1\u003e\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#biological-age-vs-numerical-age\"\u003eBiological Age vs. Numerical Age\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#importance-of-patient-consent\"\u003eImportance of Patient Consent\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#risk-factors-in-elderly-surgery\"\u003eRisk Factors in Elderly Surgery\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#transcatheter-aortic-valve-implantation\"\u003eTranscatheter Aortic Valve Implantation\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#frailty-index-and-quality-of-life\"\u003eFrailty Index and Quality of Life\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 id=\"biological-age-vs-numerical-age\"\u003eBiological Age vs. Numerical Age\u003c\/h2\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003eDr. Jürgen Ennker, MD, emphasizes the distinction between biological and numerical age when considering aortic valve replacement in elderly patients. Biological age reflects a patient's physical condition and fitness level, which can significantly impact their suitability for surgery. Some patients over 80 may be biologically younger and more fit for cardiac operations, making them better candidates for surgery.\u003c\/p\u003e\n\u003ch2 id=\"importance-of-patient-consent\"\u003eImportance of Patient Consent\u003c\/h2\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003eDr. Jürgen Ennker, MD, stresses the importance of patient consent and willingness when deciding on aortic valve replacement. Patients must express a desire for the operation and be prepared to follow post-operative recommendations, such as breathing exercises and mobilization. A patient's psychological readiness and motivation are crucial for achieving successful surgical outcomes.\u003c\/p\u003e\n\u003ch2 id=\"risk-factors-in-elderly-surgery\"\u003eRisk Factors in Elderly Surgery\u003c\/h2\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003eDr. Jürgen Ennker, MD, highlights several risk factors that must be considered before proceeding with surgery in elderly patients. These include previous operations, low cardiac output, and renal disease. For patients nearing 90 with significant risk factors, conventional surgery may not be the best option. Evaluating these risks is essential to ensure patient safety and optimize surgical outcomes.\u003c\/p\u003e\n\u003ch2 id=\"transcatheter-aortic-valve-implantation\"\u003eTranscatheter Aortic Valve Implantation\u003c\/h2\u003e\n\u003cp\u003eFor patients unsuitable for conventional surgery, \u003cmeta charset=\"utf-8\"\u003eDr. Jürgen Ennker discusses the benefits of transcatheter aortic valve implantation (TAVI). This minimally invasive procedure involves placing a catheter into the groin to replace the aortic valve, eliminating the need for open-heart surgery. TAVI offers a viable alternative for high-risk patients, with approximately 50% of elderly patients in Germany undergoing this procedure.\u003c\/p\u003e\n\u003ch2 id=\"frailty-index-and-quality-of-life\"\u003eFrailty Index and Quality of Life\u003c\/h2\u003e\n\u003cp\u003eThe frailty index is a critical tool in assessing a patient's ability to withstand surgery and their overall fitness level. \u003cmeta charset=\"utf-8\"\u003eDr. Jürgen Ennker explains that this index helps determine the likelihood of a successful outcome and improved quality of life post-surgery. For elderly patients, aortic valve replacement can significantly extend life expectancy and enhance life quality, making it a valuable consideration for those who are fit and willing.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Let's discuss aortic valve replacement in elderly patients. You have very extensive experience, having published a series of 493 consecutive elderly patients in whom you performed an aortic valve replacement. In half of those patients, you also did Coronary Artery Bypass Grafting (CABG), either close to the time of aortic valve replacement surgery or together. These are patients who are over 80 years of age.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003eDr. Jürgen Ennker, MD:\u003c\/strong\u003e What have you learned from your very large experience about heart surgery in elderly patients? What is the best way, how do you approach in your practice aortic valve replacement in elderly patients over 80 years of age?\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003eDr. Jürgen Ennker, MD:\u003c\/strong\u003e First, we have to differentiate between the biological age and the numerical age, because you have patients who are biologically much younger, and they are more fit for a cardiac operation. Second, you always have to listen to the patient. If the patient says, \"I'm too old, this is nothing for me,\" don't force the patient into any operation. The patient has to want this operation and follow the recommendations for post-operative care. They need to cough, breathe, and mobilize themselves to achieve an adequate result.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003eDr. Jürgen Ennker, MD:\u003c\/strong\u003e We also have to consider the risk factors. If a patient is nearly 90, has had previous operations, is in low cardiac output, or has renal disease, surgery may not be an adequate solution. Fortunately, for patients who are inoperable by conventional surgery, we have the TAVI technique, transcatheter aortic valve implantation. We can place a catheter into the groin, bring the valve into the patient's aortic annulus, and replace the valve without a regular operation, just the catheter procedure.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003eDr. Jürgen Ennker, MD:\u003c\/strong\u003e This is taking place in Germany right now. About 50% are operated interventionally by such a TAVI procedure, and the other half undergo a conventional procedure. Patients over 80 have to make up their minds because, for example, a man in Germany at 80 has a life expectancy of 6.9 years, and women have about 8 years. Without such an operation, they will lose several years full of quality life.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003eDr. Jürgen Ennker, MD:\u003c\/strong\u003e So this is very important. It's not just a question of biological age, but it's a question of the patient's fitness and psychological desire to undergo an operation and have a higher quality of life.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003eDr. Jürgen Ennker, MD:\u003c\/strong\u003e Absolutely! We have the so-called frailty index, which measures the ability of the patient to survive such an operation and their level of fitness, and this is very important.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068233372,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"aortic-valve-replacement-pig-or-bovine-aortic-valve","title":"Aortic Valve Replacement. Pig or bovine aortic valve. Or mechanical aortic Valve. How to choose? 3","description":"\u003ch1\u003eMechanical vs. Biological Aortic Valve Replacement: Key Factors for Patient Safety\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#mechanical-valve-risks-bleeding-and-thrombosis\"\u003eMechanical Valve Risks: Bleeding and Thrombosis\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#biological-valve-advantages-no-anticoagulation-needed\"\u003eBiological Valve Advantages: No Anticoagulation Needed\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#age-threshold-changes-younger-patients-now-eligible\"\u003eAge Threshold Changes: Younger Patients Now Eligible\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#reoperation-safety-low-mortality-rates\"\u003eReoperation Safety: Low Mortality Rates\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#valve-failure-differences-emergency-vs-planned-surgery\"\u003eValve Failure Differences: Emergency vs. Planned Surgery\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#patient-decision-making-anticoagulation-vs-future-interventions\"\u003ePatient Decision-Making: Anticoagulation vs. Future Interventions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"mechanical-valve-risks-bleeding-and-thrombosis\"\u003eMechanical Valve Risks: Bleeding and Thrombosis\u003c\/h2\u003e\n\u003cp\u003eDr. Juergen Ennker, MD, emphasizes that mechanical aortic valves require lifelong anticoagulation therapy, posing significant risks. Elderly patients face higher fall-related bleeding dangers, while inconsistent medication use can lead to valve thrombosis—a life-threatening emergency. Historical data shows a 0.7%–1% annual complication rate, accumulating to 7%–10% over a decade.\u003c\/p\u003e\n\n\u003ch2 id=\"biological-valve-advantages-no-anticoagulation-needed\"\u003eBiological Valve Advantages: No Anticoagulation Needed\u003c\/h2\u003e\n\u003cp\u003eBiological valves (pig or bovine) eliminate the need for blood thinners, reducing stroke and embolism risks. Dr. Juergen Ennker, MD, notes patients only require 100mg aspirin daily—a regimen also beneficial for cardiovascular prevention in adults over 50. The Medtronic Freestyle valve exemplifies this low-maintenance option.\u003c\/p\u003e\n\n\u003ch2 id=\"age-threshold-changes-younger-patients-now-eligible\"\u003eAge Threshold Changes: Younger Patients Now Eligible\u003c\/h2\u003e\n\u003cp\u003ePreviously reserved for patients over 70, biological valves are now implanted in 50-year-olds. Dr. Juergen Ennker, MD, explains that modern reoperation safety makes 10–15 years of anticoagulation-free life preferable, even if future replacement becomes necessary. This paradigm shift reflects improved surgical outcomes and valve durability.\u003c\/p\u003e\n\n\u003ch2 id=\"reoperation-safety-low-mortality-rates\"\u003eReoperation Safety: Low Mortality Rates\u003c\/h2\u003e\n\u003cp\u003eRepeat aortic valve surgeries now carry just 1%–3% mortality risk—comparable to initial operations. Dr. Juergen Ennker, MD, highlights this as a key factor in choosing biological valves for younger patients, as the cumulative risks of long-term anticoagulation often outweigh surgical risks.\u003c\/p\u003e\n\n\u003ch2 id=\"valve-failure-differences-emergency-vs-planned-surgery\"\u003eValve Failure Differences: Emergency vs. Planned Surgery\u003c\/h2\u003e\n\u003cp\u003eMechanical valve failure causes acute thrombosis requiring emergency care, while biological valve deterioration (e.g., leaflet tearing) allows for planned intervention. Dr. Juergen Ennker, MD, stresses this critical safety difference: tissue valve patients avoid sudden crises and can consider transcatheter options like TAVI for subsequent treatment.\u003c\/p\u003e\n\n\u003ch2 id=\"patient-decision-making-anticoagulation-vs-future-interventions\"\u003ePatient Decision-Making: Anticoagulation vs. Future Interventions\u003c\/h2\u003e\n\u003cp\u003eDr. Ennker advocates personalized choice: patients must weigh daily anticoagulation against potential future surgeries. Younger patients may prefer biological valves despite possible reoperations, while older adults benefit from avoiding blood thinners altogether. Shared decision-making ensures alignment with lifestyle and risk tolerance.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Aortic valve replacement with a mechanical valve requires anti-coagulation therapy. Use of blood-thinning medications is particularly dangerous in elderly people. They have a higher risk of falls.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e You have studied the risks of using mechanical and tissue aortic valves in aortic valve replacement surgery. What is your method of aortic valve replacement?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e What factors influence your choice of tissue aortic valve or mechanical aortic valve? How to choose the best type of aortic valve for replacement, especially in elderly patients?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Juergen Ennker, MD:\u003c\/strong\u003e This is a very important point. 20 years ago we started surgery in our institution. We implanted more than 90% mechanical valves. Now it's just the other way around.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Juergen Ennker, MD:\u003c\/strong\u003e Why did this happen? The risk of anti-coagulation is bleeding, cerebral infarction, embolism. If the patient is not taking the medication correctly, he may get a thrombosed heart valve. That is an emergency situation because the valve will be obstructed. The patient will have risk of embolism of thrombotic material.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Juergen Ennker, MD:\u003c\/strong\u003e We have patients who are not able to take their medication correctly. This leads to a risk of 0.7% to 1% complications per year. After 10 years we have 7% to 10% risk of aortic valve thrombosis. This led us to the current practice that more patients are getting biological aortic valves.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Juergen Ennker, MD:\u003c\/strong\u003e You don't need oral anti-coagulation with a Medtronic Freestyle valve. This is true with other models of biological heart valves. These patients only get 100 milligrams of aspirin per day. Aspirin is also recommended for patients older than 50 years. It's a relatively low dose of aspirin.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Juergen Ennker, MD:\u003c\/strong\u003e Absolutely, that's a very low dose. Actually I'm taking aspirin myself because I'm over 50 now. Medical articles in The New England Journal of Medicine say you get less cerebral infarction and less myocardial infarctions if you take aspirin.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Juergen Ennker, MD:\u003c\/strong\u003e We should come back to the aortic heart valves. In previous times, patients received only biological valves when they were older than 70 years of age. The idea was that the heart valve would be more durable than the life expectancy. Because the surgeons or the patients were afraid of re-operations.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Juergen Ennker, MD:\u003c\/strong\u003e Nowadays re-operation is not such a big risk. For example, we implant biological aortic heart valves also in patients of 50 years of age. If the heart valve fails after 10 or 15 years, the patient enjoyed 10 or 15 years without oral anti-coagulation. He did not have any problems. Then we will see how the medical technology will be developed.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Juergen Ennker, MD:\u003c\/strong\u003e If you have a patient 65 years of age, a re-operation is not as big a problem as it used to be. Repeat surgical operation should have the same risk, the same mortality, as the first operation. The risk of death is 1% or 2%. At least it is less than 3%. And patient is saved several percent of complications.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Juergen Ennker, MD:\u003c\/strong\u003e This would happen if a patient would have used oral anti-coagulation. So we're using biological heart valves in younger patients. We don't wait until the age of 70.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e What happens if a biological heart valve fails? Most of the time a heart valve leaflet will tear. Then patient develops cardiac insufficiency, he gets shortness of breath. But this is not a cardiac emergency. This has to be operated the same day due to the risk of embolism or thrombosis.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e So basically a patient with a tissue valve has a little bit more time to get an appropriate operation as a planned operation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Juergen Ennker, MD:\u003c\/strong\u003e Absolutely, that's the point. Patient can make a decision.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Does he want to have another cardiac operation? If he is 70 or 75 years of age, does he want to have a transcatheter aortic valve implantation? There is more time for reconsideration.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e So in your hands it looks like the tissue aortic valves are really gaining our confidence. There is a wider use of indications at the younger age for pig or cow aortic heart valves for replacement.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Juergen Ennker, MD:\u003c\/strong\u003e Yes, but there are other publications who will state that even at a younger age, mechanical heart valves are adequate. So we should inform our patients and they should make their own decision.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Do they want to take oral anti-coagulation every day? Or do they want to wait what happens to their implanted biological heart valve without having oral anti-coagulation?\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068298908,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"coronary-artery-bypass-grafting-surgery-on-a-beating-heart","title":"Coronary Artery Bypass Grafting surgery on a beating heart. Off-pump CABG. 4","description":"\u003ch1\u003eOff-Pump Coronary Artery Bypass Grafting: Benefits and Risks\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"#off-pump-heart-surgery-an-overview\"\u003eOff-Pump Heart Surgery: An Overview\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#advantages-of-off-pump-cabg\"\u003eAdvantages of Off-Pump CABG\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#reducing-stroke-risk-in-cabg\"\u003eReducing Stroke Risk in CABG\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#importance-of-surgical-expertise\"\u003eImportance of Surgical Expertise\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#patient-outcomes-and-safety\"\u003ePatient Outcomes and Safety\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"off-pump-heart-surgery\"\u003eOff-Pump Heart Surgery: An Overview\u003c\/h2\u003e\n\u003cp\u003eDr. Jürgen Ennker, MD, describes the evolution of off-pump heart surgery, which began in the 1990s in South America and later spread to North America and Europe. This technique, known as OPCAB, allows surgeons to perform coronary artery bypass grafting on a beating heart without using a heart-lung machine. The procedure involves grafting all three coronary vessels while the heart continues to beat, avoiding the complications associated with the heart-lung machine.\u003c\/p\u003e\n\n\u003ch2 id=\"advantages-of-off-pump-cabg\"\u003eAdvantages of Off-Pump CABG\u003c\/h2\u003e\n\u003cp\u003eOff-pump CABG offers significant advantages, particularly for patients with renal or pulmonary diseases. Dr. Ennker highlights that avoiding the heart-lung machine reduces the risk of cerebral edema and mental deficiencies. Patients undergoing off-pump CABG often experience a quicker recovery, similar to that of an appendectomy, without the neurological side effects associated with traditional on-pump surgery.\u003c\/p\u003e\n\n\u003ch2 id=\"reducing-stroke-risk\"\u003eReducing Stroke Risk in CABG\u003c\/h2\u003e\n\u003cp\u003eDr. Ennker emphasizes the reduced risk of stroke with off-pump CABG due to the \"aortic no-touch\" technique. By avoiding aortic manipulation, the risk of embolism and subsequent cerebral infarction is minimized. This approach, combined with the resection of the left atrium to prevent embolism from atrial fibrillation, significantly lowers the incidence of stroke in patients undergoing this procedure.\u003c\/p\u003e\n\n\u003ch2 id=\"surgical-expertise\"\u003eImportance of Surgical Expertise\u003c\/h2\u003e\n\u003cp\u003eDr. Jürgen Ennker, MD, stresses the critical role of surgical expertise in the success of off-pump CABG. The procedure requires precise technique and experience to ensure the patency and functionality of arterial grafts. Advanced tools and techniques, such as measuring blood flow and graft patency, help surgeons achieve optimal outcomes and enhance patient safety.\u003c\/p\u003e\n\n\u003ch2 id=\"patient-outcomes\"\u003ePatient Outcomes and Safety\u003c\/h2\u003e\n\u003cp\u003eOff-pump CABG is associated with improved patient outcomes, particularly for those with severe comorbidities. Dr. Ennker notes that maintaining blood pressure and heart function during surgery provides real-time feedback, ensuring the safety and effectiveness of the procedure. Patients benefit from reduced neurological complications and a faster recovery, making off-pump CABG a valuable option for high-risk individuals.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e You have performed tens of thousands of procedures. You have a particular interest in off-pump coronary artery bypass graft surgery. This is a surgery on a beating heart. It's more demanding from the surgeon technically, but off-pump coronary artery bypass graft surgery has advantages for patients. Please compare the risks and benefits of off-pump coronary artery bypass graft surgery and on-pump coronary artery bypass graft surgery. It is the classical technique of surgical operation. Tell us about your experience with this advanced technique of coronary artery bypass grafting.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Jürgen Ennker, MD:\u003c\/strong\u003e The off-pump heart surgery was introduced in the 1990s in South America. It came to developed countries in North America and Europe with the so-called MIDCAB operation. This is a small incision on the lateral chest to do a revascularization of the left anterior descending artery. From this so-called OPCAB procedure, an off-pump coronary artery beating heart procedure was developed. You can graft all three vessels on the beating heart.\u003c\/p\u003e\n\n\u003cp\u003eThe advantage is that you don't need the heart-lung machine. This is what the \"off-pump\" name says. Because you have to cannulate the aorta to use the heart-lung machine, this may lead to a dislodgement of debris of aortic plaque. This may lead to embolism, which in turn may lead to a cerebral infarction. Coronary artery patients were analyzed in the SYNTAX clinical trial. The brain stroke rate was 2.2%.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Jürgen Ennker, MD:\u003c\/strong\u003e But you can use the off-pump heart surgery technique. You can do that with the so-called T-graft. You implant the LIMA to the LAD. Then a second graft is implanted into the LIMA. This is done with the so-called aortic no-touch technique. You don't perform an aortic anastomosis. You have zero strokes. You have absolutely no cerebral infarction generated by the heart surgery. It's a huge deal!\u003c\/p\u003e\n\n\u003cp\u003eWe can decrease the risk of stroke with off-pump coronary artery bypass graft surgery. We will talk about that in a second. It is a very big deal! Yes! I'm doing off-pump coronary artery bypass graft surgery. I'm always resecting the left atrium of the heart. Because 90% of embolism from the left heart comes from the left atrium.\u003c\/p\u003e\n\n\u003cp\u003eBecause in atrial fibrillation, we have a thrombus formation. Sometimes the patient gets back into the sinus rhythm. Then the thrombus is ejected. You have brain embolism (stroke). When you resect the left heart atrium, you are eliminating the risk of brain stroke as well. So, this is another point. No aortic touch, resection of the left atrium, and then you have two major risk factors eliminated. This may lead to cerebral strokes and other neurological complications.\u003c\/p\u003e\n\n\u003cp\u003eThe off-pump procedure has many advantages. They are related not only to a neurologic outcome. It can be done in patients with major deficiencies. You can do off-pump coronary artery bypass graft surgery on patients with renal disease, with pulmonary disease. The avoidance of the heart-lung machine leads to a substantial advantage. This has been proven by literature.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Of course, you need an experienced cardiac surgeon. The surgical technique has to be adequate. But we have several tools nowadays. We are measuring the blood flow in the artery graft. We are measuring the patency of the arterial graft and the flow in it. You can exactly say that this arterial graft is patent.\u003c\/p\u003e\n\n\u003cp\u003eThe literature says that 10 to 15% of the coronary artery anastomosis have technical defects. You can detect problems in arterial anastomosis immediately. It does not happen later in the intensive care via ECG or cardiac enzymes. This is a big step towards patient safety.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Jürgen Ennker, MD:\u003c\/strong\u003e OPCAB surgery always maintains the blood pressure. You have the running ECG. You have the contracting heart. These are also parameters to tell you that you're on the safe side. You can be confident that your anastomosis is technically adequate. You can have confidence that the patient is going to do well in the long run.\u003c\/p\u003e\n\n\u003cp\u003eSo, you have feedback from the patient's body, from the heart, during that duration. This is also a significant advantage. That's exactly the point. The patients wake up in the same condition as after appendectomy. After heart-lung machine use in coronary bypass graft surgery, patients are sent into a CT scan. Doctors see a cerebral edema that lasts for some period of time. You have mental deficiencies caused by the heart-lung machine. All these are detrimental factors for the patient.\u003c\/p\u003e\n\n\u003cp\u003eYou don't have these brain swelling problems with OPCAB surgery. So it's a big step ahead. Off-pump CABG has major advantages for severely ill patients. Off-pump coronary artery bypass graft surgery is better for patients with neurological deficits. Those are the advantages. Patients profit very much from OPCAB surgery. But the key factor is a surgeon.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e The surgeon is the most important prognostic factor for the patient. There are also patient-related surgery risk factors, of course.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068331676,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"dr-juergen-ennker-cardiac-surgeon-biography-0","title":"Dr. Juergen Ennker. Cardiac Surgeon. Biography. 0","description":"\u003ch1\u003eDr. Jürgen Ennker's Contributions to Cardiac Surgery and Clinical Outcomes\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#extensive-experience-in-heart-surgery\"\u003eExtensive Experience in Heart Surgery\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#academic-role-at-university-of-witten-herdecke\"\u003eAcademic Role at University of Witten-Herdecke\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#pioneering-clinical-outcomes-research\"\u003ePioneering Clinical Outcomes Research\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#education-and-training-in-cardiac-surgery\"\u003eEducation and Training in Cardiac Surgery\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#prolific-author-in-cardiac-surgery\"\u003eProlific Author in Cardiac Surgery\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"extensive-experience-in-heart-surgery\"\u003eExtensive Experience in Heart Surgery\u003c\/h2\u003e\n\u003cp\u003eDr. Jürgen Ennker, MD, is recognized as one of Germany's most experienced heart surgeons. His clinical practice spans several hospitals, where he has performed numerous complex cardiac surgeries. Dr. Ennker's expertise in heart surgery has earned him a reputation for excellence and innovation in the field.\u003c\/p\u003e\n\n\u003ch2 id=\"academic-role-at-university-of-witten-herdecke\"\u003eAcademic Role at University of Witten-Herdecke\u003c\/h2\u003e\n\u003cp\u003eAs a professor at the University of Witten-Herdecke, Dr. Jürgen Ennker, MD, plays a crucial role in educating the next generation of cardiac surgeons. His academic contributions include mentoring students and conducting research that advances the field of cardiac surgery.\u003c\/p\u003e\n\n\u003ch2 id=\"pioneering-clinical-outcomes-research\"\u003ePioneering Clinical Outcomes Research\u003c\/h2\u003e\n\u003cp\u003eDr. Jürgen Ennker, MD, is a pioneer in the study of clinical outcomes in cardiac surgery. His research focuses on improving surgical results and patient care. Dr. Ennker's work in this area has set new standards for evaluating and enhancing the effectiveness of cardiac procedures.\u003c\/p\u003e\n\n\u003ch2 id=\"education-and-training-in-cardiac-surgery\"\u003eEducation and Training in Cardiac Surgery\u003c\/h2\u003e\n\u003cp\u003eDr. Jürgen Ennker, MD, graduated from the University of Hannover and received extensive training in cardiac surgery in Berlin and Lahr-Baden. His dedication to education and training laid the foundation for his successful career and the establishment of a cardiac surgery center of excellence.\u003c\/p\u003e\n\n\u003ch2 id=\"prolific-author-in-cardiac-surgery\"\u003eProlific Author in Cardiac Surgery\u003c\/h2\u003e\n\u003cp\u003eDr. Jürgen Ennker, MD, has authored hundreds of peer-reviewed articles and over 20 books on cardiac surgery and healthy lifestyle. His publications provide valuable insights into surgical techniques and patient care, contributing to the global body of knowledge in cardiac surgery.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Hello! Today we are with Dr. Jurgen Ennker, who is one of the most experienced heart surgeons in Germany. Dr. Jürgen Ennker, MD is a professor at the University of Witten-Herdecke in Germany and has extensive clinical practice at several hospitals.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Dr. Jürgen Ennker, MD is also well-known in Germany as a pioneer in studying results of surgery, called clinical outcomes. Dr. Ennker graduated from the University of Hannover in Germany. He had extensive training in cardiac surgery in Berlin and in Lahr-Baden, where he founded a cardiac surgery center of excellence.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Dr. Jürgen Ennker, MD is an author of hundreds of peer-reviewed articles about cardiac surgery and over 20 books on cardiac surgery and on healthy lifestyle. Dr. Ennker, hello, and welcome.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Jürgen Ennker, MD:\u003c\/strong\u003e Hello!\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068364444,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"risk-of-stroke-during-heart-surgery-how-to-predict-5","title":"Risk of stroke during heart surgery. How to predict? 5","description":"\u003ch1\u003ePredicting Stroke Risk in Cardiac Surgery: The Role of White Blood Cell Counts\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#importance-of-stroke-risk-prediction\"\u003eImportance of Stroke Risk Prediction\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#white-blood-cell-counts-and-stroke-risk\"\u003eWhite Blood Cell Counts and Stroke Risk\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#advanced-surgical-techniques\"\u003eAdvanced Surgical Techniques\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#patient-related-factors\"\u003ePatient-Related Factors\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#preparing-for-surgery\"\u003ePreparing for Surgery\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"importance-of-stroke-risk-prediction\"\u003eImportance of Stroke Risk Prediction\u003c\/h2\u003e\n\u003cp\u003eDr. Jürgen Ennker, MD, emphasizes the critical need to predict stroke risk in cardiac surgery patients. Stroke is a feared complication that can have devastating consequences. By identifying patients at higher risk, healthcare providers can implement strategies to minimize the likelihood of stroke and improve surgical outcomes.\u003c\/p\u003e\n\n\u003ch2 id=\"white-blood-cell-counts-and-stroke-risk\"\u003eWhite Blood Cell Counts and Stroke Risk\u003c\/h2\u003e\n\u003cp\u003eDr. Ennker explains that elevated white blood cell (WBC) counts before heart surgery may indicate an increased risk of stroke. A higher WBC count can suggest altered hemostasis and blood flow, both of which are risk factors for cerebral stroke. Monitoring WBC counts allows for early intervention and risk mitigation.\u003c\/p\u003e\n\n\u003ch2 id=\"advanced-surgical-techniques\"\u003eAdvanced Surgical Techniques\u003c\/h2\u003e\n\u003cp\u003eDr. Ennker discusses how advanced surgical techniques, such as off-pump coronary artery bypass grafting, have significantly reduced the risk of stroke during heart surgery. These techniques help minimize complications and improve patient safety, highlighting the importance of continuous innovation in cardiac surgery.\u003c\/p\u003e\n\n\u003ch2 id=\"patient-related-factors\"\u003ePatient-Related Factors\u003c\/h2\u003e\n\u003cp\u003eDr. Ennker notes that patient-related factors, including baseline WBC counts, play a crucial role in assessing stroke risk. A strong increase in WBC counts may necessitate additional precautions, such as blood dilution, to manage stroke risk effectively. Understanding individual patient profiles is essential for tailored care.\u003c\/p\u003e\n\n\u003ch2 id=\"preparing-for-surgery\"\u003ePreparing for Surgery\u003c\/h2\u003e\n\u003cp\u003eDr. Ennker emphasizes the importance of thorough preparation for patients with elevated stroke risk. By identifying risk factors early, healthcare providers can implement targeted interventions to reduce stroke risk and enhance surgical outcomes. This proactive approach is vital for achieving better patient results.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Stroke is a risk factor in cardiac surgery. You have published important research. It found that higher than usual white blood cell (WBC) count, the leukocyte count, before the heart surgery might signify increased risk of stroke after surgery. Stroke after cardiac surgery is a very devastating complication. Stroke is a very feared complication. Through advanced use of surgical techniques, the risk of stroke decreased.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Jürgen Ennker, MD:\u003c\/strong\u003e There is off-pump coronary artery bypass grafting. As you mentioned, you decrease the risk of stroke significantly. But predicting patients who are at increased risk of stroke is very important.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Please tell us more about your work. How can you predict the risk of stroke in patients? Can stroke risk be predicted by white blood cell count numbers?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Jürgen Ennker, MD:\u003c\/strong\u003e Yes, again, you have patient-related factors. White cell count is one of them. You may have an increase in the white cell count. You have altered hemostasis, and the blood flow is different. This is one of the risk factors that may lead to an increased risk of cerebral stroke. We are measuring the white blood cell count, and we can prepare adequate precautions to diminish the risk of stroke. We aim to have a better patient outcome.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Is there a particular WBC leukocyte count range when you start to get concerned? Does it depend on what is the patient’s white blood cell count at a baseline? How do you assess that?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Jürgen Ennker, MD:\u003c\/strong\u003e If you have a strong increase in the white cell count, we have to dilute the blood. We have to look for other risk factors. We have to prepare the patient even more than usual.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068429980,"sku":"","price":0.0,"currency_code":"USD","in_stock":false}]},{"product_id":"aortic-valve-replacement-stented-or-stentless-aortic-valves-6","title":"Aortic valve replacement. Stented or stentless aortic valves? 6","description":"\u003ch1\u003eChoosing Between Stented and Stentless Aortic Valves for Replacement\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#differences-between-stented-and-stentless-aortic-valves\"\u003eDifferences Between Stented and Stentless Aortic Valves\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#selecting-the-right-aortic-valve-for-patients\"\u003eSelecting the Right Aortic Valve for Patients\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#advantages-of-stentless-aortic-valves\"\u003eAdvantages of Stentless Aortic Valves\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#evolutionary-benefits-of-stentless-valves\"\u003eEvolutionary Benefits of Stentless Valves\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#clinical-outcomes-and-patient-feedback\"\u003eClinical Outcomes and Patient Feedback\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"differences-between-stented-and-stentless-aortic-valves\"\u003eDifferences Between Stented and Stentless Aortic Valves\u003c\/h2\u003e\n\u003cp\u003eDr. Jürgen Ennker, MD, explains that stented and stentless aortic valves differ primarily in their design and origin. Stented valves are man-made and have been developed over the last 40 to 50 years. In contrast, stentless valves are derived from pig aortic roots, reflecting millions of years of evolution. This natural design allows stentless valves to be implanted in larger sizes compared to stented valves, offering better compatibility with the patient's aortic annulus.\u003c\/p\u003e\n\n\u003ch2 id=\"selecting-the-right-aortic-valve-for-patients\"\u003eSelecting the Right Aortic Valve for Patients\u003c\/h2\u003e\n\u003cp\u003eDr. Ennker predominantly uses stentless valves in over 98% of his patients. He reserves stented valves for cases where patients require mitral valve replacement, as the presence of a mitral valve can distort the aortic annulus, leading to insufficiency in stentless valves. The choice of valve type is crucial for ensuring optimal fit and function in each patient.\u003c\/p\u003e\n\n\u003ch2 id=\"advantages-of-stentless-aortic-valves\"\u003eAdvantages of Stentless Aortic Valves\u003c\/h2\u003e\n\u003cp\u003eStentless aortic valves offer several advantages, according to Dr. Ennker. These include a larger valve size that fits better within the aortic annulus, a decreased transvalvular gradient, and a reduced risk of patient-prosthesis mismatch. These benefits contribute to improved hemodynamics and patient outcomes following valve replacement surgery.\u003c\/p\u003e\n\n\u003ch2 id=\"evolutionary-benefits-of-stentless-valves\"\u003eEvolutionary Benefits of Stentless Valves\u003c\/h2\u003e\n\u003cp\u003eDr. Ennker believes that the evolutionary design of stentless valves provides a significant advantage over stented valves. The natural structure of the pig aortic root has been refined over millions of years, offering a design that is inherently well-suited for human use. This contrasts with the relatively recent development of stented valves, which may not match the evolutionary sophistication of their stentless counterparts.\u003c\/p\u003e\n\n\u003ch2 id=\"clinical-outcomes-and-patient-feedback\"\u003eClinical Outcomes and Patient Feedback\u003c\/h2\u003e\n\u003cp\u003eDr. Ennker reports positive clinical outcomes and patient feedback with the use of stentless aortic valves. Patients often seek out these valves due to their benefits, such as the ability to eliminate aortic root aneurysms when implanted as a full root. The feedback from patients and cardiologists supports the preference for stentless valves in suitable cases, reinforcing their role in modern heart valve replacement surgery.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Let's talk about the types of aortic valves for heart valve replacement that you use. There are stented versus stentless aortic valves. You have a particular interest in determining the best type of prosthetic heart valve for individual patients. You have studied the performance of stented versus stentless aortic valves in aortic valve replacement surgery. How do these types of heart valves differ from each other?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e How do you decide which patient should get which type of aortic valve for replacement?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Jürgen Ennker, MD:\u003c\/strong\u003e I use a stentless valve predominately in more than 98% of patients. I only use a stented valve in patients who have to receive mitral valves because then the aortic annulus is distorted by the mitral valve. This results in the insufficiency of the stentless heart valve. In all other cases, I use stentless heart valves.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Jürgen Ennker, MD:\u003c\/strong\u003e Because you don't have the stent in the heart valve, this leads to the fact that you can implant a stentless valve. This valve is one to two sizes larger than a typical stented valve. This would fit into this specific patient's aortic annulus.\u003c\/p\u003e\n\n\u003cp\u003eThese stentless valves were created by nature. It's the pig aortic root. This was produced by evolution. Millions of years of evolution created this valve. Stented aortic valves are created by man over the last 40 or 50 years.\u003c\/p\u003e\n\n\u003cp\u003eSo, I've made up my mind. I think evolution is smarter than we are within 30 or 40 years. The follow-up with the patient and the feedback I receive from my patients and from my cardiologists support this view.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Jürgen Ennker, MD:\u003c\/strong\u003e Patients come exactly for this stentless aortic valve because they have an enlarged aortic annulus. They have a decreased transvalvular gradient. We also have a smaller percentage of patient-prosthesis mismatch.\u003c\/p\u003e\n\n\u003cp\u003eWe can eliminate aortic root aneurysms by implanting a freestyle valve as a full root. This is a big advantage for the patient.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068462748,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"dr-philip-darney-obstetrics-and-reproductive-gynecology-biography-0","title":"Dr. Philip Darney. Obstetrics and Reproductive Gynecology. Biography. 0","description":"\u003ch1\u003eDr. Philip Darney's Impact on Reproductive Health and Gynecology\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#academic-career-and-contributions\"\u003eAcademic Career and Contributions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#leadership-roles-in-reproductive-health\"\u003eLeadership Roles in Reproductive Health\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#research-focus-on-womens-health\"\u003eResearch Focus on Women's Health\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#publications-and-books\"\u003ePublications and Books\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#global-impact-on-family-planning\"\u003eGlobal Impact on Family Planning\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"academic-career-and-contributions\"\u003eAcademic Career and Contributions\u003c\/h2\u003e\n\u003cp\u003eDr. Philip Darney's academic career is marked by his tenure at several prestigious institutions. He is a Distinguished Professor at the University of California, San Francisco, where he has significantly contributed to the fields of obstetrics, gynecology, and reproductive sciences. Dr. Darney's educational background includes an undergraduate degree in experimental psychology from the University of California at Berkeley and an MD from UCSF. He furthered his studies with a Master of Sciences at the London School of Hygiene and Tropical Medicine.\u003c\/p\u003e\n\n\u003ch2 id=\"leadership-roles-in-reproductive-health\"\u003eLeadership Roles in Reproductive Health\u003c\/h2\u003e\n\u003cp\u003eDr. Darney has held numerous leadership positions that have shaped reproductive health policies. He is the Director of the Bixby Center for Global Reproductive Health at UCSF and a former Chief of Obstetrics and Gynecology at San Francisco General Hospital. His leadership extends to his service on the medical faculties at Harvard University and the Oregon Health Sciences University, where he has influenced many in the field of reproductive health.\u003c\/p\u003e\n\n\u003ch2 id=\"research-focus-on-womens-health\"\u003eResearch Focus on Women's Health\u003c\/h2\u003e\n\u003cp\u003eDr. Darney's research interests lie in global reproductive health, preventive medicine, and women's health and family planning. His work has been instrumental in advancing understanding and practices in these areas. Dr. Darney's research efforts are supported by his residency and fellowship training at the Brigham and Women's Hospital in Boston and the Centers for Disease Control in Atlanta, where he honed his expertise in reproductive sciences.\u003c\/p\u003e\n\n\u003ch2 id=\"publications-and-books\"\u003ePublications and Books\u003c\/h2\u003e\n\u003cp\u003eWith over 200 scientific articles and reviews, Dr. Philip Darney has made substantial contributions to the literature on family planning and reproductive health. He is also the author of three influential books that provide valuable insights into family planning practices and policies. His publications are widely recognized for their impact on both academic and clinical practices in reproductive health.\u003c\/p\u003e\n\n\u003ch2 id=\"global-impact-on-family-planning\"\u003eGlobal Impact on Family Planning\u003c\/h2\u003e\n\u003cp\u003eDr. Darney's work has had a profound global impact, particularly in the area of family planning. Through his leadership at the Bixby Center for Global Reproductive Health, he has contributed to the development of policies and practices that improve reproductive health outcomes worldwide. Dr. Darney's efforts in preventive medicine and women's health continue to influence global health strategies and improve the lives of women and families around the world.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Hello from San Francisco, California! Today we are with Dr. Philip Darney. He is a Distinguished Professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences. Dr. Philip Darney, MD, is the Director of the Bixby Center for Global Reproductive Health at the University of California, San Francisco. He is also a former Chief of Obstetrics and Gynecology at San Francisco General Hospital.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Dr. Darney received an undergraduate degree in experimental psychology from the University of California at Berkeley, his MD at UCSF, and a Master of Sciences at the London School of Hygiene and Tropical Medicine. Dr. Philip Darney, MD, completed his residency and fellowship training at the Brigham and Women's Hospital in Boston and the Centers for Disease Control in Atlanta.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Dr. Darney's clinical and research interests are in global reproductive health, preventive medicine, women's health, and family planning. He is the author of more than 200 scientific articles and reviews, as well as three books on family planning. Dr. Darney, hello and thank you, and welcome!\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Philip Darney, MD:\u003c\/strong\u003e Good morning!\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068495516,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"dr-dale-adler-cardiology-expert-biography-0","title":"Dr. Dale Adler. Cardiology expert. Biography. 0","description":"\u003ch1\u003eUnderstanding Complex Coronary Artery Disease and Valvular Heart Disease\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#dr-dale-adlers-expertise-in-cardiology\"\u003eDr. Dale Adler's Expertise in Cardiology\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#educational-background-and-training\"\u003eEducational Background and Training\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#clinical-and-research-interests\"\u003eClinical and Research Interests\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#experience-in-healthcare-management\"\u003eExperience in Healthcare Management\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#integrating-hospital-networks\"\u003eIntegrating Hospital Networks\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"dr-dale-adlers-expertise-in-cardiology\"\u003eDr. Dale Adler's Expertise in Cardiology\u003c\/h2\u003e\n\u003cp\u003eDr. Dale Adler, MD, is a world-class expert in the diagnosis and medical treatment of complex coronary artery disease. His specialization extends to valvular heart disease, where he is renowned for his medical therapy approaches. Dr. Adler's expertise is recognized globally, making significant impacts on patient care and treatment outcomes.\u003c\/p\u003e\n\n\u003ch2 id=\"educational-background-and-training\"\u003eEducational Background and Training\u003c\/h2\u003e\n\u003cp\u003eDr. Dale Adler, MD, received his medical degree from Weill Medical College of Cornell University. He completed his residency in internal medicine and fellowship in cardiovascular medicine at Brigham and Women's Hospital in Boston. This rigorous training laid the foundation for his distinguished career in cardiology.\u003c\/p\u003e\n\n\u003ch2 id=\"clinical-and-research-interests\"\u003eClinical and Research Interests\u003c\/h2\u003e\n\u003cp\u003eDr. Adler's clinical and research interests focus on cardiovascular disease, particularly complex coronary artery disease and diabetic heart disease. His work aims to advance prevention strategies and improve treatment protocols for these conditions. Dr. Adler's contributions to valvular heart disease research are also noteworthy.\u003c\/p\u003e\n\n\u003ch2 id=\"experience-in-healthcare-management\"\u003eExperience in Healthcare Management\u003c\/h2\u003e\n\u003cp\u003eBeyond his clinical expertise, Dr. Dale Adler, MD, has extensive experience in managing healthcare organizations. His leadership roles have involved overseeing medical departments and ensuring the delivery of high-quality patient care. Dr. Adler's management skills are instrumental in optimizing healthcare operations.\u003c\/p\u003e\n\n\u003ch2 id=\"integrating-hospital-networks\"\u003eIntegrating Hospital Networks\u003c\/h2\u003e\n\u003cp\u003eDr. Adler's role in integrating hospital networks highlights his ability to enhance collaboration and efficiency within healthcare systems. His efforts in this area aim to streamline processes and improve patient outcomes across multiple facilities. Dr. Adler's work in network integration is a testament to his commitment to advancing healthcare delivery.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Hello from Boston! We are with Dr. Dale Adler, MD, who is Professor of Medicine at Harvard Medical School and Executive Vice Chair, Department of Medicine at Brigham and Women's Hospital in Boston. Dr. Dale Adler, MD, received his MD at Weill Medical College of Cornell University. He did his residency in internal medicine and fellowship in cardiovascular medicine at Brigham and Women's Hospital in Boston.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Dr. Adler's clinical and research interests are in cardiovascular disease, specifically, complex coronary artery disease, diabetic heart disease and its prevention, and valvular heart disease. Dr. Adler also has extensive experience in managing healthcare organizations and integrating hospital networks. Dr. Adler, thank you and welcome!\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Thank you very much for having me.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068561052,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"valvular-heart-disease-treatment-options-1","title":"Valvular heart disease treatment options. 1","description":"\u003ch1\u003eComprehensive Treatment Approaches for Valvular Heart Disease\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#understanding-valvular-heart-disease\"\u003eUnderstanding Valvular Heart Disease\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#symptoms-and-diagnosis-of-mitral-valve-prolapse\"\u003eSymptoms and Diagnosis of Mitral Valve Prolapse\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#when-surgical-intervention-is-necessary\"\u003eWhen Surgical Intervention is Necessary\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#role-of-medical-management-in-valvular-heart-disease\"\u003eRole of Medical Management in Valvular Heart Disease\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#importance-of-second-opinions-in-treatment-decisions\"\u003eImportance of Second Opinions in Treatment Decisions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"understanding-valvular-heart-disease\"\u003eUnderstanding Valvular Heart Disease\u003c\/h2\u003e\n\u003cp\u003eValvular heart disease involves dysfunction of one or more of the heart's valves, which can lead to significant health issues if untreated. Dr. Dale Adler, MD, explains that while some patients may not exhibit symptoms, others may experience severe complications requiring intervention. Accurate diagnosis is crucial for determining the appropriate treatment path.\u003c\/p\u003e\n\n\u003ch2 id=\"symptoms-and-diagnosis-of-mitral-valve-prolapse\"\u003eSymptoms and Diagnosis of Mitral Valve Prolapse\u003c\/h2\u003e\n\u003cp\u003eMitral valve prolapse is a condition where the valve leaflets bulge backward into the left atrium, potentially causing a leak. Dr. Adler notes that while many individuals with a mitral valve click remain asymptomatic, a subset may develop symptoms such as shortness of breath and fatigue. Echocardiograms are essential for assessing valve function and guiding treatment decisions.\u003c\/p\u003e\n\n\u003ch2 id=\"when-surgical-intervention-is-necessary\"\u003eWhen Surgical Intervention is Necessary\u003c\/h2\u003e\n\u003cp\u003eSurgery is often indicated for patients with symptomatic mitral valve prolapse or significant heart changes. Dr. Adler emphasizes that surgical repair is preferred when the heart's mechanical function is compromised, as medical therapy alone may not halt disease progression. He advises caution in asymptomatic patients, where surgery may still be considered based on specific clinical indicators.\u003c\/p\u003e\n\n\u003ch2 id=\"role-of-medical-management-in-valvular-heart-disease\"\u003eRole of Medical Management in Valvular Heart Disease\u003c\/h2\u003e\n\u003cp\u003eMedical management, including diuretics and ACE inhibitors, can provide temporary relief for some patients. However, Dr. Adler cautions that these treatments do not address the underlying mechanical issues of mitral valve prolapse. Long-term reliance on medication may lead to worsening heart function, underscoring the need for timely surgical intervention when appropriate.\u003c\/p\u003e\n\n\u003ch2 id=\"importance-of-second-opinions-in-treatment-decisions\"\u003eImportance of Second Opinions in Treatment Decisions\u003c\/h2\u003e\n\u003cp\u003eDr. Anton Titov, MD, highlights the value of seeking a second opinion to confirm valvular heart disease diagnoses and treatment plans. A second opinion can provide reassurance and ensure that patients receive the most effective and personalized care. Dr. Adler supports this approach, particularly in complex cases where treatment decisions can significantly impact patient outcomes.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Valvular heart disease treatment options. Understand your heart valve treatment options. A second opinion ensures that valvular heart disease diagnosis is correct and complete. It also helps to choose the best treatment strategy for aortic stenosis or mitral regurgitation. Seek a second opinion on valvular heart disease and be confident that your treatment is the best.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Treatment options for heart valve disease are mostly surgical if there are any symptoms or signs of stress on the heart. Then heart valve disease treatment is heart valve replacement or heart valve repair. Sometimes valvular heart disease is symptomatic, and it is treated by heart surgery.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Let's start with valvular heart disease. My mother had mitral valve repair at Brigham and Women's Hospital several years ago. So I learned a lot about mitral valve repair surgery from a patient perspective. The process of treating valvular heart disease is intricate. It has to be perfectly timed and choreographed. Only then can treatment cure the patient with mitral valve prolapse. But not everyone needs the surgery immediately.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e What is the role of medical treatment in valvular heart disease? How to prepare a patient for valvular heart disease surgery? How to treat the patient after surgical operation for valvular heart disease? You are asking a very interesting question in the entire realm of cardiology.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Let's talk about mitral valve prolapse repair. 2.5% of males and 6.5% of females in the United States have mitral valve prolapse. A study was done many years ago to listen to the heart of young patients. 15% of all young patients entering college had a mitral valve click (mitral valve murmur). But only 6.5% of all women and 2.5% of all men have real mitral valve prolapse.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e In real life, 90% of all patients who have a mitral valve click will do perfectly fine throughout their lifespan. Only 10% of patients with a mitral valve murmur will need attention to their mitral valve. So it is becoming a progressively smaller number of patients who need medical attention to their heart valve.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e We see patients and take a good listen to their heart. Some of them have mitral regurgitation. So we do an echocardiogram. We study their heart valves, including the mitral valve. Some patients have a classic mitral valve prolapse. The leaflets of the mitral valve are thickened. Some leaflets of the mitral valve prolapse.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Most patients with mitral valve prolapse will not need any medical help for a long period of time. But we are always interested in a group of patients who have symptoms of mitral valve prolapse. Symptoms include shortness of breath, fatigue, and struggle on exertion. We are interested in helping this group of patients with mitral valve prolapse symptoms.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Sometimes mitral valve prolapse causes enlargement of heart chambers because the leak is very severe. Enlargement of heart chambers in mitral valve prolapse sometimes increases pressure in the lungs. Patients with mitral valve prolapse also stretch the top chamber of their heart on the left, the left atrium. This can lead to cardiac rhythm disturbances, such as atrial fibrillation arrhythmia.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e How can you prevent mitral valve prolapse consequences? Are there medical solutions to treat valvular heart disease? Is it possible to treat mitral valve prolapse without surgery?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e This is the most important lesson that we have learned over many years. Mitral valve prolapse causes the leaflets to prolapse more with time. The chambers of the heart are starting to stretch. Mitral valve prolapse worsens as time goes by. In this situation, it is a mistake to try to use medicines to treat patients with mitral valve prolapse.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e We could use medicine, but it is not a good decision. We could use diuretics. We can make the heart a little smaller. We can use \"ace inhibitors\" and \"unloading\" medicines. These medications might help a patient to feel better temporarily. But the underlying process of mitral valve prolapse and stretching of the heart is still continuing. Heart function is getting worse.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Research studies showed nicely that medical treatment of bad valvular heart disease does not help the patients. Eventually, patients get worse and worse. In mitral valve prolapse, the heart has a mechanical problem. Clinical examination and echocardiography may confirm that the mechanical problem of the heart is getting worse.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e For those patients, the best treatment of valvular heart disease is to first treat the mechanical problem. Mitral valve prolapse treatment by surgical operation is better. Only after surgical operation treats valvular heart disease, then doctors should give support to the heart by medications.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e There is one caveat. There might be a patient with very severe mitral regurgitation, but this patient feels very well. Their heart is not stretching. It is always very difficult to decide to correct severe mitral valve prolapse in a patient who does not show any symptoms. The patient might feel fine. Their heart chambers might not be enlarging. Their pulmonary artery pressures are good. Pressures within their heart chambers are good.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Should we treat this patient by surgical operation? There is a lot of discussion in the United States about the best way to approach such patients. Doctors who write clinical guidelines say that surgical repair of severe mitral valve prolapse should be considered. It should be done even if the patient feels fine.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Surgical treatment of valvular heart disease can be considered even if the heart is not stretching. Sometimes surgeons are very sure that they can repair the mitral valve. Surgeons can do surgical operation very safely. Then it's OK for surgeons to consider surgery for mitral valve prolapse. That's what some doctors say. I think we just have to be very cautious with that approach.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e In addition to the presence of a severe mechanical problem of the heart, something else could show that the heart is struggling. There could be signs that the heart is integrating the problems in a wrong way. In that situation, you must use the mechanical solution. You do a surgical operation to repair mitral valve prolapse. Do not try to use medications to treat valvular heart disease in those situations.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068593820,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"how-to-prepare-for-surgical-operation-2","title":"How to prepare for surgical operation. 2","description":"\u003ch1\u003eEffective Strategies for Preparing for Major Surgery\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#mental-preparation-for-surgery\"\u003eMental Preparation for Surgery\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#lifestyle-changes-before-surgery\"\u003eLifestyle Changes Before Surgery\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#importance-of-a-second-opinion\"\u003eImportance of a Second Opinion\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#recovery-timeline-after-surgery\"\u003eRecovery Timeline After Surgery\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#patient-success-stories\"\u003ePatient Success Stories\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"mental-preparation-for-surgery\"\u003eMental Preparation for Surgery\u003c\/h2\u003e\n\u003cp\u003eDr. Dale Adler, MD, stresses the importance of mental preparation for major surgeries like heart, spine, or cancer surgery. Surgery can be a significant source of anxiety, and preparing mentally can help patients cope better with the stress. Understanding the procedure and having a positive mindset can contribute to a smoother surgical experience and recovery.\u003c\/p\u003e\n\n\u003ch2 id=\"lifestyle-changes-before-surgery\"\u003eLifestyle Changes Before Surgery\u003c\/h2\u003e\n\u003cp\u003eDr. Adler advises patients to make specific lifestyle changes weeks before surgery. Quitting smoking at least six to eight weeks prior can significantly improve surgical outcomes. Increasing physical activity, even slightly, can also benefit patients, especially those with sedentary lifestyles. These changes help improve overall health and prepare the body for the stress of surgery.\u003c\/p\u003e\n\n\u003ch2 id=\"importance-of-a-second-opinion\"\u003eImportance of a Second Opinion\u003c\/h2\u003e\n\u003cp\u003eSeeking a second opinion is crucial, particularly for heart valve diseases such as aortic stenosis and mitral regurgitation. Dr. Adler highlights that a second opinion ensures the diagnosis is accurate and the treatment strategy is optimal. This step provides patients with confidence in their treatment plan and can lead to better surgical outcomes.\u003c\/p\u003e\n\n\u003ch2 id=\"recovery-timeline-after-surgery\"\u003eRecovery Timeline After Surgery\u003c\/h2\u003e\n\u003cp\u003eAccording to Dr. Adler, the recovery timeline after heart valve surgery varies. Some patients feel better as soon as the third day post-surgery, despite some discomfort. Generally, patients feel significantly improved within a month, and by two months, they often feel much better than before the surgery. This timeline can vary based on individual health conditions and the complexity of the surgery.\u003c\/p\u003e\n\n\u003ch2 id=\"patient-success-stories\"\u003ePatient Success Stories\u003c\/h2\u003e\n\u003cp\u003eDr. Adler shares that witnessing patients' recovery is highly rewarding. Many patients who struggled before surgery experience a dramatic improvement in their quality of life post-surgery. These success stories highlight the importance of proper preparation and the effectiveness of surgical interventions in treating heart valve diseases.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e How to prepare weeks before surgery, whether it's heart surgery, spine surgery, neurosurgery, or cancer surgery, is crucial. It is important to prepare for surgery mentally, as major surgery can make anyone anxious. Here, a top cardiologist shares his experience.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Advice to patients on preparation for surgery includes what to do several weeks in advance. This video interview with a top expert in cardiology discusses how to prepare for heart surgery and ensure a fast recovery. What can patients do to prepare for any major surgical operation? An experienced Boston cardiologist talks about the steps patients can take before surgery.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Preparation before heart surgery is similar to preparation for any surgery. People should prepare for surgery as they would for any stressful circumstance in life. We would love for patients to be fit. Sometimes a patient smokes, and it is extremely helpful if they stop smoking for at least six or eight weeks before the surgical operation.\u003c\/p\u003e\n\n\u003cp\u003eEven six or eight weeks of not smoking before surgery makes a big difference?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Yes, it makes a big difference, you are absolutely correct. Some patients lead a sedentary lifestyle. It makes a big difference if they become even a little more active before the surgical operation. It is tough because often patients have severe heart valve problems.\u003c\/p\u003e\n\n\u003cp\u003eValvular heart disease creates shortness of breath. Patients probably won't get really fit before surgery, but those actions are the only things that patients can hope to accomplish before surgery.\u003c\/p\u003e\n\n\u003cp\u003eWhat about after the surgical operation?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e The correct time for heart surgery is when patients have just started to show some symptoms of heart problems. Heart valve repair in these patients will make them feel better very quickly. Their heart will have plenty of reserve in function.\u003c\/p\u003e\n\n\u003cp\u003eSometimes it is a beautiful story. On the third day after surgery, patients already say they feel better, even though they still have discomfort from the surgical operation. That is a wonderful group, and it really doesn't take very much after the surgery to take care of these patients.\u003c\/p\u003e\n\n\u003cp\u003eOf course, you have many more patients who are different. For them, the surgical procedure itself has been a real stress to their body. They are more tired, and it just takes time. We usually say that it takes about one month for patients after heart valve surgery to feel pretty good. We hope that in two months after heart valve disease surgery, the patients feel terrific.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e It is probably very gratifying to see patients who were not doing well before.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e And after the surgery, they fly! It is wonderful! As a physician, that is your goal, and nothing makes you feel better. Preparing for major surgery involves key things to do several weeks before surgery.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068626588,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"what-causes-atrial-fibrillation-3","title":"What causes Atrial Fibrillation? 3","description":"\u003ch1\u003eUnderstanding Causes and Risk Factors of Atrial Fibrillation\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#causes-of-atrial-fibrillation\"\u003eCauses of Atrial Fibrillation\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#key-risk-factors-for-afib\"\u003eKey Risk Factors for AFib\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#triggers-and-substrates-in-afib\"\u003eTriggers and Substrates in AFib\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#effective-treatment-strategies-for-afib\"\u003eEffective Treatment Strategies for AFib\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#risks-of-anticoagulation-therapy\"\u003eRisks of Anticoagulation Therapy\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#preventive-measures-for-atrial-fibrillation\"\u003ePreventive Measures for Atrial Fibrillation\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"causes-of-atrial-fibrillation\"\u003eCauses of Atrial Fibrillation\u003c\/h2\u003e\n\u003cp\u003eAtrial fibrillation arises from irregular electrical impulses in the heart's upper chambers. Dr. Dale Adler, MD, explains that these impulses disrupt normal heart rhythm, leading to AFib. Common causes include heart surgery, thoracic surgery, and conditions that alter heart geometry or electrical signaling.\u003c\/p\u003e\n\n\u003ch2 id=\"key-risk-factors-for-afib\"\u003eKey Risk Factors for AFib\u003c\/h2\u003e\n\u003cp\u003eDr. Dale Adler, MD, highlights several risk factors for atrial fibrillation. Hypertension, thyroid dysfunction, diabetes, and heart failure significantly increase AFib risk. Age is also a critical factor, with 4% of individuals over 60 and 15% over 80 experiencing AFib. Heart valve issues and pericardial inflammation further contribute to risk.\u003c\/p\u003e\n\n\u003ch2 id=\"triggers-and-substrates-in-afib\"\u003eTriggers and Substrates in AFib\u003c\/h2\u003e\n\u003cp\u003eUnderstanding triggers and substrates is essential for managing AFib. Dr. Dale Adler, MD, describes triggers as additional electrical impulses affecting the left atrium, while substrates refer to the heart's inability to manage these impulses. Surgery, hypertension, and lung issues can create these conditions, leading to sustained AFib.\u003c\/p\u003e\n\n\u003ch2 id=\"effective-treatment-strategies-for-afib\"\u003eEffective Treatment Strategies for AFib\u003c\/h2\u003e\n\u003cp\u003eTreatment for atrial fibrillation often involves anticoagulants like warfarin to prevent stroke. Dr. Dale Adler, MD, emphasizes the importance of a second opinion to ensure accurate diagnosis and optimal treatment. Managing risk factors and understanding individual patient needs are crucial for effective AFib management.\u003c\/p\u003e\n\n\u003ch2 id=\"risks-of-anticoagulation-therapy\"\u003eRisks of Anticoagulation Therapy\u003c\/h2\u003e\n\u003cp\u003eWhile anticoagulants reduce stroke risk in AFib patients, they also carry bleeding risks. Dr. Dale Adler, MD, notes that bleeding can occur in the gastrointestinal tract, under the skin, or in the brain. Careful monitoring and individualized treatment plans are necessary to balance these risks.\u003c\/p\u003e\n\n\u003ch2 id=\"preventive-measures-for-atrial-fibrillation\"\u003ePreventive Measures for Atrial Fibrillation\u003c\/h2\u003e\n\u003cp\u003ePreventing atrial fibrillation involves managing risk factors such as hypertension and diabetes. Dr. Dale Adler, MD, advises regular monitoring and lifestyle changes to reduce AFib risk. Early intervention and comprehensive care can significantly improve patient outcomes.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Why does atrial fibrillation happen? What are the risk factors for atrial fibrillation? What can trigger atrial fibrillation? What is paroxysmal atrial fibrillation?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Hypertension is a risk factor. Thyroid dysfunction is a risk factor for atrial fibrillation. Heart geometry changes (\"substrate\") and electrical signal changes (\"trigger\") lead to cardiac arrhythmia. Diabetes and metabolic syndrome are big risk factors for AFib. Heart failure increases the risk of atrial fibrillation. Older age increases the probability of developing atrial fibrillation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e How do we treat atrial fibrillation today? A second opinion ensures that the diagnosis of atrial fibrillation is correct and complete. A second opinion also helps to choose the best treatment strategy for atrial fibrillation. Seek a second opinion on atrial fibrillation and be confident that your treatment is the best.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e You are just correct. Atrial fibrillation is a growing problem. Atrial fibrillation frequency is age-related. We know that 4% of patients older than 60 years of age have atrial fibrillation. 15% of patients older than 80 years of age have atrial fibrillation. The increase in atrial fibrillation with age makes sense because atrial fibrillation occurs when there are \"triggers\" on top of the \"substrate\".\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e What do we mean by atrial fibrillation triggers? Triggers in atrial fibrillation are additional electrical impulses that bombard the left upper chamber of the heart (left atrium of the heart). The \"substrate\" in atrial fibrillation means that the left upper chamber of the heart (left atrium) is not able to shake off those electrical impulses, \"triggers\".\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Instead, the substrate allows those triggers to become sustained in some way. Triggers for atrial fibrillation can come from several causes. We know that a patient undergoes heart surgery. There is irritation in the lining around the heart. That irritation can cause extra heartbeats.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Sometimes the top chamber of the heart, the left atrium, is stretched even before heart surgery. The electrical capabilities of the left atrium might not be perfect. In such a situation, the left atrium may perpetuate atrial fibrillation after heart surgery. Thoracic surgery similarly creates a risk for atrial fibrillation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Sometimes we remove a patient's lung. That will cause the top chamber of the heart on the right side to stretch. This could cause some extra heartbeats. They become the triggers for atrial fibrillation. Sometimes the pumping chamber on the top left side of the heart, the left atrium, is not in perfectly good health. Then you may find exactly the same situation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e The \"triggers\" after lung removal fall onto the damaged \"substrate\" of the left atrium. This causes atrial fibrillation. In patients who did not have surgery, high blood pressure (hypertension) can lead to atrial fibrillation. In hypertension, the main pumping chamber of the heart on the left side (left ventricle) has to work harder.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e The heart is a muscle. When the muscle works harder, it gets thicker. Sometimes a patient lifts weights. Then the muscles that work get thicker. Once the heart muscle is a little thicker, it means that the top chamber of the heart has to work harder to squeeze the blood into that chamber.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e When the top chamber of the heart works harder, it stretches a little bit. When the top chamber of the heart is stretched, its electrical system is also stretched. Now you have created \"the substrate\" for atrial fibrillation. When extra heartbeats fall onto the stretched top chamber of the heart, atrial fibrillation develops.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e \"The trigger\" falls onto \"substrate\" and is perpetuated in the form of atrial fibrillation. So high blood pressure (hypertension) and age are two predisposing risk factors for atrial fibrillation. Anything that perturbs the heart is a risk factor for atrial fibrillation. Heart valve problems predispose to atrial fibrillation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Because problems with heart valves can stretch the heart chambers. These problems are mitral regurgitation and aortic stenosis. Problems with the lining around the heart (pericardium) are a risk factor for atrial fibrillation. Pericardial inflammation can irritate the heart. Problems with the lungs also can cause atrial fibrillation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Electrolyte imbalance or thyroid gland problems are also predisposing factors for atrial fibrillation. But all such \"triggers\" have to land onto the \"substrate\" of the damaged top chamber of the heart. This is how atrial fibrillation appears and persists.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e You are correct that anticoagulation in atrial fibrillation is our biggest fear. The problem is that the top chamber of the heart is undulating, it is fibrillating. In such conditions, a blood clot may form. This blood clot could break off and travel along blood vessels.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Sometimes a blood clot travels from the heart into the brain, it can cause a stroke. Sometimes a blood clot travels elsewhere. It could cause an acute infarction or problem in the intestines (intestinal infarction). Blood clot can cause problems in the legs too.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e The risk of a blood clot forming inside the heart of patients with atrial fibrillation depends on how stretched that heart is. A patient's general risk for forming blood clots is also important. We can predict these risks. We can determine factors that increase the risks of clot formation in atrial fibrillation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Age is a very important risk factor to predict blood clot formation in atrial fibrillation. Age of a patient between 65 and 75 is a risk factor for clot formation. Age above 75 years is an even higher predictor of blood clot formation in atrial fibrillation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Hypertension (high blood pressure) is a risk factor for clot formation inside the heart of patients with atrial fibrillation. Because hypertension stretches the chambers of the heart. Heart failure is a very large risk factor for clot formation in patients with atrial fibrillation. Because heart failure implies that there are problems with moving the blood through the heart.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Diabetes is a predisposing risk factor for clot formation in patients with atrial fibrillation. We know that patients with diabetes have a higher incidence of clotting. History of stroke is a very big risk factor. Because a history of stroke tells us that something is wrong with the patient's blood vessels.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Diabetes creates problems with blood clotting and how all vascular risk factors come together. Women have a higher risk of increased clotting than men do. Especially women older than 65. Any vascular disease also presents an additional risk for clot formation in atrial fibrillation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e We can combine all risk factors for clot formation in a patient with atrial fibrillation. We can express these risk factors as a mathematical score. So we determine the score for a patient with atrial fibrillation. This score reflects a patient's risk of having a blood clot.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Based on that score, we can decide on atrial fibrillation treatment. We can tell if the patient should receive oral anticoagulant medication. In the past, doctors thought that aspirin may help in atrial fibrillation. But we reviewed all studies with aspirin. There was only one study where aspirin was remarkably effective.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e So we say that aspirin will treat the doctor. Aspirin is not going to treat the patient. So a patient with atrial fibrillation has the risks of forming a blood clot inside the heart. Sometimes you determine that this risk is high, you must prevent them from having a stroke. Therefore, you need to use a blood thinner. It is medication to prevent clot formation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e The standard blood thinner is warfarin (Coumadin). This medication existed for a long time and it is extremely effective. The risk of stroke in a patient who is on anticoagulant decreases 10 times. This is compared with the risk of stroke in a patient who is not on anticoagulant medication.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e But you are just correct. The process of starting a patient with atrial fibrillation on anticoagulant medication is tough. Because in the first few days of taking oral anticoagulant, the patient is at increased risk of bleeding. For patients with atrial fibrillation, there is always a risk of bleeding.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Bleeding can happen in the gastrointestinal tract. Bleeding can happen under the skin or inside the mouth. Of course, the most dreaded bleeding in a patient on oral anticoagulants is bleeding in the head.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068659356,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"direct-oral-anticoagulants-doacs-noacs-4","title":"Direct oral anticoagulants. DOACs. [NOACs] 4","description":"\u003ch1\u003eUnderstanding the Benefits and Risks of Direct Oral Anticoagulants\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#advantages-of-doacs-over-warfarin\"\u003eAdvantages of DOACs Over Warfarin\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#safety-concerns-and-reversal-of-doacs\"\u003eSafety Concerns and Reversal of DOACs\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#impact-on-different-patient-populations\"\u003eImpact on Different Patient Populations\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#clinical-trials-and-bleeding-risks\"\u003eClinical Trials and Bleeding Risks\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#importance-of-second-opinions-in-anticoagulation\"\u003eImportance of Second Opinions in Anticoagulation\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"advantages-of-doacs-over-warfarin\"\u003eAdvantages of DOACs Over Warfarin\u003c\/h2\u003e\n\u003cp\u003eDirect oral anticoagulants (DOACs) like dabigatran, rivaroxaban, and apixaban offer significant benefits over traditional anticoagulants such as warfarin. Dr. Dale Adler, MD, notes that these newer medications do not require regular laboratory testing, making them more convenient for patients. This is a major advantage, as it reduces the burden of frequent blood monitoring associated with warfarin therapy.\u003c\/p\u003e\n\u003cp\u003eAdditionally, DOACs have a lower incidence of intracranial hemorrhage compared to warfarin. Dr. Adler highlights that studies have shown a 50% reduction in brain hemorrhage risk with DOACs, and some trials even report a 75% decrease. This makes DOACs a safer option for many patients, particularly those at higher risk of bleeding.\u003c\/p\u003e\n\n\u003ch2 id=\"safety-concerns-and-reversal-of-doacs\"\u003eSafety Concerns and Reversal of DOACs\u003c\/h2\u003e\n\u003cp\u003eWhile DOACs offer many benefits, there are concerns about their reversibility in emergency situations. Dr. Adler explains that unlike warfarin, which can be quickly reversed with vitamin K, DOACs do not have an immediate reversal agent. However, new reversal medications are in development, such as idarucizumab for dabigatran and andexanet for apixaban and rivaroxaban. These agents aim to provide a solution for reversing the anticoagulant effects of DOACs in urgent scenarios.\u003c\/p\u003e\n\u003cp\u003eDr. Adler emphasizes the importance of understanding the duration of action of DOACs. Unlike warfarin, which can take several days to clear from the body, DOACs have a shorter duration, with effects dissipating within 12 hours. This characteristic can be advantageous in managing bleeding risks and planning surgical procedures.\u003c\/p\u003e\n\n\u003ch2 id=\"impact-on-different-patient-populations\"\u003eImpact on Different Patient Populations\u003c\/h2\u003e\n\u003cp\u003eDr. Dale Adler, MD, discusses how DOACs affect various patient populations differently. For instance, very thin patients may experience higher blood levels of DOACs, while very heavy patients might have lower levels. Elderly patients and those with kidney dysfunction may also face challenges with DOACs, as their serum levels may not be as predictable.\u003c\/p\u003e\n\u003cp\u003eDespite these variations, the overall safety profile of DOACs remains favorable. Dr. Adler advises that careful consideration and monitoring are essential when prescribing these medications to ensure optimal dosing and minimize risks.\u003c\/p\u003e\n\n\u003ch2 id=\"clinical-trials-and-bleeding-risks\"\u003eClinical Trials and Bleeding Risks\u003c\/h2\u003e\n\u003cp\u003eClinical trials have consistently demonstrated the reduced risk of intracranial bleeding with DOACs compared to warfarin. Dr. Adler highlights that even in cases where reversal of anticoagulation was not possible, patients on DOACs experienced less clinical bleeding than those on warfarin. This finding underscores the importance of evaluating both laboratory data and real-world clinical outcomes when assessing anticoagulant therapies.\u003c\/p\u003e\n\u003cp\u003eWhile gastrointestinal bleeding remains a concern with DOACs, Dr. Adler notes that it is generally more manageable than intracranial bleeding. The overall reduction in serious bleeding events makes DOACs an attractive option for many patients requiring anticoagulation.\u003c\/p\u003e\n\n\u003ch2 id=\"importance-of-second-opinions-in-anticoagulation\"\u003eImportance of Second Opinions in Anticoagulation\u003c\/h2\u003e\n\u003cp\u003eDr. Anton Titov, MD, emphasizes the value of seeking a second opinion when considering anticoagulation therapy. A second opinion can confirm the necessity of anticoagulation and help determine the most appropriate medication choice for conditions like atrial fibrillation and deep venous thrombosis. Dr. Adler agrees, noting that personalized treatment plans are crucial for achieving the best outcomes and minimizing risks associated with anticoagulation.\u003c\/p\u003e\n\u003cp\u003eBy consulting with experts and considering individual patient factors, healthcare providers can ensure that patients receive the most effective and safe anticoagulation therapy available.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e New blood thinners compete with old anticoagulants. Pradaxa, also known as dabigatran, Xarelto, or rivaroxaban, and Eliquis, or apixaban, are some of the new options. How safe and effective are these new oral anticoagulants? Should you choose warfarin or the new blood thinners?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e New oral anticoagulants offer several advantages. They do not require laboratory testing, unlike the classical anticoagulant warfarin, also known as Coumadin. How safe are these new blood thinners, and how should they be used properly? What are the risks associated with these new medications, and are there reversal agents available for them?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e The newer oral anticoagulant medications represent a significant breakthrough. Patients no longer need to have their blood checked regularly, which is a wonderful development. However, at the extremes of the patient population, the level of these medications in the blood might be too low or too high. For instance, a very thin patient might have higher levels of the medication, while a very heavy patient might have lower levels.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Elderly patients and those with kidney dysfunction might also experience inaccurate serum levels of these new oral blood thinners. The beauty of these medications, such as dabigatran and rivaroxaban, is the decreased risk of bleeding in the head, or intracranial hemorrhage. All novel anticoagulant medications have a lower incidence of bleeding in the head compared to older medications.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Studies have shown that the risk of brain hemorrhage is reduced by 50% to 75% with these new medications. This makes us feel much better about using them, even though there might be a higher incidence of gastrointestinal bleeding. We are happy if a patient does not have a stroke, as we can usually treat gastrointestinal bleeding.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Can we discuss the concerns some surgeons have about the reversibility of these novel oral anticoagulants? In acute situations, such as trauma or urgent surgery, the blood-thinning action of older anticoagulants like warfarin can be quickly reversed with a vitamin K injection. However, the effects of novel oral anticoagulants like Pradaxa, Xarelto, and Eliquis cannot be reversed as quickly.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Yes, this is an important question. There are new medicines in development that can reverse the blood-thinning action of these new oral anticoagulants in emergency situations. Some reversal medications are antibodies to the novel anticoagulants, while others promote clotting through alternative pathways.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e IDARUCIZUMAB is an antibody to dabigatran, and ANDEXANET and ARIPAZINE are being developed to reverse apixaban, edoxaban, and rivaroxaban. We expect to have effective reversal medications available soon. Additionally, the duration of action of these new oral anticoagulants is much shorter than that of warfarin.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e When a patient stops taking warfarin, it takes 3 to 4 days for its effects to disappear. In contrast, the effects of novel oral blood thinners may not be present in the body after just 12 hours. This is an important consideration in clinical practice.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e An interesting study showed that patients admitted to the hospital with bleeding who were on new oral anticoagulants had less clinical bleeding than those on warfarin, even though the latter group received vitamin K reversal. This highlights the difference between laboratory results and real clinical outcomes.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068692124,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"atrial-fibrillation-prevention-and-treatment-5","title":"Atrial fibrillation prevention and treatment. 5","description":"\u003ch1\u003eEffective Strategies for Atrial Fibrillation Prevention and Treatment\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#symptoms-and-causes-of-atrial-fibrillation\"\u003eSymptoms and Causes of Atrial Fibrillation\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#lifestyle-management-for-atrial-fibrillation-prevention\"\u003eLifestyle Management for Atrial Fibrillation Prevention\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#medication-options-for-atrial-fibrillation\"\u003eMedication Options for Atrial Fibrillation\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#pulmonary-vein-isolation-procedure\"\u003ePulmonary Vein Isolation Procedure\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#importance-of-a-second-opinion\"\u003eImportance of a Second Opinion\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"symptoms-and-causes-of-atrial-fibrillation\"\u003eSymptoms and Causes of Atrial Fibrillation\u003c\/h2\u003e\n\u003cp\u003eAtrial fibrillation is characterized by an irregular and often rapid heart rate that can lead to poor blood flow. Dr. Dale Adler, MD, explains that changes in heart geometry and function, such as mechanical stretching of the heart chambers, can predispose individuals to atrial fibrillation. Recognizing symptoms like palpitations, fatigue, and shortness of breath is crucial for early diagnosis and management.\u003c\/p\u003e\n\n\u003ch2 id=\"lifestyle-management-for-atrial-fibrillation-prevention\"\u003eLifestyle Management for Atrial Fibrillation Prevention\u003c\/h2\u003e\n\u003cp\u003eDr. Dale Adler, MD, emphasizes the importance of maintaining a healthy heart to prevent atrial fibrillation. Key strategies include controlling blood pressure, managing diabetes, and maintaining a healthy weight. These measures help reduce the stretch in the heart's upper chambers, decreasing the risk of anatomical changes that lead to atrial fibrillation.\u003c\/p\u003e\n\n\u003ch2 id=\"medication-options-for-atrial-fibrillation\"\u003eMedication Options for Atrial Fibrillation\u003c\/h2\u003e\n\u003cp\u003eFor patients with atrial fibrillation, Dr. Dale Adler, MD, discusses the use of oral anticoagulants to prevent stroke and medications to control heart rate. While antiarrhythmic medications can be effective, they must be used cautiously, especially in patients with structural heart disease or coronary artery issues. Dr. Adler advises that these medications are worth trying under careful medical supervision.\u003c\/p\u003e\n\n\u003ch2 id=\"pulmonary-vein-isolation-procedure\"\u003ePulmonary Vein Isolation Procedure\u003c\/h2\u003e\n\u003cp\u003eDr. Dale Adler, MD, describes pulmonary vein isolation as a highly effective treatment for atrial fibrillation. This procedure involves inserting catheters into the pulmonary vein to disconnect electrical triggers from the heart. With an 80% to 90% success rate, pulmonary vein isolation can potentially cure atrial fibrillation, although some patients may require a second procedure within months of the first.\u003c\/p\u003e\n\n\u003ch2 id=\"importance-of-a-second-opinion\"\u003eImportance of a Second Opinion\u003c\/h2\u003e\n\u003cp\u003eDr. Anton Titov, MD, highlights the value of seeking a second opinion to ensure a correct and complete atrial fibrillation diagnosis. A second opinion can also help patients choose the best treatment strategy, providing confidence in their care plan. Dr. Dale Adler, MD, supports this approach, particularly for complex cases like paroxysmal atrial fibrillation.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e How to prevent atrial fibrillation? Treatment of atrial fibrillation by pulmonary vein isolation. Second opinion ensures that atrial fibrillation diagnosis is correct and complete. Second opinion also helps to choose the best treatment strategy for atrial fibrillation. Seek second opinion on paroxysmal atrial fibrillation and be confident that your treatment is the best. New oral anticoagulants in AFib treatment.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Prevention of atrial fibrillation is based on trigger and substrate reduction. Mechanical stretching of heart chambers predisposes to AFib. Paroxysmal atrial fibrillation can signify transition to permanent cardiac arrhythmia.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e The prevention of atrial fibrillation is really in having a healthy heart. To prevent atrial fibrillation, patients need to control blood pressure very well. Patients need to control diabetes very well. Patients need to control weight very well. This should reduce the amount of stretch in the top chamber of the heart. This will reduce the risk of anatomical change that leads to atrial fibrillation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e What else can you do to treat atrial fibrillation? As we discussed, we put patients on oral anticoagulant medications. We also use medications to slow down their heart rate. But in those patients who still have atrial fibrillation, we favor the use of antiarrhythmic medications.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e We do not really like to use antiarrhythmic medications in the long term. Sometimes you are trying to alter the heart's rhythm, then you usually can make the rhythm worse potentially instead of better. But antiarrhythmic medications are worth a try. Antiarrhythmic medications in patients with atrial fibrillation have to be used cautiously.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e There are patients who have structural heart disease. There are also patients who have problems with coronary arteries that supply blood to the heart. Antiarrhythmic medications may be okay in such patients. The heart is getting plenty of blood flow. But using antiarrhythmic medications may not be okay when a patient is not getting enough blood flow to the heart.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e But after taking all precautions, we usually feel that antiarrhythmic medicine in a patient with atrial fibrillation may be used. It is useful to try for a period of time. Sometimes antiarrhythmic medicines do not work well in a patient with atrial fibrillation. Then we can do a treatment procedure called \"pulmonary vein isolation\". This treatment method can be very effective.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e \"Pulmonary vein isolation\" for atrial fibrillation works like this. Catheters are inserted into the pulmonary vein. There is an attempt to disconnect from the rest of the heart those electric triggers that come from the pulmonary vein. Patients who consider pulmonary vein isolation for atrial fibrillation might need to repeat this procedure a second time. It is repeated within the first several months of the first pulmonary vein isolation for atrial fibrillation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e But there is an 80% to 90% probability that pulmonary vein isolation will permanently cure atrial fibrillation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Cure can happen in those who agree to do pulmonary vein isolation. Atrial fibrillation prevention and treatment. How to reduce changes in heart that cause AFib. Antiarrhythmic drug therapy and pulmonary vein isolation.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068757660,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"how-to-lower-cholesterol-fast-without-statins-6","title":"How to lower cholesterol fast without statins? 6","description":"\u003ch1\u003eEffective Strategies for Lowering Cholesterol Levels\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#ldl-cholesterol-and-heart-disease-risk\"\u003eLDL Cholesterol and Heart Disease Risk\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#dietary-changes-and-supplements\"\u003eDietary Changes and Supplements\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#lifestyle-modifications-for-cholesterol-reduction\"\u003eLifestyle Modifications for Cholesterol Reduction\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#role-of-statins-in-cholesterol-management\"\u003eRole of Statins in Cholesterol Management\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#controversies-in-statin-use\"\u003eControversies in Statin Use\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#combining-lifestyle-changes-and-medications\"\u003eCombining Lifestyle Changes and Medications\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"ldl-cholesterol-and-heart-disease-risk\"\u003eLDL Cholesterol and Heart Disease Risk\u003c\/h2\u003e\n\u003cp\u003eDr. Dale Adler, MD, emphasizes that LDL cholesterol is a critical factor in assessing heart disease risk. Lowering LDL cholesterol levels can significantly reduce the risk of coronary artery disease. Dr. Adler notes that while lifestyle changes can help, medications like statins are often necessary to achieve substantial reductions in LDL cholesterol.\u003c\/p\u003e\n\n\u003ch2 id=\"dietary-changes-and-supplements\"\u003eDietary Changes and Supplements\u003c\/h2\u003e\n\u003cp\u003eDietary modifications play a crucial role in managing cholesterol levels. Dr. Adler suggests incorporating foods that are known to lower cholesterol, such as those high in fiber and healthy fats. While supplements can also aid in reducing LDL cholesterol, their impact is generally less significant compared to medications.\u003c\/p\u003e\n\n\u003ch2 id=\"lifestyle-modifications-for-cholesterol-reduction\"\u003eLifestyle Modifications for Cholesterol Reduction\u003c\/h2\u003e\n\u003cp\u003eDr. Adler highlights the importance of lifestyle changes, including regular exercise and maintaining a healthy weight, in managing cholesterol levels. However, he acknowledges that these changes alone typically result in only a 5% reduction in LDL cholesterol, underscoring the need for additional interventions in high-risk patients.\u003c\/p\u003e\n\n\u003ch2 id=\"role-of-statins-in-cholesterol-management\"\u003eRole of Statins in Cholesterol Management\u003c\/h2\u003e\n\u003cp\u003eStatins are a cornerstone in cholesterol management, capable of lowering LDL cholesterol by 20-50%. Dr. Adler discusses the importance of using statins in appropriate doses, as established in clinical trials, to maximize their effectiveness in reducing heart disease risk.\u003c\/p\u003e\n\n\u003ch2 id=\"controversies-in-statin-use\"\u003eControversies in Statin Use\u003c\/h2\u003e\n\u003cp\u003eRecent changes in clinical guidelines for statin use have sparked debate within the medical community. Dr. Adler addresses these controversies, particularly regarding the appropriate dosing of statins and the extent to which they reduce coronary heart disease risk.\u003c\/p\u003e\n\n\u003ch2 id=\"combining-lifestyle-changes-and-medications\"\u003eCombining Lifestyle Changes and Medications\u003c\/h2\u003e\n\u003cp\u003eDr. Adler advocates for a synergistic approach, combining lifestyle modifications with statin therapy to achieve optimal cholesterol management. This strategy is particularly beneficial for patients with a history of heart disease or those at high risk, ensuring comprehensive risk reduction.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e LDL cholesterol level determines heart disease risks. What foods can lower cholesterol? Can supplements lower LDL cholesterol? Diet and lifestyle changes can lower cholesterol by 5% at best. Only statins can lower cholesterol by 20-50%.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Best ways to lower cholesterol fast. When should you use only lifestyle changes to lower cholesterol? How low should cholesterol be? When should medications, like statins, be used to lower blood lipids? Dietary changes can help lower blood lipids and cholesterol.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Since the early 1980s, we have learned that LDL cholesterol is the bad cholesterol. Any lifestyle modifications and medications that specifically lower the level of LDL cholesterol almost always benefit the patient. It seems that the lower you make the LDL cholesterol level, the lower the risk of coronary artery disease.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Can LDL cholesterol be too low? Sometimes LDL cholesterol is too low. Can this create a problem? This has been a controversial issue. Probably too low a level of LDL cholesterol is not really a problem for most patients. We are not so worried that LDL cholesterol is going to be too low.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Some patients do not have very high risks for coronary heart disease. We would love to see them work on improving their lifestyle. No question about that. Who has a low-risk profile for coronary heart disease? Those patients who do not have a family history of very premature coronary artery disease, do not have diabetes, and have never had any heart-related health event whatsoever.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e But lifestyle change is a tough proposition. Relatively few patients can keep their weight just where it should be. Few patients can exercise on a regular basis. Few patients have a very good diet. Let's now look at patients who have already had a heart-related health problem, like a heart attack. Some patients have diabetes. Some patients have a strong family history of premature coronary artery disease.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e In my clinical practice, I support healthy diet and lifestyle changes. This is all terrific. But diet and lifestyle lower LDL cholesterol in these patients by only 5%. Medications, the statins, often lower cholesterol by 20% to 40%. Medications and lifestyle\/dietary changes are synergistic. So it's wonderful to put them together. So I say to my patients, \"Let's make your LDL cholesterol very low. Let's drive it down.\"\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e The recent clinical guidelines on the use of statins to lower cholesterol are controversial in several areas. One controversy is about the dose of statins to treat patients. Also, there is controversy about evidence on how much coronary heart disease risk is lowered.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e I agree very much with the guidelines when they say this. Sometimes you're going to use the statin to lower cholesterol. Then use statin in a dose that was used in the clinical trial. For example, simvastatin is a very nice medication to lower cholesterol. In the clinical trials, simvastatin was used at 40 milligrams per day. But a lot of physicians prescribe simvastatin at 5 milligrams or 10 milligrams per day.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e I say this: Sometimes it's worth treating a patient with a statin medication. Then start medication in a dose that was established and shown to make a big difference. Sometimes the patient has trouble tolerating statin at that dose. Then you may have to decrease the dose of medication. That even occurred in some of the clinical trials.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Best ways to lower cholesterol. Who can only use lifestyle and diet changes? When to add medications to help lower cholesterol? How to use statins correctly?\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068790428,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"coronary-artery-disease-treatment-without-surgical-operation-7","title":"Coronary artery disease treatment without surgical operation. 7","description":"\u003ch1\u003eNon-Surgical Treatment Options for Coronary Artery Disease\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#medical-treatment-effectiveness\"\u003eMedical Treatment Effectiveness\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#diagnosis-and-treatment-stratification\"\u003eDiagnosis and Treatment Stratification\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#lifestyle-changes-and-medication\"\u003eLifestyle Changes and Medication\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#managing-asymptomatic-patients\"\u003eManaging Asymptomatic Patients\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#treatment-for-symptomatic-patients\"\u003eTreatment for Symptomatic Patients\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#invasive-treatment-options\"\u003eInvasive Treatment Options\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#importance-of-second-opinions\"\u003eImportance of Second Opinions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"medical-treatment-effectiveness\"\u003eMedical Treatment Effectiveness\u003c\/h2\u003e\n\u003cp\u003eDr. Dale Adler, MD, explains that medical treatment for coronary artery disease can be as effective as surgical procedures like angioplasty or open-heart surgery. By focusing on drug therapy, patients can significantly reduce their risk of heart attacks and strokes. This approach is particularly beneficial for patients with stable coronary artery disease, where invasive procedures may not be necessary.\u003c\/p\u003e\n\n\u003ch2 id=\"diagnosis-and-treatment-stratification\"\u003eDiagnosis and Treatment Stratification\u003c\/h2\u003e\n\u003cp\u003eAccurate diagnosis is essential in determining the appropriate treatment for coronary artery disease. Dr. Adler emphasizes the importance of stratifying patients based on their symptoms and diagnostic results. This ensures that each patient receives the most suitable treatment, whether it involves lifestyle changes, medication, or more invasive procedures.\u003c\/p\u003e\n\n\u003ch2 id=\"lifestyle-changes-and-medication\"\u003eLifestyle Changes and Medication\u003c\/h2\u003e\n\u003cp\u003eFor many patients, lifestyle changes and medication can effectively manage coronary artery disease. Dr. Adler highlights the importance of lowering cholesterol levels, controlling blood pressure, and improving blood vessel health through medication. These measures can help prevent the progression of the disease and reduce the likelihood of symptoms developing.\u003c\/p\u003e\n\n\u003ch2 id=\"managing-asymptomatic-patients\"\u003eManaging Asymptomatic Patients\u003c\/h2\u003e\n\u003cp\u003ePatients with asymptomatic coronary artery disease can often be managed successfully with lifestyle changes and medication. Dr. Adler discusses a study conducted by Intermountain Healthcare, which found that managing risk factors in asymptomatic patients can lead to excellent outcomes. This approach focuses on preventing the development of symptoms and maintaining heart health.\u003c\/p\u003e\n\n\u003ch2 id=\"treatment-for-symptomatic-patients\"\u003eTreatment for Symptomatic Patients\u003c\/h2\u003e\n\u003cp\u003eFor patients experiencing symptoms such as shortness of breath or chest pain, a more intensive treatment approach may be necessary. Dr. Adler explains that while some symptomatic patients respond well to medication, others may require more aggressive interventions if their heart function remains compromised. Regular monitoring and stress tests can help determine the best course of action.\u003c\/p\u003e\n\n\u003ch2 id=\"invasive-treatment-options\"\u003eInvasive Treatment Options\u003c\/h2\u003e\n\u003cp\u003eIn cases where coronary artery disease is severe, invasive treatments like coronary angioplasty or coronary artery bypass graft (CABG) surgery may be required. Dr. Adler notes that patients with significant heart function impairment or multiple affected arteries often benefit from these procedures. Early intervention can help restore blood flow and improve heart function.\u003c\/p\u003e\n\n\u003ch2 id=\"importance-of-second-opinions\"\u003eImportance of Second Opinions\u003c\/h2\u003e\n\u003cp\u003eDr. Anton Titov, MD, emphasizes the value of seeking a second medical opinion for coronary artery disease. A second opinion can confirm the accuracy of the diagnosis and ensure that the chosen treatment strategy is the most appropriate for the patient's condition. This step can provide patients with confidence in their treatment plan and improve overall outcomes.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Medical treatment of coronary artery disease is often as effective as angioplasty or open-heart surgery. Correct heart disease diagnosis stratifies a patient to the correct treatment category. Drug therapy for heart diseases reduces risks of heart attack and stroke.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e How to treat coronary heart disease conservatively? When is medical treatment of coronary heart disease best? Who benefits most from medical treatment for coronary artery disease? When to do angioplasty or interventional procedure in coronary artery disease? What treatment of coronary artery disease works best in my situation?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Sometimes we talk about coronary artery heart disease, we always have to separate patients into separate groups. There are patients who may have had a cardiac CT scan. Heart CT shows they have calcium in their coronary arteries. We say appropriately that these patients have coronary artery disease. They have absolutely no symptoms. Sometimes you put them on a treadmill. Then they would perform the running test wonderfully. There is no suggestion even at high workloads that their heart has a problem. That is an ideal group of patients. This is one extreme example of patients with coronary artery disease.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e We can say about them this: \"This is a systemic process. We want to use lifestyle changes. We want to make their cholesterol as low as we can.\" We are very happy to use beta blockers (medicines) to make sure their blood pressure is perfect. We are very happy to use other medicines that make the linings of their blood vessels better. There is no question about that. That is a group of patients that you can really target and probably help them a lot to stay healthy and prevent symptoms of coronary artery heart disease.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Research study was done on such group of asymptomatic coronary artery disease patients. Doctors at Intermountain Healthcare group looked at all their patients with diabetes. And they said this: We are going to do CT scans of the heart on these patients. We are going to look at patients who have known coronary artery disease based on coronary artery calcification. We are going to manage one group of asymptomatic diabetes patients with more invasive therapy. We will do coronary artery angiograms and look at their heart function with technological methods.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e There was another group of diabetes patients with asymptomatic heart disease. Then doctors focused on managing risk factors for coronary artery disease. This is what the study showed. Sometimes you manage heart disease risks well in this population of asymptomatic patients. Therefore, they can do extremely well.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e So that part we understand. Now we move to another group of patients. This is the group of patients who have symptoms of coronary artery heart disease. They may have shortness of breath or chest pain with exercise. Sometimes you put these symptomatic patients on a treadmill. Then you will find a problem. There are substantial areas of their heart that are not getting enough blood flow. This situation with symptomatic patients becomes very different from the first group of patients.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e How to treat them? On one hand, there are still doctors who say this: Look at the clinical trial results. You can treat heart disease risks of these patients very vigorously with medications. Then these patients will do fine. And the answer is that many of such patients will do fine. You just have to be extremely honest in your conclusion that they are doing great.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e After a period of intensive management of heart disease risks in these patients, you can put them on a treadmill test again. Sometimes their heart is getting plenty of blood flow. But previously these patients had a problem with blood flow. Then these patients are doing well. But some patients will still struggle with their heart function even after you manage all their heart risks. They will still show heart disease symptoms during exercise stress test performance.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Then such patients have to be moved to the active treatment group. This was done in the Intermountain Healthcare study. It's time to treat heart disease in such patients more intensively. And there is a third group of patients. They have coronary artery disease that is bad enough correct from the beginning. This group of patients is very interesting. Because these patients are missing a reserve capacity in their heart function.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Sometimes some bad event occurred in one coronary artery, they already have problems in other coronary arteries. Therefore their heart will not do so well.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Because there is no reserve in their heart's function. So you have to use more invasive, more interventional methods of treatment early in this group of patients. These patients have more severe coronary artery heart disease. You can do coronary angioplasty, coronary artery bypass graft CABG surgery.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Can you avoid surgery or angioplasty? Can medical treatment and lifestyle changes be successful in heart disease therapy?\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068823196,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"sudden-cardiac-death-symptoms-and-causes-8","title":"Sudden cardiac death. Symptoms and causes. 8","description":"\u003ch1\u003ePreventing Sudden Cardiac Death: Risk Factors and Screening\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#identifying-risk-factors-for-sudden-cardiac-death\"\u003eIdentifying Risk Factors for Sudden Cardiac Death\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#the-role-of-genetic-screening-in-prevention\"\u003eThe Role of Genetic Screening in Prevention\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#ekg-and-echocardiography-in-risk-detection\"\u003eEKG and Echocardiography in Risk Detection\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#sudden-cardiac-death-in-young-athletes\"\u003eSudden Cardiac Death in Young Athletes\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#advancements-in-preventive-cardiac-defibrillators\"\u003eAdvancements in Preventive Cardiac Defibrillators\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"identifying-risk-factors-for-sudden-cardiac-death\"\u003eIdentifying Risk Factors for Sudden Cardiac Death\u003c\/h2\u003e\n\u003cp\u003eDr. Dale Adler, MD, emphasizes the importance of identifying risk factors for sudden cardiac death, which can often be silent for decades. Key risk factors include hypertrophic cardiomyopathy, long QT syndrome, and ischemic heart disease. Understanding these factors allows for targeted prevention strategies, potentially saving lives.\u003c\/p\u003e\n\n\u003ch2 id=\"the-role-of-genetic-screening-in-prevention\"\u003eThe Role of Genetic Screening in Prevention\u003c\/h2\u003e\n\u003cp\u003eGenetic screening plays a crucial role in preventing sudden cardiac death. Dr. Adler highlights how advancements in understanding genetic abnormalities, such as those associated with long QT syndrome, enable the assessment of family members for potential risks. This proactive approach allows for early intervention and management.\u003c\/p\u003e\n\n\u003ch2 id=\"ekg-and-echocardiography-in-risk-detection\"\u003eEKG and Echocardiography in Risk Detection\u003c\/h2\u003e\n\u003cp\u003eElectrocardiograms (EKG) and echocardiography are vital tools in detecting subclinical conditions that may lead to sudden cardiac death. Dr. Adler notes that these tests can identify conditions like hypertrophic cardiomyopathy, providing a pathway for early diagnosis and treatment, thus reducing the risk of sudden cardiac events.\u003c\/p\u003e\n\n\u003ch2 id=\"sudden-cardiac-death-in-young-athletes\"\u003eSudden Cardiac Death in Young Athletes\u003c\/h2\u003e\n\u003cp\u003eSudden cardiac death in young athletes is a significant concern, as highlighted by Dr. Adler. He discusses the importance of screening athletes for structural heart abnormalities, such as hypertrophic cardiomyopathy, to prevent tragic events. A detailed clinical examination and EKG are recommended for those participating in sports.\u003c\/p\u003e\n\n\u003ch2 id=\"advancements-in-preventive-cardiac-defibrillators\"\u003eAdvancements in Preventive Cardiac Defibrillators\u003c\/h2\u003e\n\u003cp\u003eDr. Adler discusses the advancements in preventive cardiac defibrillators, which are now smaller and potentially wireless. These devices are crucial in managing patients at risk of sudden cardiac death, offering a less invasive option with fewer complications, thus improving patient outcomes and quality of life.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e How to prevent sudden cardiac death? Sudden cardiac death risk factors are present silently for decades. How to screen young athletes for risk of sudden death? Sudden heart death survival rate is low.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Reduce risks of sudden cardiac death. Sudden Cardiac Death happens in athletes. How can death due to sudden cardiac arrest be prevented? Sudden cardiac arrest prevention focuses on identification of risk factors: hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, and ischemic heart disease. Long QT syndrome and subclinical hypertrophic cardiomyopathy are major risk factors for sudden cardiac death.\u003c\/p\u003e\n\n\u003cp\u003eSecond opinion ensures that hypertrophic cardiomyopathy diagnosis is correct and complete. Second opinion also helps to choose the best treatment strategy for cardiac arrhythmia. Seek second opinion on ischemic and non-ischemic cardiomyopathy and be confident that your treatment is the best. Healthy lifestyle reduces risk of sudden cardiac death, but genetic screening is important.\u003c\/p\u003e\n\n\u003cp\u003ePrediction and prevention of sudden cardiac death involves EKG and echocardiography testing. EKG can find subclinical hypertrophic cardiomyopathy. Prevention of sudden cardiac death is a key challenge for cardiologists and patients.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e You are just correct. Sudden cardiac death is obviously highly dreaded. In one small area, you have the genetic abnormalities. You have heart rhythm disturbances. You have the long QT syndromes, where if there is a family history of cardiac arrhythmia or sudden death as its consequence. We are much better now in understanding the genes that are associated with sudden cardiac death. We can assess other family members. We can see if they have those genes. And if they do, we can take care of them in the correct way.\u003c\/p\u003e\n\n\u003cp\u003eLong QT syndromes are identified on electrocardiogram [EKG, ECG]. You can identify long QT syndrome on an electrocardiogram. There are many gray areas on the electrocardiogram. But that's where EKG is helpful. If there really is a family history of sudden death, then you add the genetic information to it. You make a correct diagnosis of sudden death risks. Then you find the best treatment to prevent sudden death.\u003c\/p\u003e\n\n\u003cp\u003eThere are many more issues in terms of sudden death in patients with structural heart disease. Some of the structural heart disease could also be genetic. There is the hypertrophic cardiomyopathy group. There is the Arrhythmogenic Right Ventricular Dysplasia (ARVD) group. And those also can have a genetic component. Sometimes there is a family history of sudden cardiac death. Then patients can be screened for sudden death genetic risks. Their genes can be assessed. You know how to follow them.\u003c\/p\u003e\n\n\u003cp\u003eBut there is a much larger group of patients with sudden death. They are the patients who have some problem with the overall pumping capacity of their heart. But they do not have a problem with blood flow to the heart. We would call this problem a nonischemic cardiomyopathy. Many times there may be a genetic component to such patients. And then the big share of patients with sudden cardiac death is this. We worry about them very much. It is the ischemic cardiomyopathy.\u003c\/p\u003e\n\n\u003cp\u003eThese patients are not getting enough blood flow. Sometimes patients are brought into a hospital following a cardiac arrest. They are taken to the catheterization laboratory. At least half of the time, we will find that they have an occlusion of a blood vessel of the heart. To prevent sudden death, it is important to take care of the heart blood vessels. It is a big deal, of course. Identification of families that are at risk for sudden cardiac death is a big deal. And also identification of patients who have problems with the overall pumping capacity of the heart is a big deal.\u003c\/p\u003e\n\n\u003cp\u003eDespite all that, we know sudden death is an enormous issue. Because once patients get to the hospital with a heart attack, we can help them well. There is a group of sudden cardiac death patients that never gets to the hospital. This group of patients troubles us very much. The other piece to the sudden death equation is this.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e When you identified risk factors, what to do about them? Sudden cardiac death risk factors could be a genetic basis, or dilatation of the heart, or problems with coronary arteries, or the scar on the heart. Then treatment of underlying cause is important. It is the use of preventive defibrillators. And that has been an area with tremendous progress.\u003c\/p\u003e\n\n\u003cp\u003eSo the devices that we use nowadays are much smaller than in the past. I think all of us are very encouraged by the development of a device that is actually going to be wireless. Preventive cardiac defibrillator will be implanted underneath the skin. You don't actually have to have wires in the bloodstream. And that kind of device we would hope could last for a long period of time. We hope wireless cardiac defibrillator will not create the complications of the wires going across valves and into the heart. We hope there will not be risk of infection.\u003c\/p\u003e\n\n\u003cp\u003eSome sudden cardiac death events happen in young athletes. And not necessarily professional athletes, but somebody who might be playing soccer in school. Young athletes that play other sports. In Italy, all athletes are screened for structural abnormalities of the heart. All athletes are screened for hypertrophic cardiomyopathy.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e What are the best ways to screen for hypertrophic cardiomyopathy? Does it make sense? Because risk of sudden cardiac death makes a lot of parents very worried. Because sudden death events happen. Even though overall in population of many people sudden cardiac death events are rare. But any one sudden cardiac death is one death too many.\u003c\/p\u003e\n\n\u003cp\u003eYou are absolutely correct. And of course sudden death events in young athletes receive a tremendous amount of media attention. And it is a tragedy like all sudden deaths. All deaths that you think might have been able to be prevented. And you are just correct. Hypertrophic cardiomyopathy ranks up high in sudden cardiac death events in young athletes.\u003c\/p\u003e\n\n\u003cp\u003eThere are some other genetic syndromes. They would be much more rare. Everybody in this country is very aware of the Italian experience. We would say that without question a careful clinical exam is important. All athletes, anybody going to participate in any kind of sport, should have a detailed clinical examination. It may not find risks for sudden death. An EKG [electrocardiography] is wonderful. But there's been a tremendous amount of controversy over whether patients must have an EKG. Who you must act on if you find an EKG abnormality? Whether that should be done.\u003c\/p\u003e\n\n\u003cp\u003eI think that it [EKG] is an inexpensive test. EKG is easy to perform. If there is any hint anywhere of family history of cardiac arrhythmias or sudden death, I think it's nice to do EKG. And so for parents, I don't think it's ever a bad idea to do the following diagnostic tests. To do a careful clinical cardiology exam. Electrocardiogram is definitely not a bad thing for someone to undergo.\u003c\/p\u003e\n\n\u003cp\u003eCardiac echocardiography is another diagnostic step. Nevertheless, echocardiogram is probably even more precise. Somebody is very much worried about the sudden cardiac death situation. Perhaps it's worth taking an ultrasound of the heart.\u003c\/p\u003e\n\n\u003cp\u003eYes, and there could be additional diagnostic tests if there's a pathology found on the electrocardiogram. Physicians might move forward to additional diagnostic tests. One of the issues is that none of these diagnostic tests are failsafe. Because in hypertrophic cardiomyopathy, patients can carry a gene mutation. They could have a risk of having a sudden cardiac death event. But they haven't manifested this risk yet.\u003c\/p\u003e\n\n\u003cp\u003eAnd that is sudden death risk identification area that we are very interested in. Because if you can identify those patients, possibly we could treat those patients early. They will never have sudden death. They will not show phenotype of hypertrophic cardiomyopathy.\u003c\/p\u003e\n\n\u003cp\u003eThat's the ultimate 4P medicine (Predictive, Preventive, Personalized, Participatory). It is very much so, correct. Sudden cardiac death risk factors are often hidden until a cardiac arrest happens. Who is at risk? Hypertrophic cardiomyopathy, Arrhythmogenic Right Ventricular Dysplasia.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852068888732,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"how-to-treat-hypertension-effectively-9","title":"How to treat hypertension effectively? 9","description":"\u003ch1\u003eEffective Hypertension Management: Lifestyle, Monitoring, and Advanced Treatments\u003c\/h1\u003e\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#lifestyle-changes-for-hypertension-control\"\u003eLifestyle Changes for Hypertension Control\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#importance-of-regular-blood-pressure-monitoring\"\u003eImportance of Regular Blood Pressure Monitoring\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#medications-for-high-blood-pressure\"\u003eMedications for High Blood Pressure\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#advanced-treatments-renal-denervation\"\u003eAdvanced Treatments: Renal Denervation\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#value-of-a-second-medical-opinion\"\u003eValue of a Second Medical Opinion\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 id=\"lifestyle-changes-for-hypertension-control\"\u003eLifestyle Changes for Hypertension Control\u003c\/h2\u003e\n\u003cp\u003eDr. Dale Adler, MD, emphasizes that a healthy diet and regular exercise are crucial in managing high blood pressure. He advises patients to maintain a balanced diet and stay physically active to help keep blood pressure levels low. Dr. Adler shares a story of a patient whose blood pressure improved significantly after dietary changes post-stroke, highlighting the strong link between diet and hypertension.\u003c\/p\u003e\n\u003ch2 id=\"importance-of-regular-blood-pressure-monitoring\"\u003eImportance of Regular Blood Pressure Monitoring\u003c\/h2\u003e\n\u003cp\u003eDr. Adler stresses the importance of regular blood pressure monitoring, recommending patients check their blood pressure about three times a week under various conditions. He advises measuring blood pressure in both arms, as a significant difference between the two can indicate underlying vascular issues. Monitoring helps patients and doctors track blood pressure trends and adjust treatment plans accordingly.\u003c\/p\u003e\n\u003ch2 id=\"medications-for-high-blood-pressure\"\u003eMedications for High Blood Pressure\u003c\/h2\u003e\n\u003cp\u003eDr. Adler discusses the role of medications in hypertension management, mentioning drugs like Carvedilol, Spironolactone, and Eplerenone. These medications help control blood pressure, especially in patients with resistant hypertension. Dr. Adler notes that while lifestyle changes are essential, medications are often necessary to achieve optimal blood pressure control.\u003c\/p\u003e\n\u003ch2 id=\"advanced-treatments-renal-denervation\"\u003eAdvanced Treatments: Renal Denervation\u003c\/h2\u003e\n\u003cp\u003eDr. Adler explores renal denervation, an advanced treatment for resistant hypertension. This procedure involves radiofrequency ablation of sympathetic nerves around the renal artery to reduce blood pressure. Although initial studies showed promise, later blinded clinical trials did not confirm its effectiveness. Dr. Adler suggests that further research is needed to fully understand the potential of renal denervation.\u003c\/p\u003e\n\u003ch2 id=\"value-of-a-second-medical-opinion\"\u003eValue of a Second Medical Opinion\u003c\/h2\u003e\n\u003cp\u003eDr. Anton Titov, MD, highlights the importance of seeking a second medical opinion for hypertension diagnosis and treatment. A second opinion ensures that patients receive a comprehensive evaluation and the most effective treatment strategy. Dr. Adler agrees, emphasizing that a second opinion can provide reassurance and confidence in managing high blood pressure.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Good diet and regular exercise are key to controlling blood pressure. Blood pressure should be kept as low as possible. How often should one check blood pressure? Hypertension natural treatment is important. There is a story of a patient with high blood pressure who had a stroke. Renal denervation is a treatment for resistant hypertension. A second opinion ensures that the hypertension diagnosis is correct and complete. It also helps to choose the best treatment strategy for high blood pressure. Seek a second opinion on hypertension to be confident that your treatment is the best.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Yes, you are correct. People often do not have good control of their blood pressure. We have so much data linking high blood pressure especially to stroke. Hypertension also causes kidney problems and is linked to definite heart attacks, albeit a little less. But high blood pressure causes hypertensive heart disease. The heart muscle gets thicker, and in patients with hypertension, the heart muscle becomes more rigid and less compliant.\u003c\/p\u003e\n\u003cp\u003eIt is always remarkable that even today in the United States, 25% of patients with hypertension do not have good control of their high blood pressure. Treatment of hypertension is so basic, yet many patients do not succeed in its treatment. What is the best way to treat hypertension? The first step is to know how high your blood pressure is. We live in an era when everyone has equipment to measure blood pressure. It's very easy for patients to check their blood pressure.\u003c\/p\u003e\n\u003cp\u003eI always tell my patients not to go crazy checking blood pressure all the time. Check your blood pressure about three times per week in different circumstances. Sometimes you have been very busy and active, or you are under stress. Check it once. Is it useful to check blood pressure on both arms? A difference of blood pressure results of more than 15 mm between two arms has been linked to a higher risk of death. A large difference in blood pressure results between two arms can indicate a problem in the aorta or blockage in different blood vessels.\u003c\/p\u003e\n\u003cp\u003eSo it is absolutely true. Check blood pressure in both arms at the same time, at least the first time you take a blood pressure measurement. We also want patients to check their blood pressure in the morning when they wake up. People should also check blood pressure when they are under stress and when they are relaxed. Blood pressure is similar to LDL cholesterol. The lower the level of blood pressure, the better it is for your health. The same is true with LDL cholesterol levels. Lower blood pressure results mean a lower risk of stroke.\u003c\/p\u003e\n\u003cp\u003eIt is important not to make blood pressure so low that patients have symptoms. Sometimes the blood pressure is too low, and patients may feel dizzy, have blurred vision, or feel they are about to pass out. We don't need to make blood pressure very low by using medications. People should be really mindful of how they eat, keep their weight in good order, and be really fit. By doing these three things, they can help themselves a huge amount.\u003c\/p\u003e\n\u003cp\u003eI always tell my patients a sad story. It is about a man who always had very high blood pressure. His hypertension was very difficult to treat. I always said to him, \"I am worried about your diet.\" He always replied, \"My diet is great.\" Then unfortunately, one day this man had a stroke. After the stroke, he could not eat on his own. His hand was paralyzed. Since that time, we never had a problem with his blood pressure. Never. Not once.\u003c\/p\u003e\n\u003cp\u003eIt is possible that the stroke changed something in his brain, but there is a better explanation for his normal blood pressure after the stroke. What he ate after the stroke was controlled by others, and his food became more healthy. So often, there is a strong dietary component to hypertension. We have strong medications at our disposal to treat hypertension. In some patients with resistant hypertension, we need to use three and four medications. But almost always, we can get a patient's blood pressure under control.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e What are examples of medicines we use today to treat hypertension? Carvedilol is a nonselective beta blocker and also an alpha blocker. Carvedilol can be very helpful to treat high blood pressure. Medicines that antagonize aldosterone are useful to treat hypertension. For example, Spironolactone or Eplerenone can also be very helpful to treat hypertension in difficult cases.\u003c\/p\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003cstrong\u003eDr. Dale Adler, MD: \u003c\/strong\u003eThe technology of renal denervation received a lot of attention recently. Can you put a catheter into the renal artery? Can you apply radiofrequency ablation? Ablation of sympathetic nerves around the renal artery can decrease the sympathetic nervous system drive from the renal arteries. Many studies on renal denervation have been done. Very careful studies in animals showed renal sympathetic denervation would have a good effect. There were also small clinical trials in humans. It looked like renal denervation was very effective.\u003c\/p\u003e\n\u003cp\u003eThese trials were not “blinded,” which is the usual method to conduct clinical trials. But a \"blinded\" clinical trial did not show a good effect of the renal denervation procedure on lowering high blood pressure. Maybe one day we will know more about that technology. This clinical trial is SYMPLICITY HTN-3. Hypertension natural treatment by diet and exercise. Can you avoid medications? How to treat resistant hypertension? Medications and renal denervation.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852069085340,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"how-to-keep-heart-healthy-10","title":"How to keep heart healthy? 10","description":"\u003ch1\u003eEffective Strategies for Maintaining Heart Health\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#importance-of-optimal-weight-for-heart-health\"\u003eImportance of Optimal Weight for Heart Health\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#impact-of-being-overweight-on-the-heart\"\u003eImpact of Being Overweight on the Heart\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#role-of-cardiovascular-fitness-in-heart-health\"\u003eRole of Cardiovascular Fitness in Heart Health\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#avoiding-supplements-and-vitamins-for-heart-health\"\u003eAvoiding Supplements and Vitamins for Heart Health\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#lifelong-commitment-to-fitness-for-heart-health\"\u003eLifelong Commitment to Fitness for Heart Health\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"importance-of-optimal-weight-for-heart-health\"\u003eImportance of Optimal Weight for Heart Health\u003c\/h2\u003e\n\u003cp\u003eDr. Dale Adler, MD, emphasizes that maintaining an optimal weight is crucial for heart health. Excess weight increases blood volume, causing the heart to work harder. This can lead to heart muscle thickening and increased risk of high blood pressure. Keeping a healthy weight reduces these risks and supports overall cardiovascular function.\u003c\/p\u003e\n\n\u003ch2 id=\"impact-of-being-overweight-on-the-heart\"\u003eImpact of Being Overweight on the Heart\u003c\/h2\u003e\n\u003cp\u003eBeing overweight has several negative effects on heart health. Dr. Adler explains that it can lead to diabetes, which is detrimental to blood vessels and cholesterol levels. Overweight individuals often experience higher blood pressure, further straining the heart. Managing weight is essential to prevent these complications and maintain heart health.\u003c\/p\u003e\n\n\u003ch2 id=\"role-of-cardiovascular-fitness-in-heart-health\"\u003eRole of Cardiovascular Fitness in Heart Health\u003c\/h2\u003e\n\u003cp\u003eCardiovascular fitness plays a vital role in maintaining heart health. Dr. Dale Adler, MD, notes that regular physical activity helps the heart relax between beats and keeps blood vessels in good condition. A consistent fitness routine supports heart compliance and reduces the risk of cardiovascular diseases.\u003c\/p\u003e\n\n\u003ch2 id=\"avoiding-supplements-and-vitamins-for-heart-health\"\u003eAvoiding Supplements and Vitamins for Heart Health\u003c\/h2\u003e\n\u003cp\u003eDr. Anton Titov, MD, and Dr. Adler agree that supplements and vitamins are unnecessary for heart health when optimal weight and fitness are prioritized. These foundational practices provide the necessary benefits for a healthy heart, making additional supplements redundant.\u003c\/p\u003e\n\n\u003ch2 id=\"lifelong-commitment-to-fitness-for-heart-health\"\u003eLifelong Commitment to Fitness for Heart Health\u003c\/h2\u003e\n\u003cp\u003eDr. Dale Adler, MD, advocates for a lifelong commitment to physical fitness as a key strategy for heart health. Regular exercise not only supports heart function but also enhances overall well-being. By maintaining an active lifestyle, individuals can significantly improve their heart health and quality of life.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e What is the best way to keep the heart healthy?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e From everything we learned, an optimal weight goes a very long way. When people are overweight, there's a higher blood volume. There's more blood flow coming into the heart every time, which can cause the heart to stretch. Overweight individuals tend to have higher blood pressure, meaning the heart overworks, and the heart muscle can become thicker.\u003c\/p\u003e\n\n\u003cp\u003eBeing overweight also leads to diabetes, which is detrimental to blood vessels and worsens cholesterol levels. So, maintaining an optimum weight is crucial for heart health.\u003c\/p\u003e\n\n\u003cp\u003eCardiovascular fitness is the other key factor. Studies show that people who consistently push themselves physically throughout their lives retain better heart compliance. Between heartbeats, their hearts can relax better, and they maintain healthier blood vessels.\u003c\/p\u003e\n\n\u003cp\u003eIt may sound boring, but maintaining an optimal weight and engaging in a good fitness program will significantly contribute to lifelong heart health.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e You do not need food supplements or vitamins to keep your heart healthy.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852069118108,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"healthcare-future-is-patient-monitoring-at-home-11","title":"Healthcare future is patient monitoring at home. 11","description":"\u003ch1\u003eAdvancements in Home-Based Patient Monitoring and Healthcare\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#referral-networks-and-hospital-strategies\"\u003eReferral Networks and Hospital Strategies\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#shift-to-home-based-healthcare\"\u003eShift to Home-Based Healthcare\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#personal-health-tracking-devices\"\u003ePersonal Health Tracking Devices\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#benefits-of-remote-monitoring\"\u003eBenefits of Remote Monitoring\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#challenges-in-data-management\"\u003eChallenges in Data Management\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#future-of-healthcare-services\"\u003eFuture of Healthcare Services\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"referral-networks-and-hospital-strategies\"\u003eReferral Networks and Hospital Strategies\u003c\/h2\u003e\n\u003cp\u003eLarge hospitals are increasingly securing referral networks by acquiring private physician practices and partnering with smaller hospitals. This strategy is crucial as referrals account for 75% of hospital patient volume. Dr. Anton Titov, MD, notes that this trend is part of a broader movement in healthcare.\u003c\/p\u003e\n\n\u003ch2 id=\"shift-to-home-based-healthcare\"\u003eShift to Home-Based Healthcare\u003c\/h2\u003e\n\u003cp\u003eDr. Anton Titov, MD, highlights a significant shift in healthcare delivery, moving away from traditional hospital settings to more patient-centric models. This includes the use of ambulatory services, remote monitoring, and telemedicine, allowing healthcare to reach patients directly in their homes.\u003c\/p\u003e\n\n\u003ch2 id=\"personal-health-tracking-devices\"\u003ePersonal Health Tracking Devices\u003c\/h2\u003e\n\u003cp\u003eDr. Dale Adler, MD, emphasizes the potential of personal health tracking devices. These devices enable patients to monitor vital signs such as blood pressure, heart rate, and blood sugar levels. Such technology empowers patients to manage their health proactively without frequent hospital visits.\u003c\/p\u003e\n\n\u003ch2 id=\"benefits-of-remote-monitoring\"\u003eBenefits of Remote Monitoring\u003c\/h2\u003e\n\u003cp\u003eRemote monitoring offers significant benefits, particularly for patients with chronic conditions like heart failure. Dr. Dale Adler, MD, discusses a device that measures pulmonary artery pressure, helping to detect early signs of deterioration in heart failure patients. This proactive approach can prevent hospitalizations and improve patient outcomes.\u003c\/p\u003e\n\n\u003ch2 id=\"challenges-in-data-management\"\u003eChallenges in Data Management\u003c\/h2\u003e\n\u003cp\u003eWith the influx of data from remote monitoring devices, managing and interpreting this information is a challenge. Dr. Dale Adler, MD, points out the need for effective data processing to understand its implications for patient health. This is especially important for conditions like atrial fibrillation, where data interpretation can guide treatment decisions.\u003c\/p\u003e\n\n\u003ch2 id=\"future-of-healthcare-services\"\u003eFuture of Healthcare Services\u003c\/h2\u003e\n\u003cp\u003eThe future of healthcare lies in integrating advanced technologies into patient care. Dr. Dale Adler, MD, envisions a healthcare system where patients can track their health metrics seamlessly, and healthcare providers can leverage this data to deliver personalized care. This evolution promises to enhance patient engagement and improve health outcomes.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Referrals of patients provide 75% volume of hospital patients. So large hospitals are trying to secure the referral networks. They buy private physician practices in their areas. What kind of business models do you think benefit patients most?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e There is a lot of mergers and acquisitions happening in the healthcare services business in the United States. The large hospitals are really getting their patients through the referrals. Referrals of patients provide 75% volume of hospital patients. So large hospitals are trying to secure the referral networks. They buy private physician practices in their areas. They partner with smaller hospitals.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e But at the same time, the prevailing trend in healthcare is to move away from hospitals. Healthcare moves into an iPhone. Healthcare moves into more ambulatory services. It moves to remote monitoring and telemedicine. Some countries such as Denmark are already very advanced in progressive models of healthcare. Healthcare goes to the patients instead of bringing the patient into the healthcare system.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e You have a lot of experience integrating hospital networks. You have experience in healthcare management. What kind of business models do you think benefit patients most? Where do you see the healthcare business in medical services advancing in the next 10 years?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e These are very interesting questions. I will take first the personal side of medicine. People being able to track their blood pressure or their heart rate. And we hope one day people can very easily check their blood sugar. For example, people who have asthma might be able to track their peak flow. It is the amount of air they're able to force through their lungs at once.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e So there could be a tremendous amount of information that patients will be able to track on their own. And you are correct. Patients can check their health without coming into the hospital. I think everyone is excited about a particular device now. It allows us to detect the pressure inside the pulmonary artery. So we can tell in those patients who've had problems with heart failure if they're starting to go in the wrong direction.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e We obviously can do a lot with heart rhythm issues monitoring remotely. So it's a very exciting area. And we hope that we'll learn more about it. We have to learn how to process the data. Because right now we've done studies in patients who come to the hospital with atrial fibrillation. We know what their history is.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Dale Adler, MD:\u003c\/strong\u003e Then you have to do additional studies to say this. What about a person who has a pacemaker? We can detect when they have atrial fibrillation for just one minute in a month. What does that mean? So that's a whole other area for us to try to figure out how do we handle that huge amount of data that's coming in. We have to know what does it actually mean for patient's health. So that's an area that's very exciting.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852069183644,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"mitral-valve-repair-method-alfieri-technique-edge-to-edge-valve-repair-1","title":"Mitral valve repair method. Alfieri technique. ‘Edge-to-edge’ valve repair. 1","description":"\u003ch1\u003eInnovative Mitral Valve Repair: The Alfieri Edge-to-Edge Technique\u003c\/h1\u003e\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#development-of-the-alfieri-technique\"\u003eDevelopment of the Alfieri Technique\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#patient-selection-for-edge-to-edge-repair\"\u003ePatient Selection for Edge-to-Edge Repair\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#advantages-of-the-alfieri-method\"\u003eAdvantages of the Alfieri Method\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#functional-vs-structural-mitral-regurgitation\"\u003eFunctional vs. Structural Mitral Regurgitation\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#clinical-indications-for-alfieri-technique\"\u003eClinical Indications for Alfieri Technique\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 id=\"development-of-the-alfieri-technique\"\u003eDevelopment of the Alfieri Technique\u003c\/h2\u003e\n\u003cp\u003eProfessor \u003cmeta charset=\"utf-8\"\u003e\u003cstrong\u003e\u003cspan\u003eDr. Ottavio Alfieri, MD \u003c\/span\u003e\u003c\/strong\u003eintroduced the Edge-to-edge technique in 1991 to address mitral valve regurgitation. This method involves approximating the free edges of the mitral valve leaflets at the point of regurgitation, effectively eliminating the issue. At the time, mitral valve repair was not widely practiced, with most surgeons opting for valve replacement. The Alfieri technique provided a new option, particularly for patients with challenging anatomical conditions.\u003c\/p\u003e\n\u003ch2 id=\"patient-selection-for-edge-to-edge-repair\"\u003ePatient Selection for Edge-to-Edge Repair\u003c\/h2\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003cstrong\u003e\u003cspan\u003eDr. Ottavio Alfieri, MD\u003c\/span\u003e\u003c\/strong\u003e emphasizes the importance of selecting the right patients for the Edge-to-edge technique. Ideal candidates are those with localized mitral insufficiency, where the regurgitation jet can be precisely identified. By placing a surgical stitch at this point, a double orifice mitral valve is created, eliminating insufficiency. This method is particularly effective for patients with anterior leaflet prolapse and bi-leaflet mitral valve prolapse.\u003c\/p\u003e\n\u003ch2 id=\"advantages-of-the-alfieri-method\"\u003eAdvantages of the Alfieri Method\u003c\/h2\u003e\n\u003cp\u003eThe Alfieri technique offers significant advantages in cases where conventional mitral valve repair methods yield suboptimal results. It is particularly beneficial for treating anterior leaflet prolapse and mitral valve prolapse at the commissure. Additionally, the technique is convenient for functional mitral regurgitation and situations where the mechanism of regurgitation is unclear.\u003c\/p\u003e\n\u003ch2 id=\"functional-vs-structural-mitral-regurgitation\"\u003eFunctional vs. Structural Mitral Regurgitation\u003c\/h2\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003cstrong\u003e\u003cspan\u003eDr. Ottavio Alfieri, MD\u003c\/span\u003e\u003c\/strong\u003e distinguishes between organic and functional mitral valve regurgitation. Organic regurgitation involves intrinsic abnormalities of the valve, whereas functional regurgitation occurs due to left ventricular dilatation and dysfunction, despite a structurally normal valve. Understanding this distinction is crucial for determining the appropriate surgical approach.\u003c\/p\u003e\n\u003ch2 id=\"clinical-indications-for-alfieri-technique\"\u003eClinical Indications for Alfieri Technique\u003c\/h2\u003e\n\u003cp\u003eThe Alfieri technique is indicated for patients with isolated anterior leaflet prolapse, Barlow's disease with bi-leaflet prolapse, and prolapse at the mitral valve commissure. While the Edge-to-edge method can be extended to many patients, it is essential to consider other mitral valve repair techniques that may also provide excellent results. The Alfieri technique remains a valuable option for specific clinical scenarios.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Let's start with the mitral valve regurgitation surgical treatment options. Thirty years ago, I developed a specific method of mitral valve repair. It's called the Edge-to-edge technique, now known as the Alfieri technique of mitral valve repair. Could you please tell us about your method of mitral valve repair? How did the Alfieri method of mitral valve repair come about, and how do you select the patients appropriately for your particular method and technique of mitral valve repair?\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003e \u003cspan\u003eDr. Ottavio Alfieri, MD\u003c\/span\u003e:\u003c\/strong\u003e The Edge-to-edge technique approximates the free edges of the mitral valve leaflets exactly at the point of mitral regurgitation. It is done in such a way that mitral regurgitation is eliminated. We introduced that technique back in 1991. At that time, the repair of the mitral valve was not very much developed. It was not spread out among the surgeons, and only a few people were performing mitral valve repair. The rest of the surgeons around the world were invariably replacing the mitral valve for mitral regurgitation. With mitral valve repair, there are particular subsets of anatomy which are very good for repair. They are associated with excellent long-term results.\u003c\/p\u003e\n\u003cp\u003eOn the other hand, there are also some subsets of patients that present with anatomy which were not ideal for mitral valve repair, and the mitral valve repair in those cases was associated with suboptimal results. So, the technique was invented with the idea of making a repair possible with good results. It is used in those patients who could not have good results with the conventional methods of mitral valve repair at the time, specifically, patients who had anterior leaflet prolapse.\u003c\/p\u003e\n\u003cp\u003ePatients with the anterior leaflet prolapse did not have good results with the techniques of mitral valve repair. On the other hand, with the technique of the edge-to-edge mitral valve repair, we could eliminate anterior leaflet prolapse. We could repair bi-leaflet mitral valve prolapse. These were incremental factors for suboptimal surgical operation results. There were other situations where the edge-to-edge mitral valve repair technique was really convenient. For instance, mitral valve prolapse at the site of the mitral valve commissure was also another very difficult entity to be treated with the mitral valve repair. And that became very easy with the edge-to-edge technique.\u003c\/p\u003e\n\u003cp\u003eAlso, for functional mitral regurgitation, the edge-to-edge technique was very convenient. This mitral valve repair also worked well for situations that are occurring occasionally, where you don't know exactly what is the mechanism responsible for mitral valve regurgitation. Then in those cases, the edge-to-edge mitral valve repair takes care of the problem.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003e \u003cspan\u003eDr. Ottavio Alfieri, MD\u003c\/span\u003e:\u003c\/strong\u003e As you said, in organic mitral valve regurgitation, there is an intrinsic abnormality and anatomic normality of the valve. On the other hand, in functional mitral regurgitation, the valve is intrinsically normal. The regurgitation of the mitral valve is only due to dilatation and dysfunction of the left ventricle. So, this is the difference.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProfessor Alfieri:\u003c\/strong\u003e A patient is being considered for surgical treatment of mitral valve repair. They are discussing with their surgeon how a surgeon would approach the mitral valve treatment. A patient might have heard the edge-to-edge technique of mitral valve repair. Should a patient ask their surgeon, what about using the edge-to-edge technique of mitral valve repair? What would be the characteristics of a patient that would make it particularly well suited for the edge-to-edge mitral valve repair technique?\u003c\/p\u003e\n\u003cp\u003eThe ideal patient for the Alfieri technique is the patient who has a localized mitral insufficiency. So when you can identify exactly where the regurgitation jet is located, you can put a surgical stitch exactly at that point. You can create a double orifice mitral valve. This will, of course, eliminate the mitral valve insufficiency.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProfessor Alfieri:\u003c\/strong\u003e You can extend the use of the edge-to-edge mitral valve repair method to many patients. But, of course, we also have other mitral valve repair techniques, which can have very good results. These heart valve repair methods can be used alternatively to the edge-to-edge Alfieri technique. Certainly, the isolated anterior leaflet prolapse is an excellent indication of the Alfieri technique. As well as Barlow's disease with the bi-leaflet mitral valve prolapse. As I also said, the prolapse corresponding to the commissure of the mitral valve can be treated very conveniently with the Alfieri technique.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852069216412,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"dr-ottavio-alfieri-cardiac-surgeon-biography-0","title":"Dr. Ottavio Alfieri.  Cardiac Surgeon. Biography. 0","description":"\u003ch1\u003eInnovations in Heart Valve Surgery: Insights from Dr. Ottavio Alfieri\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#career-highlights-of-dr-ottavio-alfieri\"\u003eCareer Highlights of Dr. Ottavio Alfieri\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#pioneering-heart-valve-techniques\"\u003ePioneering Heart Valve Techniques\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#educational-background-and-fellowships\"\u003eEducational Background and Fellowships\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#leadership-and-contributions-to-cardiac-surgery\"\u003eLeadership and Contributions to Cardiac Surgery\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#impact-on-modern-cardiac-surgery\"\u003eImpact on Modern Cardiac Surgery\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"career-highlights-of-dr-ottavio-alfieri\"\u003eCareer Highlights of Dr. Ottavio Alfieri\u003c\/h2\u003e\n\u003cp\u003eDr. Ottavio Alfieri, MD, has had a remarkable career as a cardiac surgeon, serving as Professor and Chairman of Cardiac Surgery at San Raffaele University Hospital in Milan, Italy. His expertise in heart valve surgical treatments has made him a consultant to the cardiac surgery department at the same institution. Dr. Alfieri's leadership in cardiac surgery has been recognized both nationally and internationally.\u003c\/p\u003e\n\n\u003ch2 id=\"pioneering-heart-valve-techniques\"\u003ePioneering Heart Valve Techniques\u003c\/h2\u003e\n\u003cp\u003eOver two decades ago, Dr. Ottavio Alfieri developed the \"Alfieri technique,\" a method of mitral valve repair that has become the basis for the most common percutaneous transcatheter therapy for mitral regurgitation today. This innovative approach has revolutionized the treatment of heart valve diseases, offering less invasive options for patients.\u003c\/p\u003e\n\n\u003ch2 id=\"educational-background-and-fellowships\"\u003eEducational Background and Fellowships\u003c\/h2\u003e\n\u003cp\u003eDr. Ottavio Alfieri obtained his MD from the University of Parma in Italy. He pursued multiple fellowships in cardiac surgery and cardiovascular research at prestigious institutions, including the University of Bergamo, the University of New York in Buffalo, and the University of Birmingham in Alabama. His international experience also includes serving as a cardiac surgeon in Utrecht, Netherlands.\u003c\/p\u003e\n\n\u003ch2 id=\"leadership-and-contributions-to-cardiac-surgery\"\u003eLeadership and Contributions to Cardiac Surgery\u003c\/h2\u003e\n\u003cp\u003eDr. Alfieri has held significant leadership roles, including President of the European Association for Cardio-Thoracic Surgery. He has been a Director of Cardiac Surgery Units in Turin and Brescia, Italy, and a visiting Professor at universities in Rome, Brescia, and Pisa. His contributions to cardiac surgery are reflected in his extensive publication record and numerous presentations at international conferences.\u003c\/p\u003e\n\n\u003ch2 id=\"impact-on-modern-cardiac-surgery\"\u003eImpact on Modern Cardiac Surgery\u003c\/h2\u003e\n\u003cp\u003eDr. Ottavio Alfieri's work has had a profound impact on modern cardiac surgery. His development of the Alfieri technique has paved the way for advancements in minimally invasive heart valve treatments. With over 700 peer-reviewed publications, Dr. Alfieri continues to influence the field through his research and dedication to improving patient outcomes in cardiac surgery.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e Hello, thank you for having me. It's a pleasure to be here and discuss these important topics in cardiac surgery.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e Open heart surgery has been the cornerstone of cardiac treatment for many years. It involves opening the chest and performing surgery directly on the heart. This method is highly effective for many conditions, but it does come with significant risks and a long recovery time.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e In recent years, minimally invasive transcatheter methods have gained popularity. These techniques allow us to treat heart valve issues without the need for large incisions. They are less invasive, which means shorter recovery times and fewer complications for patients.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e One of the most significant advancements in this field is the development of the edge-to-edge technique for mitral valve repair. This technique, which I developed over 20 years ago, has become a standard in percutaneous transcatheter therapy for mitral regurgitation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e What are the main challenges you see in the treatment of heart disease today?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e The main challenges include improving the durability of valve repairs and replacements, as well as expanding the availability of these advanced treatments to more patients worldwide. We also need to continue researching to refine these techniques and develop new ones.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e The future of heart disease treatment is promising. With ongoing research and technological advancements, we are moving towards more personalized and effective treatments. The goal is to improve patient outcomes and quality of life significantly.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852069413020,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"mitral-valve-repair-how-to-choose-the-best-method-2","title":"Mitral valve repair. How to  choose the best method? 2","description":"\u003ch1\u003eChoosing the Best Mitral Valve Repair Method: Surgery vs. Transcatheter Techniques\u003c\/h1\u003e\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#mitral-valve-treatment-options\"\u003eMitral Valve Treatment Options\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#importance-of-individualized-care\"\u003eImportance of Individualized Care\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#role-of-centers-of-excellence\"\u003eRole of Centers of Excellence\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#heart-team-approach-in-treatment\"\u003eHeart Team Approach in Treatment\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#annuloplasty-limitations-and-alternatives\"\u003eAnnuloplasty Limitations and Alternatives\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#advanced-surgical-techniques-for-mitral-valve-repair\"\u003eAdvanced Surgical Techniques for Mitral Valve Repair\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 id=\"mitral-valve-treatment-options\"\u003eMitral Valve Treatment Options\u003c\/h2\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003cspan\u003eDr. Ottavio Alfieri, MD, \u003c\/span\u003eoutlines the main treatment options for mitral valve disease, focusing on mitral valve regurgitation and prolapse. Traditional open heart surgery remains a cornerstone, but minimally invasive percutaneous transcatheter techniques are gaining traction. These methods offer less invasive alternatives with promising outcomes.\u003c\/p\u003e\n\u003ch2 id=\"importance-of-individualized-care\"\u003eImportance of Individualized Care\u003c\/h2\u003e\n\u003cp\u003eChoosing the best mitral valve repair method requires careful consideration of each patient's clinical profile, age, and personal preferences. \u003cmeta charset=\"utf-8\"\u003e\u003cspan\u003eDr. Ottavio Alfieri, MD, \u003c\/span\u003eemphasizes that personalized treatment plans are crucial for achieving optimal outcomes, highlighting the need for a tailored approach in mitral valve therapy.\u003c\/p\u003e\n\u003ch2 id=\"role-of-centers-of-excellence\"\u003eRole of Centers of Excellence\u003c\/h2\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003cspan\u003eDr. Ottavio Alfieri, MD, \u003c\/span\u003estresses the importance of seeking treatment at Centers of Excellence, where a full range of therapeutic options is available. These centers provide access to sophisticated teams capable of offering the most appropriate treatment for each patient, ensuring high-quality care and better results.\u003c\/p\u003e\n\u003ch2 id=\"heart-team-approach-in-treatment\"\u003eHeart Team Approach in Treatment\u003c\/h2\u003e\n\u003cp\u003eThe Heart Team concept, involving collaboration among various specialists, is pivotal in modern heart disease treatment. \u003cmeta charset=\"utf-8\"\u003e\u003cspan\u003eDr. Ottavio Alfieri \u003c\/span\u003eexplains how this multidisciplinary approach ensures comprehensive decision-making and delivery of the best possible care for patients with mitral valve disease.\u003c\/p\u003e\n\u003ch2 id=\"annuloplasty-limitations-and-alternatives\"\u003eAnnuloplasty Limitations and Alternatives\u003c\/h2\u003e\n\u003cp\u003eAnnuloplasty, which addresses the mitral valve annulus, may not suffice for all patients. \u003cmeta charset=\"utf-8\"\u003e\u003cspan\u003eDr. Ottavio Alfieri, MD,\u003c\/span\u003e discusses its limitations, particularly when anatomical changes like chordae tendineae rupture are present. In such cases, annuloplasty alone may not resolve mitral regurgitation, necessitating alternative techniques.\u003c\/p\u003e\n\u003ch2 id=\"advanced-surgical-techniques-for-mitral-valve-repair\"\u003eAdvanced Surgical Techniques for Mitral Valve Repair\u003c\/h2\u003e\n\u003cp\u003eFor complex mitral valve issues, advanced surgical techniques are essential. \u003cmeta charset=\"utf-8\"\u003e\u003cspan\u003eDr. Ottavio Alfieri, MD,\u003c\/span\u003e highlights the use of artificial chordae tendineae, such as GORE-TEX sutures, and procedures like quadrangular resection and the Alfieri edge-to-edge technique. These methods effectively address specific structural problems, offering improved outcomes for patients.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003e \u003cspan\u003eDr. Ottavio Alfieri, MD\u003c\/span\u003e:\u003c\/strong\u003e Let's take a step back and discuss mitral valve disease treatment options in more general terms. It's mostly about treating mitral valve regurgitation and mitral valve prolapse. Open heart surgery is a classic option for mitral valve treatment. But minimally invasive percutaneous transcatheter treatment techniques are being developed. Now there is a fair amount of experience with transcatheter mitral valve repair.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003e \u003cspan\u003eDr. Anton Titov, MD\u003c\/span\u003e:\u003c\/strong\u003e How do you choose the correct method of mitral valve therapy for each patient? How to compare open heart surgery with transcatheter mitral valve repair techniques?\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003e \u003cspan\u003eDr. Ottavio Alfieri, MD\u003c\/span\u003e:\u003c\/strong\u003e In this new millennium, this is something different from the past. There is the availability of many therapeutic options to correct the mitral valve with repair methods. As a matter of fact, we have conventional mitral valve surgery, which is performed through a midline sternotomy. Also, we can have minimally invasive mitral valve surgery, which can be accomplished through a small incision in the right part of the chest. These surgical operations can also be done with the help of robotic technology.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003e \u003cspan\u003eDr. Ottavio Alfieri, MD\u003c\/span\u003e:\u003c\/strong\u003e Finally, we also have possibilities of correcting the mitral valve by using the catheter in the catheterization laboratory. So these are the main options that we can have for mitral valve repair.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003e \u003cspan\u003eDr. Ottavio Alfieri, MD\u003c\/span\u003e:\u003c\/strong\u003e Of course, we have to choose the best treatment option for the individual patient. So we have really to take into account the clinical characteristics of the individual patient. We have to take into account the individual profile of that patient, the age, and so on. We have also to take into account the wishes of the patient.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003e \u003cspan\u003eDr. Anton Titov, MD\u003c\/span\u003e:\u003c\/strong\u003e So for the individual patient, taking into account all these things, we can offer the patient the best possible treatment. And of course, this is possible only in so-called Centers of Excellence, where you have the availability of all the therapeutic options.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003e \u003cspan\u003eDr. Ottavio Alfieri, MD\u003c\/span\u003e:\u003c\/strong\u003e So that touches on an important point. As they say, sometimes the best surgeon for a patient is the surgeon who is available at the moment when the surgery is required. So the comparison between open heart surgery and transcatheter treatment options depends on the availability of the sophisticated team that can offer those methods.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003e \u003cspan\u003eDr. Ottavio Alfieri, MD\u003c\/span\u003e:\u003c\/strong\u003e Exactly. Everything should be available. Because if you have only one technique, obviously, you use that technique which is maybe not appropriate for that individual patient. So the secret nowadays is to be treated - this is very important for the patient - where all these techniques are available. In such a way, the patient can be offered the best solution for his medical problem.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003e \u003cspan\u003eDr. Ottavio Alfieri, MD\u003c\/span\u003e:\u003c\/strong\u003e It's crucial for patients to seek the Centers of Excellence and the surgeons and interventional cardiology specialists who work together to offer the best treatment for that specific patient.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003e \u003cspan\u003eDr. Ottavio Alfieri, MD\u003c\/span\u003e:\u003c\/strong\u003e Exactly. One of the new things in the treatment of disease, especially heart disease, is the Heart Team. The Heart Team means that there are many specialists that are cooperating on the side for the patient to make the best decision for the patient and also to deliver the best treatment for him.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003e \u003cspan\u003eDr. Ottavio Alfieri, MD\u003c\/span\u003e:\u003c\/strong\u003e One of the reviews caught my eye when researching your extensive medical literature. It is a medical review paper. Is annuloplasty sufficient for early-stage mitral valve repair? You discuss the comparison even when annuloplasty might be suitable for some patients with mitral valve regurgitation, but it really may not be optimal for other patients. Could you please talk a little bit more about those dilemmas?\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003e \u003cspan\u003eDr. Ottavio Alfieri, MD\u003c\/span\u003e:\u003c\/strong\u003e Exactly. The annuloplasty addresses only the annulus of the mitral valve. The mitral valve is a very complex structure. You have the annulus of the mitral valve. You have the leaflets. You have the chordae tendineae. You have the papillary muscle and also the ventricular wall, where the papillary muscles are attached. So the mitral valve is a very complex structure.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003e \u003cspan\u003eDr. Ottavio Alfieri, MD, \u003c\/span\u003e:\u003c\/strong\u003e Annuloplasty can only be effective when the annulus is dilated. In those patients, this is the only change responsible for mitral regurgitation. Very often, the dilatation of the mitral annulus is associated with other changes, including anatomical changes on the valve. For instance, rupture of the chordae tendineae is producing mitral valve prolapse. Of course, in those cases, annuloplasty is not sufficient because a surgeon can reduce the annulus. Still, it is leaving the mitral valve prolapse, which is responsible for mitral regurgitation.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003e \u003cspan\u003eDr. Ottavio Alfieri, MD, \u003c\/span\u003e:\u003c\/strong\u003e In the case of the chordae tendineae rupture, what is considered to be the optimal technique for the treatment of the mitral valve regurgitation created by the ruptured chordae tendineae?\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003e \u003cspan\u003eDr. Ottavio Alfieri, MD, \u003c\/span\u003e:\u003c\/strong\u003e We have nowadays the use of the artificial chordae tendineae. The GORE-TEX suture chordae are very effective in this situation. Alternatively, you can use the resection of the mitral valve leaflet exactly at the point where the chordae tendineae ruptured. Then it is called quadrangular resection, triangular resection, and other types of these surgical techniques.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003e \u003cspan\u003eDr. Ottavio Alfieri, MD, \u003c\/span\u003e:\u003c\/strong\u003e Also, the edge-to-edge Alfieri technique can be effective in those mitral valve regurgitation situations. There are particular circumstances when the chordae tendineae is ruptured. Then you can simply approximate the free edge of the mitral valve leaflets where the chordae tendineae is ruptured. That will eliminate mitral regurgitation.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852069478556,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"mitral-valve-repair-options-mitraclip-transcatheter-mitral-valve-repair-3","title":"Mitral valve repair options. MitraClip transcatheter mitral valve repair. 3","description":"\u003ch1\u003eTranscatheter Mitral Valve Repair: MitraClip System Explained\u003c\/h1\u003e\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#mitraclip-benefits-for-mitral-valve-regurgitation\"\u003eMitraClip Benefits for Mitral Valve Regurgitation\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#patient-selection-for-mitraclip-procedure\"\u003ePatient Selection for MitraClip Procedure\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#comparison-with-open-heart-surgery\"\u003eComparison with Open-Heart Surgery\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#functional-vs-organic-mitral-regurgitation\"\u003eFunctional vs. Organic Mitral Regurgitation\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#guidelines-and-recommendations-for-mitraclip\"\u003eGuidelines and Recommendations for MitraClip\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 id=\"mitraclip-benefits-for-mitral-valve-regurgitation\"\u003eMitraClip Benefits for Mitral Valve Regurgitation\u003c\/h2\u003e\n\u003cp\u003eThe MitraClip system is a leading transcatheter technique for mitral valve repair, particularly beneficial for patients with mitral valve regurgitation. Dr. Ottavio Alfieri, MD:, highlights that the MitraClip offers a minimally invasive alternative to traditional surgery, making it suitable for patients with high surgical risk. Over 100,000 patients worldwide have benefited from this edge-to-edge repair method, which is based on the Alfieri technique.\u003c\/p\u003e\n\u003ch2 id=\"patient-selection-for-mitraclip-procedure\"\u003ePatient Selection for MitraClip Procedure\u003c\/h2\u003e\n\u003cp\u003eDr. Alfieri emphasizes that the MitraClip is ideal for patients who are older, have comorbidities, or exhibit frailty, as well as those with severe left ventricular dysfunction. These factors contribute to a high surgical risk, making the MitraClip a preferable option. Patient preferences also play a role, especially for those seeking faster recovery or who are apprehensive about open-heart surgery.\u003c\/p\u003e\n\u003ch2 id=\"comparison-with-open-heart-surgery\"\u003eComparison with Open-Heart Surgery\u003c\/h2\u003e\n\u003cp\u003eWhile open-heart surgery offers excellent long-term outcomes for mitral valve disease, Dr. Alfieri notes that the MitraClip provides a viable alternative for high-risk patients. He advises against the transcatheter approach for patients who can safely undergo surgery, as surgical results are superior. However, for those unable to tolerate surgery, the MitraClip presents a low-risk, effective solution.\u003c\/p\u003e\n\u003ch2 id=\"functional-vs-organic-mitral-regurgitation\"\u003eFunctional vs. Organic Mitral Regurgitation\u003c\/h2\u003e\n\u003cp\u003eThe MitraClip is particularly effective for functional mitral regurgitation, often associated with heart failure and left ventricular remodeling. Dr. Alfieri explains that in cases where the left ventricle is dilated and not contracting properly, the MitraClip is a recommended first-line treatment. For organic mitral regurgitation, open-heart surgery remains the preferred option due to better outcomes.\u003c\/p\u003e\n\u003ch2 id=\"guidelines-and-recommendations-for-mitraclip\"\u003eGuidelines and Recommendations for MitraClip\u003c\/h2\u003e\n\u003cp\u003eAccording to recent European Guidelines, the MitraClip is recommended with a 2A grade for patients with functional mitral regurgitation, indicating it should be considered for these cases. Dr. Alfieri points out that open-heart surgery holds a 2B grade recommendation, suggesting it may be considered but is not the primary choice. The MitraClip's role in treating functional mitral regurgitation underscores its importance in modern cardiac care.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Transcatheter mitral valve repair is a treatment option today for many patients with functional mitral valve regurgitation and organic mitral valve regurgitation. What is a MitraClip system for mitral valve repair? Which patients benefit most from the MitraClip system for the repair of their diseased mitral valve?\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e One of the big merits of the edge-to-edge mitral valve repair technique is to open the way to the percutaneous method of mitral valve repair. As a matter of fact, the edge-to-edge technique represented the basis for the percutaneous treatment of mitral valve repair. Nowadays, it is used very extensively around the world.\u003c\/p\u003e\n\u003cp\u003eYou have to think that more than 100,000 patients benefited from the edge-to-edge percutaneous technique (Alfieri technique). Certainly, the patients who were treated in this way are those who have a high surgical risk—those patients who are particularly older, who have comorbidities or frailty. Patients who have severe left ventricular dysfunction are suitable for transcatheter mitral valve repair.\u003c\/p\u003e\n\u003cp\u003eAll these things are making the surgical risk very high - up to the point that the benefit of the surgical operation doesn't exist anymore. So I think that in those patients, in particular, the percutaneous edge-to-edge technique of mitral valve repair can have a very important role in treatment.\u003c\/p\u003e\n\u003cp\u003eAnd the MitraClip was developed by you and your colleagues. Now it's accepted around the world as one of the most common transcatheter mitral valve repair methods.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e MitraClip is certainly, definitely, the most common percutaneous mitral valve repair technique which is used nowadays in the world. By far, there is a large distance between MitraClip and the second next one. MitraClip is really by far the most commonly used technique for transcatheter percutaneous mitral valve repair.\u003c\/p\u003e\n\u003cp\u003eAnd we also have other percutaneous techniques, of course—for example, annuloplasty, which can be performed by percutaneously reproducing the ring annuloplasty. Percutaneous annuloplasty is carried out occasionally but less frequently compared with the MitraClip.\u003c\/p\u003e\n\u003cp\u003eWe also have the possibility of replacing the mitral valve with the transcatheter percutaneous methods. This is not very much standardized (yet). Not large numbers of the patient have received the mitral valve via a catheter-based percutaneous treatment methods.\u003c\/p\u003e\n\u003cp\u003eSo replacement of the mitral valve is also possible with transcatheter techniques. What kind of patients would benefit most? Is it just an unacceptable surgical risk for open mitral valve replacement that serves as an indication for percutaneous mitral valve repair?\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e There are nowadays patients who are at very, very high risk for conventional surgery. Those patients can benefit from the MitraClip. Because if we can offer them an effective percutaneous treatment with the MitraClip, this has to be preferred because the risk of the MitraClip procedure is extremely low.\u003c\/p\u003e\n\u003cp\u003eSo you mentioned a little bit earlier in the conversation that the wishes of the patient also play a significant role in choosing between open heart surgery techniques (for example, mitral valve repair) and transcatheter techniques of mitral valve treatment. So perhaps somebody is not considered the highest surgical risk based on medical definitions. But that patient perhaps wants to perhaps recover faster or is genuinely afraid of open-heart surgery. How would they weigh the results of transcatheter techniques today with the open heart surgery regarding the mitral valve treatment?\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e In mitral valve disease, open heart surgery offers the best results and the long-term outcome is extremely good. So it's difficult to propose a transcatheter technique for somebody who can have open heart surgery at very low risk and with excellent results from the open-heart surgery.\u003c\/p\u003e\n\u003cp\u003eSo in those particular cases, I would be rather reluctant to consider the patient's wish because it is not in his interest. And in those cases, it is usually very easy to talk with the patient. It is easy to convince him that the transcatheter method of mitral valve treatment is not the best way.\u003c\/p\u003e\n\u003cp\u003eOf course, the percutaneous method [of mitral valve repair or replacement] can be very attractive. But we have to face reality. We have to face the results and take into account the long-term benefits of each treatment procedure.\u003c\/p\u003e\n\u003cp\u003ePerhaps a patient nevertheless chooses the percutaneous transcatheter method of mitral valve treatment. Does that mean that they can expect to have the repeat surgery done in 10 years or five years? Or just the functional results are not as good as with open surgery?\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e Yeah, this depends on the anatomy [of mitral valve and heart]. The results are nothing compared with the results of open-heart surgery, particularly in organic mitral regurgitation situations. It is different in functional mitral regurgitation. In those cases, where the problem is particularly located in the left ventricle. It is not contracting properly. The left ventricle is dilated, and so on.\u003c\/p\u003e\n\u003cp\u003eIn those cases, the MitraClip can be suggested as the first treatment option. MitraClip is a more attractive option compared with surgical mitral valve repair methods. As a matter of fact, in the recent European Guidelines, the edge-to-edge transcatheter mitral valve repair is given as a recommendation of 2A grade. That means it should be considered for those particular patients.\u003c\/p\u003e\n\u003cp\u003eThe open-heart surgery option is not 2A grade. It is 2B grade recommendation so that open surgery may be considered.\u003c\/p\u003e\n\u003cp\u003eThat's very important. MitraClip for functional mitral regurgitation, meaning mitral regurgitation due to heart failure and intrinsic heart disease with the remodeling of the left ventricle.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e Exactly, exactly. So for those cases, the MitraClip, if it is suitable from the anatomical point of view, can be the correct treatment choice.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852069511324,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"tricuspid-valve-regurgitation-transcatheter-valve-repair-early-treatment-is-crucial-4","title":"Tricuspid valve regurgitation. Transcatheter valve repair. Early treatment is crucial. 4","description":"\u003ch1\u003eEarly Intervention in Tricuspid Valve Regurgitation: Surgical and Transcatheter Options\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#understanding-tricuspid-valve-regurgitation\"\u003eUnderstanding Tricuspid Valve Regurgitation\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#aggressive-treatment-strategies\"\u003eAggressive Treatment Strategies\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#role-of-mitral-regurgitation-in-tricuspid-valve-disease\"\u003eRole of Mitral Regurgitation in Tricuspid Valve Disease\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#transcatheter-techniques-for-tricuspid-valve-repair\"\u003eTranscatheter Techniques for Tricuspid Valve Repair\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#importance-of-early-diagnosis-and-treatment\"\u003eImportance of Early Diagnosis and Treatment\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#clinical-team-proactivity-in-managing-tricuspid-regurgitation\"\u003eClinical Team Proactivity in Managing Tricuspid Regurgitation\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"understanding-tricuspid-valve-regurgitation\"\u003eUnderstanding Tricuspid Valve Regurgitation\u003c\/h2\u003e\n\u003cp\u003eTricuspid valve regurgitation is a condition where the valve between the right atrium and right ventricle fails to close properly, leading to blood flow backward into the atrium. Dr. Ottavio Alfieri, MD, explains that this condition is often undertreated and can significantly complicate heart failure. It is crucial to address tricuspid regurgitation early to prevent poor prognosis and further heart complications.\u003c\/p\u003e\n\n\u003ch2 id=\"aggressive-treatment-strategies\"\u003eAggressive Treatment Strategies\u003c\/h2\u003e\n\u003cp\u003eDr. Titov emphasizes the need for aggressive treatment of tricuspid regurgitation, especially when associated with left-side heart valve diseases. Even if the regurgitation is not severe, intervention is necessary if there is tricuspid annulus dilatation. Early surgical intervention during left-side valve surgery can prevent further complications and improve patient outcomes.\u003c\/p\u003e\n\n\u003ch2 id=\"role-of-mitral-regurgitation-in-tricuspid-valve-disease\"\u003eRole of Mitral Regurgitation in Tricuspid Valve Disease\u003c\/h2\u003e\n\u003cp\u003eMitral regurgitation can contribute to the development of tricuspid regurgitation. Dr. Titov advises treating mitral problems first and, if possible, addressing tricuspid regurgitation simultaneously. This approach does not significantly increase surgical risk but can lead to substantial improvements in patient outcomes.\u003c\/p\u003e\n\n\u003ch2 id=\"transcatheter-techniques-for-tricuspid-valve-repair\"\u003eTranscatheter Techniques for Tricuspid Valve Repair\u003c\/h2\u003e\n\u003cp\u003eTranscatheter techniques for tricuspid valve repair are emerging as alternatives to open-heart surgery, particularly for high-risk patients. However, Dr. Titov notes that these methods are not yet as standardized as those for mitral valve treatment. He suggests reserving percutaneous treatments for patients with higher surgical risks and emphasizes the importance of early surgical intervention for those with low surgical risks.\u003c\/p\u003e\n\n\u003ch2 id=\"importance-of-early-diagnosis-and-treatment\"\u003eImportance of Early Diagnosis and Treatment\u003c\/h2\u003e\n\u003cp\u003eDr. Titov stresses the importance of early diagnosis and treatment of tricuspid valve regurgitation. Assessing right ventricular function and addressing regurgitation before severe symptoms or right ventricular dysfunction occur can lead to better outcomes and lower surgical risks. Early intervention is key to preventing pulmonary hypertension and ensuring long-term patient health.\u003c\/p\u003e\n\n\u003ch2 id=\"clinical-team-proactivity-in-managing-tricuspid-regurgitation\"\u003eClinical Team Proactivity in Managing Tricuspid Regurgitation\u003c\/h2\u003e\n\u003cp\u003eThe role of the clinical team, including surgeons and cardiologists, is crucial in managing tricuspid regurgitation. Dr. Titov highlights the need for proactive treatment at the earliest stages of the disease. Delaying surgery due to minimal symptoms can be a mistake, as early intervention significantly reduces surgical risks and enhances long-term benefits for patients.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD\u003c\/strong\u003e Let's discuss functional tricuspid regurgitation and tricuspid valve disease, which mostly means tricuspid regurgitation. It's a very undertreated problem, and functional tricuspid valve regurgitation often has a poor prognosis. It complicates overall heart failure. What are the treatment options today for tricuspid valve regurgitation? Especially, there is also the development of percutaneous transcatheter techniques. How does this compare with open-heart surgery?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD\u003c\/strong\u003e Certainly, tricuspid valve regurgitation is a problem, which is different in different scenarios. First of all, we can have tricuspid regurgitation associated with left-side heart valve diseases. Tricuspid regurgitation in those cases has to be treated very aggressively. In other words, even if tricuspid regurgitation is not severe, but we have tricuspid annulus dilatation, we have to correct tricuspid regurgitation when we do left-side valve surgery.\u003c\/p\u003e\n\n\u003cp\u003eThis is one scenario—tricuspid regurgitation in association with the mitral problem or the aortic problem. Then we have the scenario of isolated tricuspid regurgitation. You can have this scenario in the context of heart failure in patients who have been previously treated with left-side heart valve surgery. Patients could previously be treated with the MitraClip procedure. So we are faced now with isolated tricuspid regurgitation.\u003c\/p\u003e\n\n\u003cp\u003eIn this case, we have to be very aggressive. Even the recent guidelines of heart surgery suggest this. The right ventricle can be dilated, and even it may not be excessively dysfunctioned. But because we have right ventricular dysfunction, we have pulmonary hypertension. Then the surgical treatment is associated with a very high risk. So the message is to be very aggressive in those patients and treat tricuspid regurgitation. Even without severe symptoms, even with minimal symptoms, provided the ventricle is dilated, it will start to dysfunctional.\u003c\/p\u003e\n\n\u003cp\u003eThere is a subcategory of patients, which are difficult to treat. It's called HFpEF, heart failure with preserved ejection fraction. Sometimes it's a dysfunction of the right ventricle. Are these patients also affected with mitral regurgitation, or is that purely a medical problem to treat?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD\u003c\/strong\u003e I think that mitral regurgitation can have a role in developing tricuspid regurgitation. Once we have mitral problems, we have to treat the mitral problem first. And concomitantly, if possible, we have to treat tricuspid regurgitation.\u003c\/p\u003e\n\n\u003cp\u003eDuring the same surgery? During the same surgery, for sure. The tricuspid valve surgery in that context is not adding too much to the operation in terms of risk. But it is associated with a remarkable improvement in outcome.\u003c\/p\u003e\n\n\u003cp\u003eThe transcatheter treatment methods for tricuspid valve regurgitation. Do they also apply to the same kind of patient category?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD\u003c\/strong\u003e Tricuspid percutaneous treatment is not so much standardized as mitral valve treatment. Tricuspid percutaneous treatment certainly can be considered in higher-risk patients. But I would be reluctant to consider percutaneous tricuspid treatment in patients with the surgical tricuspid repair or replacement with a very low surgical risk.\u003c\/p\u003e\n\n\u003cp\u003eA very low surgical risk is in a very early stage of the tricuspid valve disease before symptoms appear. We only have right ventricular dilatation and initial dysfunction of the right ventricle.\u003c\/p\u003e\n\n\u003cp\u003eThat's very important. So it speaks to the necessity of really assessing the right ventricular function and right ventricular tricuspid valve regurgitation early to offer patients the best outcome and the least risk of surgery.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD\u003c\/strong\u003e Exactly! And the recent guidelines are really pointing out that. The secret to having good results in tricuspid valve surgery or percutaneous treatment is just to be aggressive. You must treat the patient before they develop severe symptoms, before the right ventricle is dysfunctional, and before pulmonary hypertension develops.\u003c\/p\u003e\n\n\u003cp\u003eSo this is where the role of the treating clinical team - the surgeon, the cardiologist - comes in. They have to be proactive in offering appropriate treatment at the earliest stages of the disease.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD\u003c\/strong\u003e Exactly. The early treatment at the early stages is the secret of this. It has to be very well considered by the cardiological community. The cardiological community tends to delay in the operation because the patients are reasonably well, because the patient is responding very well, for instance, to the diuretic medications. But this is basically a mistake.\u003c\/p\u003e\n\n\u003cp\u003eWe have to take into consideration that if surgery is done properly in the early stage of right ventricular disease, the risk of surgery is extremely low, approaching zero. And the benefit, in the long run, is very high.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852069544092,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"heart-failure-surgical-treatment-options-left-ventricular-remodeling-5","title":"Heart failure. Surgical treatment options.  Left ventricular remodeling. 5","description":"\u003ch1\u003eAdvanced Surgical Options for Congestive Heart Failure and Left Ventricular Remodeling\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#understanding-heart-failure-and-left-ventricular-remodeling\"\u003eUnderstanding Heart Failure and Left Ventricular Remodeling\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#benefits-of-surgical-restoration-of-the-left-ventricle\"\u003eBenefits of Surgical Restoration of the Left Ventricle\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#addressing-mitral-insufficiency-and-arrhythmias\"\u003eAddressing Mitral Insufficiency and Arrhythmias\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#hybrid-surgical-approaches-for-heart-failure\"\u003eHybrid Surgical Approaches for Heart Failure\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#the-role-of-a-multidisciplinary-heart-team\"\u003eThe Role of a Multidisciplinary Heart Team\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"understanding-heart-failure-and-left-ventricular-remodeling\"\u003eUnderstanding Heart Failure and Left Ventricular Remodeling\u003c\/h2\u003e\n\u003cp\u003eCongestive heart failure involves a complex disease process, including left ventricular remodeling. Dr. Ottavio Alfieri, MD, explains that heart failure can stem from various causes, such as idiopathic cardiomyopathy and ischemic cardiomyopathy, which affects about two-thirds of heart failure patients. These conditions lead to poor heart contraction, often due to ischemia, myocardial hibernation, or stunning. Addressing these pathophysiological components is crucial in managing heart failure effectively.\u003c\/p\u003e\n\n\u003ch2 id=\"benefits-of-surgical-restoration-of-the-left-ventricle\"\u003eBenefits of Surgical Restoration of the Left Ventricle\u003c\/h2\u003e\n\u003cp\u003eSurgical restoration of the left ventricle offers significant benefits for patients with heart failure. Dr. Ottavio Alfieri, MD highlights that this procedure reduces the size of the left ventricle and restores its physiological elliptical shape, enhancing contractility and eliminating dyssynchrony. By resecting arrhythmia-causing foci, the surgery also addresses malignant arrhythmias, improving overall heart function and patient quality of life.\u003c\/p\u003e\n\n\u003ch2 id=\"addressing-mitral-insufficiency-and-arrhythmias\"\u003eAddressing Mitral Insufficiency and Arrhythmias\u003c\/h2\u003e\n\u003cp\u003eMitral insufficiency and arrhythmias, such as atrial fibrillation, are common contributors to heart failure. Dr. Ottavio Alfieri, MD notes that surgical interventions can correct mitral valve issues and perform ablation procedures to eliminate atrial fibrillation. These treatments, combined with revascularization, tackle the underlying causes of left ventricular dysfunction, such as ischemia and myocardial hibernation.\u003c\/p\u003e\n\n\u003ch2 id=\"hybrid-surgical-approaches-for-heart-failure\"\u003eHybrid Surgical Approaches for Heart Failure\u003c\/h2\u003e\n\u003cp\u003eDr. Alfieri describes hybrid surgical approaches that combine multiple procedures in a single operation. For example, left ventricular restoration can be performed alongside mitral valve correction, atrial fibrillation ablation, and coronary artery bypass grafting. Alternatively, a hybrid approach may involve surgical remodeling with percutaneous interventions, such as coronary stenting or atrial fibrillation ablation, tailored to the patient's surgical risk and clinical profile.\u003c\/p\u003e\n\n\u003ch2 id=\"the-role-of-a-multidisciplinary-heart-team\"\u003eThe Role of a Multidisciplinary Heart Team\u003c\/h2\u003e\n\u003cp\u003eA multidisciplinary heart team is essential in the treatment of heart failure, as emphasized by Dr. Alfieri. This team approach ensures comprehensive decision-making and execution of complex procedures, involving specialists from various fields. By collaborating, the heart team can offer personalized treatment plans that optimize outcomes for patients with congestive heart failure and left ventricular remodeling.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e So let's discuss surgical therapy options in congestive heart failure. There is a disease process that happens in congestive heart failure. It's called a left ventricular remodeling. Heart transplantation has historically been the only option for congestive heart failure and end-stage congestive heart failure. But now new surgical techniques exist to reverse the left ventricular remodeling or at least to slow it down in congestive heart failure. Could you please discuss the surgical treatment options for patients with congestive heart failure today?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e Once you have patients with congestive heart failure, you have to consider the possible pathophysiological components of heart failure. For instance, you can have idiopathic cardiomyopathy, when the heart doesn't contract properly. This is one type of congestive heart failure. This is not so common compared with ischemic cardiomyopathy. Ischemic cardiomyopathy affects about two-thirds of the patients with heart failure.\u003c\/p\u003e\n\n\u003cp\u003eThe components of heart failure are different. You can have ischemia, you can have a hibernation of the myocardium. You can have a stunning of the myocardium. So the heart doesn't receive enough blood and it reacts by a poor contraction. Then you can have other reasons. For instance, you have a dilatation of the heart ventricle, some areas which are now akinetic, or dyskinetic. These factors can contribute to left ventricular dysfunction.\u003c\/p\u003e\n\n\u003cp\u003eYou can also have arrhythmias, for instance, atrial fibrillation. It contributes significantly to the poor left ventricular function. You can also have malignant arrhythmias, for instance. They contribute to problems in this situation. Obviously, you have to consider all these pathophysiological components. You may have, for instance, a dyskinetic area and dilatation of the left ventricle. You can propose a kind of a surgical restoration of the left ventricle.\u003c\/p\u003e\n\n\u003cp\u003eThis can be very effective because you reduce remarkably the size of the left ventricle. You also achieve the physiological shape of the left ventricle, which is not a ball, but it's an elliptic shape. The shape of the heart ventricle is very important for contraction. By offering this type of operation, so-called surgical restoration of the left ventricle, you will improve the quality of life. You improve the performance of the contractility of the left ventricle.\u003c\/p\u003e\n\n\u003cp\u003eYou will have eliminated dyssynchrony of a contraction of the left ventricle. Also, you can eliminate the malignant arrhythmias because you also resect the foci, which are responsible for the arrhythmia. There are many advantages of this type of operation. In addition, if mitral insufficiency is also present, you can treat the insufficiency of the mitral valve. Mitral regurgitation also contributes to heart failure. You can also eliminate this component of heart failure.\u003c\/p\u003e\n\n\u003cp\u003eYou can also eliminate atrial fibrillation with an ablation procedure. Then you can, of course, take care of that cardiac arrhythmia. You can also revascularize the patient. This will treat the hibernation of the ventricle or ischemia of the left ventricle. They produce this dysfunction of the contraction of the left ventricle. So putting together all these operations, you can really eliminate heart failure.\u003c\/p\u003e\n\n\u003cp\u003eWhen heart failure is too advanced, and you have a very, very low ejection fraction, almost the entire ventricle is fibrotic. Then you have options only of heart transplantation or left ventricular assist device or replacement of the heart or an artificial heart. But this, of course, is a more rare situation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e These surgical techniques are when you plan a heart failure surgery to stop advancement or to even reverse the left ventricular remodeling. Do you do that in one surgery? Or do you do it in sequential surgical operations?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e Many things you can do during the same surgery. For instance, you can make a restoration of the left ventricle together with correction of mitral insufficiency, ablation of atrial fibrillation, and revascularization of the heart. This is eliminating the problem of hibernation of the myocardium of the left ventricle.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Okay, that's very important. So you can do the hybrid heart surgery. You can do the coronary artery bypass grafting and at the same time you can solve the valvular problem. And that addresses the heart failure, left ventricular remodeling.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e You can do both surgical operations together. Or you can use also a hybrid type of approach. For instance, you can do the surgical remodeling of the left ventricle and use, for instance, a percutaneous coronary intervention to solve the ischemia problem of the left ventricle. You can also use, for instance, percutaneous ablation of atrial fibrillation in combination with the surgical left ventricle restoration.\u003c\/p\u003e\n\n\u003cp\u003eYou can really decide the correct intervention according to the surgical risk of the patient, the clinical profile, and the age of the patient. So you can try to offer the best treatment for the patient.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e So that's also important to emphasize the multidisciplinary approach.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e Exactly! What you have noticed from what I said is that there are different specialties interacting in this treatment. This is a typical example of the heart team. It is very important not only in the decision-making but also in performing the procedures.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852069609628,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"postoperative-complications-after-heart-surgery-low-cardiac-output-atrial-fibrillation-6","title":"Postoperative complications after heart surgery. Low cardiac output. Atrial fibrillation. 6","description":"\u003ch1\u003eManaging Postoperative Atrial Fibrillation and Low Cardiac Output After Heart Surgery\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#atrial-fibrillation-after-heart-surgery\"\u003eAtrial Fibrillation After Heart Surgery\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#treatment-of-postoperative-atrial-fibrillation\"\u003eTreatment of Postoperative Atrial Fibrillation\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#temporary-vs-chronic-atrial-fibrillation\"\u003eTemporary vs. Chronic Atrial Fibrillation\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#low-cardiac-output-post-surgery\"\u003eLow Cardiac Output Post-Surgery\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#other-postoperative-complications\"\u003eOther Postoperative Complications\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"atrial-fibrillation-after-heart-surgery\"\u003eAtrial Fibrillation After Heart Surgery\u003c\/h2\u003e\n\u003cp\u003eDr. Ottavio Alfieri, MD, notes that atrial fibrillation is a common complication following open-heart surgery. It typically occurs within the first few days to a week post-surgery. This condition can significantly impact a patient's prognosis if it persists, affecting both survival and quality of life.\u003c\/p\u003e\n\n\u003ch2 id=\"treatment-of-postoperative-atrial-fibrillation\"\u003eTreatment of Postoperative Atrial Fibrillation\u003c\/h2\u003e\n\u003cp\u003eDr. Ottavio Alfieri, MD explains that postoperative atrial fibrillation is usually treated with amiodarone, an antiarrhythmic medication. In cases where amiodarone is ineffective, electroshock therapy may be employed. Prompt treatment often results in a favorable outcome, allowing patients to maintain a normal long-term prognosis.\u003c\/p\u003e\n\n\u003ch2 id=\"temporary-vs-chronic-atrial-fibrillation\"\u003eTemporary vs. Chronic Atrial Fibrillation\u003c\/h2\u003e\n\u003cp\u003eAccording to Dr. Alfieri, temporary atrial fibrillation is typical in the immediate postoperative period. If atrial fibrillation persists beyond a month or two, it may be considered chronic. In such cases, ablation of arrhythmogenic foci might be considered to manage the condition effectively.\u003c\/p\u003e\n\n\u003ch2 id=\"low-cardiac-output-post-surgery\"\u003eLow Cardiac Output Post-Surgery\u003c\/h2\u003e\n\u003cp\u003eDr. Ottavio Alfieri, MD highlights low cardiac output as a significant postoperative complication, especially in patients with pre-existing ventricular dysfunction. Treatment options include medication, intra-aortic balloon counterpulsation, and ECMO. While severe cases are rare, they can be life-threatening if not addressed promptly.\u003c\/p\u003e\n\n\u003ch2 id=\"other-postoperative-complications\"\u003eOther Postoperative Complications\u003c\/h2\u003e\n\u003cp\u003eDr. Alfieri also mentions other potential complications following heart surgery, such as renal dysfunction, pulmonary problems, and rare but severe brain injuries. These complications, though infrequent, underscore the importance of vigilant postoperative care and early intervention to ensure optimal patient outcomes.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Let us discuss postoperative complications after open heart surgery and after minimally invasive transcatheter heart valve treatment procedures. One of the common complications is atrial fibrillation, but it's not the only one. How to treat postoperative atrial fibrillation? What is the prognosis in postoperative atrial fibrillation after heart surgery?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e Atrial fibrillation is one of the possible complications. It is, I must say, quite common after open-heart surgery. Usually, the patient responds very fast to the treatment with amiodarone. The situation can be very well controlled. The patient will have a long-term prognosis which is absolutely normal.\u003c\/p\u003e\n\n\u003cp\u003eIf atrial fibrillation persists after the surgical treatment of some heart disease, then the impact on prognosis is not negligible. It is so because atrial fibrillation has a negative impact on survival and the quality of life. A patient has to have oral anticoagulation. Certainly, also the style of life is totally different. But this is true if atrial fibrillation was not present before the surgical operation.\u003c\/p\u003e\n\n\u003cp\u003eIt is very difficult if the atrial fibrillation has been present in the long term. If atrial fibrillation is only temporary, those cases can be very easily treated with antiarrhythmic medications.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e What do you consider a period during which you would say to a patient? Okay, your postoperative atrial fibrillation is transient. Let's give it another month or two months.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e Usually, atrial fibrillation occurs after surgery in the first few days, in the first week. If a heart valve operation has been successful, rarely, atrial fibrillation occurs later on. So temporary atrial fibrillation is typical of the first week after cardiac surgery.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e How long does usually atrial fibrillation last after surgical operation?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e The patient is still hospitalized in this case, and atrial fibrillation is treated immediately and almost invariably with a very good result. Atrial fibrillation treatment is usually an infusion of amiodarone. If this is not effective, electroshock can be used.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e So if it goes on for a month or two months, that's already considered chronic atrial fibrillation?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e This is very uncommon, but if atrial fibrillation was not present before the surgical operation, it's very uncommon that atrial fibrillation is present postoperatively. It is very uncommon that atrial fibrillation lasts a long time.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Then you consider the ablation of the arrhythmogenic foci?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e You can consider ablation of arrhythmogenic foci and treat atrial fibrillation when it becomes chronic.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e What are the other common complications postoperatively in heart valve surgery?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e One of the most common complications can be different degrees of low cardiac output. Low cardiac output is quite common, particularly if the operation is carried out not in the very early stage of heart disease. Heart valve problems can be present for a long time. There was ventricular dysfunction before the surgical operation. Then you can have a low cardiac output postoperatively.\u003c\/p\u003e\n\n\u003cp\u003eLow cardiac output is treated first with the medication. Then you can use intraaortic balloon counterpulsation. You can even use ECMO, which supplies the heart and the lungs for a while with artificially oxygenated blood. Low cardiac output can be treated. Sometimes low cardiac output can be so severe. It can also be fatal. Fortunately, it is very, very rare nowadays.\u003c\/p\u003e\n\n\u003cp\u003eThen you can have other complications like renal dysfunction. You can also have pulmonary problems. And this is very catastrophic, but it is very, very rare. You can have a brain injury after cardiac surgery. That is really something that is a tragedy. It occurs very, very rarely today, but it's something that can happen.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852069642396,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"how-to-choose-best-treatment-for-heart-disease-famous-surgeon-explains-7","title":"How to choose best treatment for heart disease? Famous surgeon explains. 7","description":"\u003ch1\u003eChoosing Optimal Heart Valve Disease Treatment: Insights from a Cardiac Surgeon\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#early-detection-of-heart-valve-disease\"\u003eEarly Detection of Heart Valve Disease\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#importance-of-diagnostic-testing\"\u003eImportance of Diagnostic Testing\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#exploring-treatment-options\"\u003eExploring Treatment Options\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#choosing-a-center-of-excellence\"\u003eChoosing a Center of Excellence\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#proactive-approach-to-treatment\"\u003eProactive Approach to Treatment\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#benefits-of-early-intervention\"\u003eBenefits of Early Intervention\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"early-detection-of-heart-valve-disease\"\u003eEarly Detection of Heart Valve Disease\u003c\/h2\u003e\n\u003cp\u003eDr. Ottavio Alfieri, MD, stresses that heart valve disease often lacks immediate symptoms, making early detection crucial. Patients should be vigilant for subtle changes, such as arrhythmias or shortness of breath, which may indicate underlying heart issues. Early detection allows for timely evaluation and intervention, potentially preventing further complications.\u003c\/p\u003e\n\n\u003ch2 id=\"importance-of-diagnostic-testing\"\u003eImportance of Diagnostic Testing\u003c\/h2\u003e\n\u003cp\u003eDr. Ottavio Alfieri, MD highlights echocardiography as a key diagnostic tool for assessing heart valve function. This non-invasive test provides valuable insights into the severity of heart valve disease. If significant disease is detected, it is essential to consider treatment options promptly to avoid progression and associated risks.\u003c\/p\u003e\n\n\u003ch2 id=\"exploring-treatment-options\"\u003eExploring Treatment Options\u003c\/h2\u003e\n\u003cp\u003eAccording to Dr. Ottavio Alfieri, MD, heart valve disease treatment varies from minimally invasive procedures to more traditional surgical approaches. Transcatheter treatments offer advantages such as no need for anesthesia or incisions, but patients must weigh these benefits against long-term effectiveness, especially for younger individuals seeking lifelong solutions.\u003c\/p\u003e\n\n\u003ch2 id=\"choosing-a-center-of-excellence\"\u003eChoosing a Center of Excellence\u003c\/h2\u003e\n\u003cp\u003eDr. Alfieri advises patients to seek treatment at specialized heart valve centers with comprehensive expertise. These centers provide access to a full spectrum of therapeutic options, ensuring personalized care tailored to each patient's unique needs. A center of excellence can offer the best chance for successful outcomes.\u003c\/p\u003e\n\n\u003ch2 id=\"proactive-approach-to-treatment\"\u003eProactive Approach to Treatment\u003c\/h2\u003e\n\u003cp\u003eDr. Ottavio Alfieri, MD, emphasizes the importance of not ignoring symptoms or delaying treatment. Proactive management, including timely surgical intervention, can significantly improve recovery and quality of life. Patients should engage actively with their healthcare providers to explore all available treatment paths.\u003c\/p\u003e\n\n\u003ch2 id=\"benefits-of-early-intervention\"\u003eBenefits of Early Intervention\u003c\/h2\u003e\n\u003cp\u003eEarly intervention in heart valve disease, as noted by Dr. Alfieri, can prevent complications such as ventricular dysfunction and pulmonary hypertension. Addressing structural heart issues before symptoms worsen leads to outcomes comparable to those of the general population, underscoring the value of early treatment.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Professor Alfieri, you are a world-renowned cardiac surgeon. You pioneered several methods of heart surgery and have treated tens of thousands of patients with heart valve disease and other heart diseases of every degree of difficulty. How should a patient with heart disease think about choosing the best treatment, especially for patients in your specialty in cardiac heart valve disease?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e First of all, you have to be aware that very often, heart valve disease doesn't produce immediately important symptoms. So, as a patient, you have to be rather careful and try to detect something different from what was the condition before. You may feel, for instance, some arrhythmias or dyspnea. If you are short of breath or have some of these symptoms, you need to evaluate your situation. This can be very easily done in any place. You can have an echocardiogram showing how the heart valves are functioning.\u003c\/p\u003e\n\n\u003cp\u003eIf important heart valve disease is found, then it is very important to be treated in heart valve centers where you can find all the experience and expertise to offer you the best treatment for your situation. The important thing is to be aware that heart valve disease can be treated differently. Treatment can be more invasive, or it can be minimally invasive. Treatment can even be done with catheters.\u003c\/p\u003e\n\n\u003cp\u003eObviously, we are all attracted by the fact that transcatheter heart disease treatment doesn't require anesthesia, an incision, extracorporeal circulation, or thoracotomy. Nothing! So everybody is very much attracted by that. But we have to consider the result of the treatment. If you're a young patient, you really have to consider that the most important thing is to have a treatment that can be effective for your entire life. You have to solve your problem definitively.\u003c\/p\u003e\n\n\u003cp\u003eThese are the considerations you need to have to be treated properly. You have to be in contact all the time with your doctors and be aware of all therapeutic options available today. You must have confidence in your doctors, particularly in their ability to have the availability of all the therapeutic options. If your doctor has only one way to treat the heart valve disease, then you're going to have that treatment. You are not offered what may be the best treatment. So it's very important to choose a center of excellence where you can have all the procedures available. In such a way, you can be sure that doctors will offer you the best treatment for your individual need.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e So what I hear is it's important for patients, as soon as they notice that something is not as perfect as it might have been in the past, to be proactive in doing appropriate diagnostic testing. You mentioned echocardiography.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e Echocardiography is probably the easiest diagnostic test. If echocardiography shows important heart valve disease, then you have to think about the treatment. The treatment should be carried out in centers that have experience and expertise.\u003c\/p\u003e\n\n\u003cp\u003eAlso, it's important to be proactive. A patient should not ignore the symptoms and sometimes follow just a conservative therapy path. Because doing the surgery early, at the appropriate time, is key to recovery.\u003c\/p\u003e\n\n\u003cp\u003eYes, because this is very typical for some heart valve diseases. For instance, mitral regurgitation, tricuspid valve regurgitation, aortic valve insufficiency, and many valve diseases are all asymptomatic for a long time. Unfortunately, when the patient becomes symptomatic, it is often too late because we already have some degree of left ventricular dysfunction, right ventricular dysfunction, or pulmonary hypertension. Your life, even after treatment, is not going to be as normal as that of the general population.\u003c\/p\u003e\n\n\u003cp\u003eAddressing the structural heart valve disease early leads to the best result.\u003c\/p\u003e\n\n\u003cp\u003eExactly! Early treatment leads to a quality of life that is similar to a normal population. But the secret is early treatment!\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852069675164,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"heart-valve-problems-can-be-a-sign-of-systemic-disease-treatment-options-8","title":"Heart valve problems \u2028can be a sign of systemic disease. Treatment options. 8","description":"\u003ch1\u003eHeart Valve Disorders as Indicators of Systemic Diseases\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#systemic-diseases-affecting-heart-valves\"\u003eSystemic Diseases Affecting Heart Valves\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#impact-of-oncologic-treatments-on-valve-function\"\u003eImpact of Oncologic Treatments on Valve Function\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#genetic-disorders-and-heart-valve-disease\"\u003eGenetic Disorders and Heart Valve Disease\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#autoimmune-conditions-and-valve-health\"\u003eAutoimmune Conditions and Valve Health\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#surgical-approach-to-systemic-valve-disease\"\u003eSurgical Approach to Systemic Valve Disease\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"systemic-diseases-affecting-heart-valves\"\u003eSystemic Diseases Affecting Heart Valves\u003c\/h2\u003e\n\u003cp\u003eDr. Ottavio Alfieri, MD, explains that heart valve problems can often be a sign of underlying systemic diseases. Conditions such as Marfan syndrome, systemic lupus erythematosus, and rheumatoid arthritis are known to affect heart valves. Early diagnosis of these systemic diseases is crucial, as it can help in managing heart valve issues more effectively.\u003c\/p\u003e\n\n\u003ch2 id=\"impact-of-oncologic-treatments-on-valve-function\"\u003eImpact of Oncologic Treatments on Valve Function\u003c\/h2\u003e\n\u003cp\u003eDr. Ottavio Alfieri, MD notes that oncologic treatments, including radiation and certain medications, can adversely affect heart valve function. Post-radiotherapy valvular problems are increasingly common, necessitating awareness among healthcare providers. Monitoring and managing these effects are essential to prevent long-term damage to heart valves.\u003c\/p\u003e\n\n\u003ch2 id=\"genetic-disorders-and-heart-valve-disease\"\u003eGenetic Disorders and Heart Valve Disease\u003c\/h2\u003e\n\u003cp\u003eGenetic conditions like Marfan syndrome are frequently associated with heart valve abnormalities, particularly affecting the mitral and aortic valves. Dr. Ottavio Alfieri, MD emphasizes the importance of recognizing these genetic links to provide timely and appropriate treatment for affected patients.\u003c\/p\u003e\n\n\u003ch2 id=\"autoimmune-conditions-and-valve-health\"\u003eAutoimmune Conditions and Valve Health\u003c\/h2\u003e\n\u003cp\u003eAutoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis can also manifest as heart valve problems. Dr. Ottavio Alfieri, MD highlights the need for a multidisciplinary approach in managing these patients, ensuring that cardiac surgeons and cardiologists work closely with other specialists to address the complex needs of these patients.\u003c\/p\u003e\n\n\u003ch2 id=\"surgical-approach-to-systemic-valve-disease\"\u003eSurgical Approach to Systemic Valve Disease\u003c\/h2\u003e\n\u003cp\u003eDr. Ottavio Alfieri, MD, advocates for an aggressive surgical approach to heart valve disease caused by systemic conditions. He stresses the importance of early intervention to prevent irreversible changes, such as left ventricular dilation and fibrosis. By addressing heart valve issues promptly, the risk of reaching a terminal stage of heart disease can be minimized.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Professor Alfieri, you are a world-renowned expert in the surgical treatment of heart valves. Sometimes the heart valve problem with the aortic valve, the mitral valve, or the tricuspid valve could be a sign of systemic disease. It's important to diagnose the systemic disease as early as possible, perhaps based on the heart valve symptoms. Would you please discuss some systemic diseases that may manifest as heart valve problems?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e They're quite common nowadays. Patients present with some oncologic problems which are treated with drugs or radiation. Of course, radiation and drugs can influence the function of heart valves. This is a common situation nowadays to have post-radiotherapy valvular problems.\u003c\/p\u003e\n\n\u003cp\u003eYou can also have specific tumors, like the carcinoid heart valve, which can affect the heart valves, particularly the right-side heart valves, the tricuspid, and a pulmonary valve. You can have Marfan syndrome, for instance. It is quite often associated with the genetic disease of the mitral valve and also with aortic valve insufficiency.\u003c\/p\u003e\n\n\u003cp\u003eYou can have systemic lupus erythematosus, for instance. You can have rheumatoid arthritis and antiphospholipid syndrome. And you can have all these systemic diseases which can be associated with heart valve diseases.\u003c\/p\u003e\n\n\u003cp\u003eSo, a cardiac surgeon and a cardiologist should be very aware of the systemic diseases and work in concert with other multidisciplinary teams and other specialists.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Exactly! Particularly if some symptoms typical of heart valve disease are present. In those particular subsets of patients, you have to be aware that valves can be involved.\u003c\/p\u003e\n\n\u003cp\u003eFrom a surgical perspective, are you as aggressive in treating heart valve disease that's caused by systemic disease? Are there other differences in your approach?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e No, I think that you have to be similarly aggressive with this heart valve disease. The important thing is to avoid situations that are becoming irreversible. For instance, the left side of the heart is becoming too dilated, fibrotic, and the wall of the left ventricle is becoming thinner. Then it is something with this situation that was lost there. So we have to avoid being in this terminal stage of heart valve disease. We have to do things earlier.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852069707932,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"future-in-cardiac-surgery-heart-disease-treatment-will-be-like-going-to-a-dentist-today-9","title":"Future in cardiac surgery. Heart disease treatment will be like going to a dentist today. 9","description":"\u003ch1\u003eFuture Advancements in Heart Disease Treatment: A Vision for Routine Care\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#future-of-heart-surgery-less-invasive-procedures\"\u003eFuture of Heart Surgery: Less Invasive Procedures\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#innovative-medical-devices-for-heart-disease\"\u003eInnovative Medical Devices for Heart Disease\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#personalized-heart-disease-treatment\"\u003ePersonalized Heart Disease Treatment\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#precision-surgery-in-heart-care\"\u003ePrecision Surgery in Heart Care\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#comprehensive-treatment-for-heart-failure\"\u003eComprehensive Treatment for Heart Failure\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"future-of-heart-surgery-less-invasive-procedures\"\u003eFuture of Heart Surgery: Less Invasive Procedures\u003c\/h2\u003e\n\u003cp\u003eDr. Ottavio Alfieri, MD, envisions a future where heart surgery becomes less invasive, akin to a routine dental visit. He predicts that in 10 to 20 years, heart disease treatments will be quick and efficient, potentially completed in a single afternoon. This shift towards minimally invasive procedures aims to enhance patient comfort and recovery.\u003c\/p\u003e\n\n\u003ch2 id=\"innovative-medical-devices-for-heart-disease\"\u003eInnovative Medical Devices for Heart Disease\u003c\/h2\u003e\n\u003cp\u003eDr. Ottavio Alfieri, MD highlights the continuous development of medical devices designed to treat heart disease. Each year, the array of available devices expands, offering more sophisticated and targeted solutions. These innovations are tailored to address specific cardiac conditions, contributing to more effective and individualized patient care.\u003c\/p\u003e\n\n\u003ch2 id=\"personalized-heart-disease-treatment\"\u003ePersonalized Heart Disease Treatment\u003c\/h2\u003e\n\u003cp\u003eAccording to Dr. Alfieri, the future of heart disease treatment lies in personalization. Treatments will be increasingly individualized, catering to the unique needs of each patient. This approach ensures that therapeutic interventions are precisely aligned with the patient's specific cardiac condition, enhancing treatment efficacy.\u003c\/p\u003e\n\n\u003ch2 id=\"precision-surgery-in-heart-care\"\u003ePrecision Surgery in Heart Care\u003c\/h2\u003e\n\u003cp\u003eDr. Ottavio Alfieri, MD, emphasizes the emergence of precision surgery in heart care. This advancement goes beyond precision medicine, offering surgical interventions that are finely tuned to the patient's unique cardiac anatomy and pathology. Precision surgery promises improved outcomes and reduced recovery times for heart disease patients.\u003c\/p\u003e\n\n\u003ch2 id=\"comprehensive-treatment-for-heart-failure\"\u003eComprehensive Treatment for Heart Failure\u003c\/h2\u003e\n\u003cp\u003eDr. Alfieri shares insights into the comprehensive treatment of heart failure, where multiple cardiac issues are addressed simultaneously. He recalls cases where patients with complex conditions, such as ischemia and arrhythmias, received coordinated care within heart valve centers. This collaborative approach ensures that all aspects of heart failure are managed effectively, leading to better patient outcomes.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Professor Alfieri, what is the future in the surgical treatment of heart disease? What is heart surgery moving towards? What can patients expect to see as treatments in the next five to 10 years?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e To foresee the future is obviously difficult. But I can see the situation more or less. The idea is that the toolbox of the therapeutic options is going to increase gradually. Treatments are going to be less invasive. I would say maybe in 10 to 20 years, patients with heart disease could go to have the treatment like today somebody goes to the dentist. Treatment of heart disease takes a very short time, just in one afternoon, for instance. So that is a vision. But I think that probably this is the direction of heart disease treatment.\u003c\/p\u003e\n\n\u003cp\u003eThere are more and more medical devices for heart disease treatment.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e Exactly! As I told you, the toolbox every year will be more sophisticated. There will be more devices invented. Devices will be designed for just specific situations, and so on. The treatment will be more and more personalized, more and more individualized. Heart disease treatments will just respond to the individual needs of the individual patient.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e So not just precision medicine, but precision surgery is coming to all patients. Exactly! Is there a patient story that you could discuss that perhaps illustrates some of the topics we talked about today?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e I think that probably the most important aspect is what we mentioned before. When a patient can have many problems altogether, for instance, typically it is a patient with heart failure. To be able to identify all the components of heart failure is crucial to have a very good result of treatment. I can recall patients that have been very impressive for me. Those patients could receive many treatments together in the context of a heart valve center. They had all the pathophysiological components of heart failure solved.\u003c\/p\u003e\n\n\u003cp\u003eI mentioned patients with ischemia, myocardial hibernation, myocardial stunning, arrhythmias, dilatation of the heart ventricle, dyskinesia. All these things can be treated altogether. I think that this is a very good example of something that can be done today. All these patients are treated by physicians that cooperate effectively within the heart team and within a heart valve center.\u003c\/p\u003e\n\n\u003cp\u003eIt is very important to have multiple abnormalities and symptoms and pathophysiology treated at the same center. Treatment may involve perhaps several procedures, but all problems are addressed in one place.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852069773468,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"try-to-avoid-unnecessary-treatments-eminent-cardiac-surgeon-shares-his-wisdom-10","title":"‘Try to avoid unnecessary treatments!’ Eminent cardiac surgeon shares his wisdom. 10","description":"\u003ch1\u003ePersonalized Treatment in Heart Valve Disease: Insights from a Leading Cardiac Surgeon\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#importance-of-personalized-treatment\"\u003eImportance of Personalized Treatment\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#unique-patient-profiles\"\u003eUnique Patient Profiles\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#skillful-neglection-in-treatment\"\u003eSkillful Neglection in Treatment\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#focus-on-essential-treatments\"\u003eFocus on Essential Treatments\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#simplicity-and-effectiveness\"\u003eSimplicity and Effectiveness\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"importance-of-personalized-treatment\"\u003eImportance of Personalized Treatment\u003c\/h2\u003e\n\u003cp\u003eDr. Ottavio Alfieri, MD, highlights the critical need for personalized treatment in heart valve disease. He stresses that each patient is unique, with distinct genetic and clinical profiles. Personalized treatment ensures that therapies are tailored to individual needs, improving outcomes and patient satisfaction.\u003c\/p\u003e\n\n\u003ch2 id=\"unique-patient-profiles\"\u003eUnique Patient Profiles\u003c\/h2\u003e\n\u003cp\u003eDr. Ottavio Alfieri, MD explains that every patient has a unique genetic makeup and life history. These factors, along with personal preferences, should guide treatment decisions. Recognizing these differences allows for more effective and patient-centered care, particularly in heart valve disease management.\u003c\/p\u003e\n\n\u003ch2 id=\"skillful-neglection-in-treatment\"\u003eSkillful Neglection in Treatment\u003c\/h2\u003e\n\u003cp\u003eIntroducing the concept of \"skillful neglection,\" Dr. Alfieri advises focusing on the most critical aspects of a patient's condition. By avoiding unnecessary treatments, healthcare providers can concentrate on interventions that significantly impact patient well-being, especially in older and fragile individuals.\u003c\/p\u003e\n\n\u003ch2 id=\"focus-on-essential-treatments\"\u003eFocus on Essential Treatments\u003c\/h2\u003e\n\u003cp\u003eDr. Ottavio Alfieri, MD emphasizes the importance of addressing the core issues responsible for a patient's discomfort. By targeting essential treatments, physicians can reduce the burden of disease and improve quality of life. This approach is particularly beneficial for older patients who may not tolerate extensive interventions.\u003c\/p\u003e\n\n\u003ch2 id=\"simplicity-and-effectiveness\"\u003eSimplicity and Effectiveness\u003c\/h2\u003e\n\u003cp\u003eDr. Alfieri advocates for simplicity and effectiveness in treatment plans. He suggests avoiding overly complex or prolonged therapies, instead opting for straightforward solutions that directly address patient needs. This philosophy has guided his clinical practice and contributes to better patient outcomes.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Professor Alfieri, is there a topic or a question that I didn't ask but should have asked? Is there anything in your interest or your experience that you'd like to share?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Ottavio Alfieri, MD:\u003c\/strong\u003e During our full conversation, we touched on many points. I think that one thing, one message, should be very, very important. Every patient is unique. The genetic profile of the patient, the wishes of that patient, the history of the life of a patient up to the present time. Every patient has the right to choose whatever treatment he likes. Also, the clinical profile can be very different from patient to patient.\u003c\/p\u003e\n\n\u003cp\u003eA very important message is that we have to personalize the treatment very much. We should not give the same treatment to everybody, and the therapy should be very much personalized. So, I think that is a very important aspect to consider in the modern treatment of heart valve disease.\u003c\/p\u003e\n\n\u003cp\u003eThe other important point I think is this. Particularly when we have older and fragile people, we have to treat the most important aspect of the disease. It is what I call 'skillful neglection.' Try to avoid unnecessary treatments. Really try to just focus on the important aspect of treatment that can reduce the problem of the patient.\u003c\/p\u003e\n\n\u003cp\u003eSo I think that is a very important aspect which has to be taken into consideration. A doctor has just to address what is responsible for the not-well-being of the patient. And this is particularly important for older and fragile patients.\u003c\/p\u003e\n\n\u003cp\u003eThe other important thing is the simplicity of the treatment plan. Try not to do things in a very sophisticated way or to prolong the treatment of the patient. Just be simple and effective, and address the problem of that particular patient. So these are the principles that have been the basis of my clinical practice all the time. I think they should be taken into consideration for the well-being of the patients.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Professor Alfieri, thank you very much for sharing your wisdom and knowledge, but much beyond that. It's a pleasure to have this conversation. We hope to come back to you in the future as cardiac surgery, and all the specialties around cardiac surgery are further developed. Thank you very much!\u003c\/p\u003e\n\n\u003cp\u003eOkay, thank you. It was a very nice conversation. I enjoyed talking with you. And I hope that some patients can also take advantage of our conversation. Thank you. Thank you!\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852069806236,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"dr-nadir-arber-cancer-prevention-and-screening-expert-biography-0","title":"Dr. Nadir Arber. Cancer prevention and screening expert. Biography. 0","description":"\u003ch1\u003eEffective Strategies for Cancer Prevention and Early Detection\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#cancer-prevention-expertise\"\u003eCancer Prevention Expertise\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#academic-and-professional-background\"\u003eAcademic and Professional Background\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#gastrointestinal-cancer-focus\"\u003eGastrointestinal Cancer Focus\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#innovations-in-cancer-screening\"\u003eInnovations in Cancer Screening\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#contributions-to-cancer-gene-therapy\"\u003eContributions to Cancer Gene Therapy\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#leadership-and-publications\"\u003eLeadership and Publications\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"cancer-prevention-expertise\"\u003eCancer Prevention Expertise\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, is renowned for his expertise in cancer prevention and early detection. As the head of the Integrated Cancer Prevention Center at Tel Aviv Sourasky Medical Center, he focuses on strategies to prevent cancer and detect it at an early stage. His work emphasizes the importance of screening and prevention in reducing cancer incidence and improving patient outcomes.\u003c\/p\u003e\n\n\u003ch2 id=\"academic-and-professional-background\"\u003eAcademic and Professional Background\u003c\/h2\u003e\n\u003cp\u003eDr. Arber's academic journey began at Hadassah Medical School in Jerusalem, where he earned his MD. He furthered his education with a Master of Science from Tel Aviv University and an MBA from the Reckanti School of Business Administration. His residency in internal medicine was completed at Rabin Medical Center, followed by a fellowship in gastroenterology at Tel Aviv Medical Center. Dr. Arber also completed a research fellowship at Columbia University's Comprehensive Cancer Center in New York.\u003c\/p\u003e\n\n\u003ch2 id=\"gastrointestinal-cancer-focus\"\u003eGastrointestinal Cancer Focus\u003c\/h2\u003e\n\u003cp\u003eDr. Arber's clinical and research interests are centered on gastrointestinal cancers, including esophageal, pancreatic, and colorectal cancer. Since 1999, he has led the Gastrointestinal Oncology Unit at Tel Aviv Medical Center. His work involves developing new molecular markers for these cancers, aiming to enhance early detection and treatment options.\u003c\/p\u003e\n\n\u003ch2 id=\"innovations-in-cancer-screening\"\u003eInnovations in Cancer Screening\u003c\/h2\u003e\n\u003cp\u003eDr. Arber is at the forefront of developing novel screening methods for colorectal cancer. His research includes creating devices that can navigate the intestines to detect cancer early. These innovations are crucial for improving screening accuracy and patient compliance, ultimately leading to better cancer outcomes.\u003c\/p\u003e\n\n\u003ch2 id=\"contributions-to-cancer-gene-therapy\"\u003eContributions to Cancer Gene Therapy\u003c\/h2\u003e\n\u003cp\u003eDr. Arber is actively involved in advancing cancer gene therapy, particularly for gastrointestinal cancers like pancreatic and colorectal cancer. His research aims to harness genetic insights to develop targeted therapies that can improve treatment efficacy and patient survival rates.\u003c\/p\u003e\n\n\u003ch2 id=\"leadership-and-publications\"\u003eLeadership and Publications\u003c\/h2\u003e\n\u003cp\u003eIn 2014, Dr. Arber was elected President of the Israeli Society of Gastroenterology, reflecting his leadership in the field. He has authored nearly 400 peer-reviewed publications and frequently presents at international conferences, sharing his insights on cancer prevention, screening, and treatment. His contributions continue to shape the future of cancer care.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Hello from Tel Aviv! We are with Dr. Nadir Arber, MD, who is a Professor of Medicine and Gastroenterology at Tel Aviv University and Head of the Integrated Cancer Prevention Center at Tel Aviv Sourasky Medical Center. Dr. Arber obtained his MD from the Medical School at Hadassah, Jerusalem. He completed his Master of Science at Tel Aviv University and an MBA from the Recanati School of Business Administration.\u003c\/p\u003e\n\n\u003cp\u003eDr. Arber did his residency in internal medicine at Rabin Medical Center and a fellowship in gastroenterology at Tel Aviv Medical Center. He also completed a research fellowship at the Comprehensive Cancer Center at Columbia University in New York. In 1999, Dr. Nadir Arber became the head of the Gastrointestinal Oncology Unit at the Department of Gastroenterology at Tel Aviv Medical Center.\u003c\/p\u003e\n\n\u003cp\u003eIn 2002, Dr. Arber established the Integrated Cancer Prevention Center at Tel Aviv Medical Center. In 2014, he was chosen as the President of the Israeli Society of Gastroenterology. Dr. Arber's clinical and research interests include the prevention, screening, diagnosis, and treatment of gastrointestinal cancers, including esophageal, pancreatic, and colorectal cancer.\u003c\/p\u003e\n\n\u003cp\u003eHe leads the development of new molecular markers for gastrointestinal cancers and develops novel ways to screen for colorectal cancer with devices that can pass through the intestines. Dr. Arber is actively involved in the development of cancer gene therapy for gastrointestinal cancers, including pancreatic and colorectal cancer.\u003c\/p\u003e\n\n\u003cp\u003eDr. Arber has authored and co-authored almost 400 peer-reviewed publications in international medical journals and has presented numerous talks on cancer prevention, screening, and treatment at international conferences. Dr. Arber, hello and welcome!\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852069839004,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"diagnosing-cancer-early-cancer-or-no-cancer-screening-test-1","title":"Diagnosing cancer early. Cancer or no cancer? Screening test. 1","description":"\u003ch1\u003eInnovative Blood Tests for Early Cancer Detection\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#cancer-screening-importance\"\u003eCancer Screening Importance\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#rising-cancer-rates-and-causes\"\u003eRising Cancer Rates and Causes\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#advancements-in-cancer-detection\"\u003eAdvancements in Cancer Detection\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#blood-tests-for-cancer-detection\"\u003eBlood Tests for Cancer Detection\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#universal-cancer-detection-tests\"\u003eUniversal Cancer Detection Tests\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#future-of-cancer-screening\"\u003eFuture of Cancer Screening\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"cancer-screening-importance\"\u003eCancer Screening Importance\u003c\/h2\u003e\n\u003cp\u003eCancer screening plays a crucial role in early detection, which can significantly improve treatment outcomes. Dr. Nadir Arber, MD, emphasizes the need for screening methods that answer the fundamental question: Is there cancer in the body? Early detection allows for targeted diagnostic tests, reducing unnecessary exposure to radiation and invasive procedures.\u003c\/p\u003e\n\n\u003ch2 id=\"rising-cancer-rates-and-causes\"\u003eRising Cancer Rates and Causes\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, notes the alarming increase in cancer rates, attributing it to environmental degradation, sedentary lifestyles, and longer life expectancies. With 14 million new cancer cases annually, the need for effective screening and prevention methods is more critical than ever.\u003c\/p\u003e\n\n\u003ch2 id=\"advancements-in-cancer-detection\"\u003eAdvancements in Cancer Detection\u003c\/h2\u003e\n\u003cp\u003eDespite the rising incidence of cancer, Dr. Nadir Arber, MD highlights improvements in mortality rates for certain cancers, such as lung and colon cancer. He points to recent studies from Johns Hopkins and Australia that showcase promising new cancer detection methods, particularly in the realm of blood tests.\u003c\/p\u003e\n\n\u003ch2 id=\"blood-tests-for-cancer-detection\"\u003eBlood Tests for Cancer Detection\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, discusses the development of blood tests capable of detecting multiple cancers, including pre-cancerous conditions like colon polyps. These tests differentiate between cancerous and healthy individuals, offering a non-invasive option for early detection and guiding further diagnostic procedures like colonoscopies.\u003c\/p\u003e\n\n\u003ch2 id=\"universal-cancer-detection-tests\"\u003eUniversal Cancer Detection Tests\u003c\/h2\u003e\n\u003cp\u003eDr. Arber envisions a future where a universal cancer detection test, similar to a \"liquid biopsy,\" becomes available. Such tests would screen for cancer markers in the blood, providing a simple yet comprehensive method for early cancer detection across various types.\u003c\/p\u003e\n\n\u003ch2 id=\"future-of-cancer-screening\"\u003eFuture of Cancer Screening\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, predicts that universal cancer detection tests will be available within the next five years. These tests will revolutionize cancer screening by offering a single, efficient method to detect cancer presence, ultimately improving early diagnosis and treatment outcomes.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Best cancer screening method answers first a simple question. Is there a cancer in the body? Or not? If the answer is ‘yes’, then more targeted cancer diagnostic tests can be employed. If ‘no’, a patient is saved from potential risks of radiation exposure and invasive cancer testing.\u003c\/p\u003e\n\n\u003cp\u003eCancer rates increase due to worsening environment. Cancer risks increase due to the sedentary lifestyle of people. There is more cancer because people are living longer. But a lot of cancer screening and prevention methods are very old. What is new in cancer prevention? What is new in cancer screening?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e It's true that the incidence of cancer is increasing worldwide. Cancer rate comes to alarming levels of 14 million new cancer cases every year. About two-thirds of cancer patients are going to die every year. But at the same time, there is some improvement in cancer screening. We do see some decline in the mortality from a few cancers. There is less mortality from lung cancer and colon cancer.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e It's true. Usually, early cancer detection is lagging behind the novel cancer therapies. Cancer screening lags behind the rise in cancer incidence. But still, we have new cancer detection methods on the horizon.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e There were two articles just this year. One cancer screening article is from Johns Hopkins. It is from the Dr. Burt Vogelstein group. Another cancer prevention article is from Australia. There are blood tests that can detect cancers. Diagnostic tests can find several cancers. In my eyes, this is a real breakthrough. If you can find a blood test that can tell us if there is cancer there or not, this could be a breakthrough!\u003c\/p\u003e\n\n\u003cp\u003eWe are also developing similar cancer detection tests in our lab. We are using simple blood tests. You can identify about 6-7-8 cancers. It depends on the difference between people with cancer and healthy people. In particular, we are happy that we are able to detect some pre-cancers. We can detect colon polyps. If you are able to detect polyps, then we know who needs a colonoscopy. Because these people are prone to develop colorectal cancer.\u003c\/p\u003e\n\n\u003cp\u003eYou are correct. We are lagging behind in early cancer detection. But at the same time, there are promising new cancer diagnostic tests. The ultimate cancer detection test is a blood test. If it can be a general preclinical cancer stage blood test, it can tell you, \"yes or no for any cancer.” This is the best early cancer detection test. A general early cancer detection test is better than a separate diagnostic test for breast or colon cancer tests. Because it is complicated.\u003c\/p\u003e\n\n\u003cp\u003eYou're looking for something that is similar to CRP, C-reactive protein. CRP tells us if there is inflammation in a patient or not. Sometimes we can have similar things for early cancer presence overall. Early cancer detection is going to be a breakthrough. Eventually, we are going to achieve it. Is any cancer present?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e The preclinical cancer detection test is going to be found sooner than we think. This is very interesting.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e We are talking about something similar to a \"liquid biopsy\" for people who might already have cancer. But liquid biopsy is looking for circulating tumor cells in a patient’s blood. Perhaps there will be blood tests that are similar to liquid biopsy. These will be diagnostic tests for screening a general population for certain cancer markers. These cancer markers are present on circulating normal cells. Maybe early cancer screening tests can do tumor cells detection?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Yes, in liquid biopsy it's true.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e We are looking for CTC, circulating tumor cells. There are also some other molecular cancer markers. We are working on CD24. We think CD24 is a very promising early cancer detection marker. There are some other early cancer markers. Most probably there will have to be combinations of several early cancer detection tests. But the wisdom is to have one cancer detection test in one test tube. Obtain a medical second opinion on cancer. Then it's going to achieve the real impact.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e You think a universal cancer detection test will come to the market in the next 5 to 10 years?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e It must be in the next five years!\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Next 5 years for a universal cancer detection test?\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852069871772,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"two-diagnostic-markers-of-early-cancer-cd24-apc-gene-polymorphism-2","title":"Two diagnostic markers of early cancer. CD24. APC gene polymorphism. 2","description":"\u003ch1\u003eEarly Cancer Detection: CD24 and APC Gene Polymorphism\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#cd24-an-early-cancer-marker\"\u003eCD24: An Early Cancer Marker\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#apc-gene-polymorphism-and-cancer-risk\"\u003eAPC Gene Polymorphism and Cancer Risk\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#importance-of-routine-screening\"\u003eImportance of Routine Screening\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#monitoring-cd24-expression-levels\"\u003eMonitoring CD24 Expression Levels\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#integrative-cancer-prevention-strategies\"\u003eIntegrative Cancer Prevention Strategies\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"cd24-an-early-cancer-marker\"\u003eCD24: An Early Cancer Marker\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, highlights the role of CD24 as a significant marker for early cancer detection. CD24 is rarely expressed on normal cells but is overexpressed in cancer cells, making it a potential universal marker for various cancers. This overexpression suggests CD24's involvement in cancer pathways, providing a promising target for both detection and treatment.\u003c\/p\u003e\n\n\u003ch2 id=\"apc-gene-polymorphism-and-cancer-risk\"\u003eAPC Gene Polymorphism and Cancer Risk\u003c\/h2\u003e\n\u003cp\u003eThe APC gene polymorphism, particularly at position 1307, is a critical indicator of increased cancer risk. Dr. Nadir Arber, MD explains that this genetic variation can significantly elevate cancer susceptibility, especially in men, who are prone to more than eight different cancers. Women with this mutation are at risk for colon, breast, and skin cancers, but tend to have better overall cancer survival rates.\u003c\/p\u003e\n\n\u003ch2 id=\"importance-of-routine-screening\"\u003eImportance of Routine Screening\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, stresses the necessity of routine cancer screening for individuals with APC gene mutations. He advocates for annual check-ups to monitor for various cancers, emphasizing that early detection is crucial for effective treatment and prevention. This proactive approach is vital for those at increased genetic risk.\u003c\/p\u003e\n\n\u003ch2 id=\"monitoring-cd24-expression-levels\"\u003eMonitoring CD24 Expression Levels\u003c\/h2\u003e\n\u003cp\u003eRegular monitoring of CD24 expression levels is a key strategy in early cancer detection. Dr. Anton Titov, MD, discusses the potential of annual screenings to track CD24 levels in blood cells. Increased expression may indicate heightened cancer risk, allowing for timely intervention and potentially improved outcomes.\u003c\/p\u003e\n\n\u003ch2 id=\"integrative-cancer-prevention-strategies\"\u003eIntegrative Cancer Prevention Strategies\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, introduces his Integrative Cancer Prevention Centre, where individuals with APC gene mutations receive comprehensive screening and prevention strategies. He opposes the \"ostrich strategy\" of ignoring cancer risk, advocating instead for vigilant monitoring and early intervention to reduce cancer incidence and mortality.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Holy grail of cancer detection is a “yes or no” test for subclinical cancer. CD24 molecule level is one test for early cancer. Mutations in the APC gene can also signal early cancer presence or increased risk for many cancers. Leading cancer expert explains.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e You mentioned that you work on particular tumor markers. They are overexpressed on the circulating normal blood cells. You published several very interesting papers on a CD24 early cancer marker. You also did research on the polymorphism of the APC gene. Please describe how those tumor markers can help detect early cancer.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e Polymorphism of the APC gene is very interesting. We have 3 billion bases in our genome. There could be a mutation in one of the DNA building blocks in the gene of APC in position 1307. There is an exchange of one amino acid, isoleucine, for valine. It can tell us that mutation carriers are susceptible to cancer more than the general population. Especially for men. Men with APC gene mutation are susceptible to more than eight cancers. They are all different cancers, and there is an increased cancer mortality rate.\u003c\/p\u003e\n\n\u003cp\u003eWomen with APC gene mutation are less vulnerable to cancers. Women are prone to three cancers: colon cancer, breast cancer, and skin cancer. But surprisingly, the overall outcome cancer survival is better. Cancer patients with APC gene mutation do better than non-carriers. This is just an example of what a simple early cancer blood test can tell us. It is a single nuclear polymorphism in our genome. It can tell that this particular person is at a significant increased risk of having cancer.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e We published results of early cancer detection test. And from my daily clinical practice, I know it is working. I tell a patient to do this routine cancer detection checkup. I tell them this. You should do a cancer screening test. But this early cancer detection test is also based on your genome. Obtain medical second opinion on cancer. Then the acceptance rate for cancer screening is much higher.\u003c\/p\u003e\n\n\u003cp\u003eCD24 is not a new gene. CD24 was gene number 24 that was found. Today we have over 250 CD genes. CD24 was one of the few earlier genes. But not many research groups are working on CD24.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e We believe that CD24 is a very important gene for early cancer detection. It is very important to play a role upstream. CD24 gene is involved in many pathways, especially in cancer pathways. CD24 is rarely expressed on normal cells. Only on B lymphocytes. CD24 has some importance in the development of the brain, kidneys, and some other organs. But when you have the mouse knockout CD24 phenotype, it is normal. But we do see that CD24 is overexpressed on all cancers. This tells us that CD24 has general importance in cancer formation. It's a general phenomenon in the development of cancer.\u003c\/p\u003e\n\n\u003cp\u003eThis is something that I like. Because if you can use CD24 to detect cancer, or to treat cancer, we can have one test and one medicine for many cancers. We do that in the lab in mice. Now we are switching detection and treatment of early cancer in human beings.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e It is interesting the APC is not just the polymorphism. One single nucleotide just could be present in a normal individual. But it could indicate the increased risk for eight different cancers. It is not only a risk factor for colorectal cancer?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e Exactly, exactly! Between 1.5% and 2% of people carry APC gene polymorphism. It is a lot of people. They have 50 to 100% more likelihood or risk to develop cancer than the general population. This is quite significant! This is what I have established. You're going to come to discuss my unique Integrative Cancer Prevention Centre.\u003c\/p\u003e\n\n\u003cp\u003eWe tell people with APC gene mutation. At least once a year you have to come to my clinic here in Tel Aviv Medical Center. We have to do this routine screening for different cancers because you are prone to develop cancer. I'm against the ostrich strategy in cancer screening. We have to look with open eyes. If we are susceptible to cancer, we have to try to detect it early. It is even better to prevent cancer.\u003c\/p\u003e\n\n\u003cp\u003eCertainly! Well, that's the only strategy to go forward, clearly! And CD24 importance in early cancer detection is this. Normally, if a person does not have any risk of cancer, CD24 will be expressed at a low level. If cancer risk increases, CD24 will then start to be expressed at a higher level.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e In other words, the strategy could be to get checked at regular intervals for the CD24 expression on all blood cells?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e Exactly! Once a year. Once a year! This is the magic number, obviously. There is no published medical literature. But I believe that if you do early cancer screening once a year, then it's something that is doable. It's like testing your car. You can do it once a year.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852069937308,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"cancer-risk-screening-next-generation-sequencing-of-your-genome-3","title":"Cancer risk screening. Next Generation Sequencing of your genome. 3","description":"\u003ch1\u003eAdvancements in Cancer Risk Screening with Genomic Sequencing\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#genomic-sequencing-for-cancer-risk-assessment\"\u003eGenomic Sequencing for Cancer Risk Assessment\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#personalized-medicine-through-genomic-data\"\u003ePersonalized Medicine Through Genomic Data\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#pharmacogenomics-and-medication-response\"\u003ePharmacogenomics and Medication Response\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#early-cancer-detection-with-genomic-insights\"\u003eEarly Cancer Detection with Genomic Insights\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#the-future-of-genomic-sequencing-in-healthcare\"\u003eThe Future of Genomic Sequencing in Healthcare\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"genomic-sequencing-for-cancer-risk-assessment\"\u003eGenomic Sequencing for Cancer Risk Assessment\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, explains how next-generation sequencing (NGS) and whole exome sequencing (WES) provide detailed insights into individual cancer risks. These technologies allow for the identification of DNA mutations that can significantly impact diagnostic and treatment decisions. By analyzing a person's genome, healthcare providers can better predict cancer risks and tailor prevention strategies accordingly.\u003c\/p\u003e\n\n\u003ch2 id=\"personalized-medicine-through-genomic-data\"\u003ePersonalized Medicine Through Genomic Data\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD emphasizes the role of genomic data in personalizing medical care. As genomic sequencing becomes more accessible, individuals will receive personalized health information that can guide their medical decisions. This approach allows for a more targeted prevention strategy, focusing on specific genetic predispositions to various diseases, including cancer.\u003c\/p\u003e\n\n\u003ch2 id=\"pharmacogenomics-and-medication-response\"\u003ePharmacogenomics and Medication Response\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, discusses the importance of pharmacogenomics in understanding how genetic variations affect medication responses. Genomic data can reveal how individuals metabolize drugs differently, which is crucial for optimizing medication dosages and minimizing adverse effects. This personalized approach ensures safer and more effective treatments for patients.\u003c\/p\u003e\n\n\u003ch2 id=\"early-cancer-detection-with-genomic-insights\"\u003eEarly Cancer Detection with Genomic Insights\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD highlights the potential of genomic sequencing in early cancer detection. By identifying genetic mutations associated with increased cancer risk, healthcare providers can implement early intervention strategies. This proactive approach can significantly improve outcomes by catching cancer at an earlier, more treatable stage.\u003c\/p\u003e\n\n\u003ch2 id=\"the-future-of-genomic-sequencing-in-healthcare\"\u003eThe Future of Genomic Sequencing in Healthcare\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, envisions a future where genomic sequencing is an integral part of healthcare. As the cost of sequencing continues to decrease, more individuals will have access to this valuable information. Dr. Arber predicts that within the next decade, personal genomic data will be widely used to guide health decisions, leading to better prevention and treatment of diseases.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Next Generation Sequencing, NGS, and Whole Exome Sequencing, WES, allow for a more granular assessment of individual cancer risks and predict reactions to many medications. When a child is born, soon doctors will hand a flash drive with the child’s genome, helping to assess lifetime health risks. One in four people is found to have DNA mutations that affect diagnostic and treatment considerations.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Cancer risk evaluation by next-generation sequencing, NGS, and early cancer risk detection by Whole Exome Sequencing, WES, are becoming more popular and available. Next-generation sequencing is certainly cheaper. What are the opportunities to screen for increased cancer risks by whole genome sequencing?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e I think this is the way to go. This is an early cancer diagnosis strategy in the near future. There is a project of the European Union 2020 or Horizon 2020. This is how I envision gene sequencing for cancer risk detection. A child is going out of the delivery room, and physicians will give the parents a small disk or a flash drive key with the words, \"This is the genome of your child.\" Whenever you approach physicians, be careful—they are dangerous! Consult with this DNA data because it's been shown that genes affect how you respond to medicines.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e When I give someone with a fever paracetamol, I give 500 to 1000 milligrams for everyone. But obviously, everyone has a different metabolism rate and will react differently. With paracetamol, the gap between efficacy and toxicity is huge. You're not concerned about anything. But for other medications, the therapeutic window is much narrower. Cancer risk detection is definitely worth a personal approach. This is called pharmacokinetics.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e Genomic data can also tell us a lot about the risk of developing different cancers, the diseases you're prone to, and where you should put your prevention efforts. Sometimes someone has a lot of obesity-predisposing genes. Then we'll be able to watch weight more carefully, or vice versa. I think whole genome sequencing is going to tell us a lot about personal health risks. Obviously, it's not going to replace clinical medicine, but it's going to help us a lot in educating patients.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e Personal genome sequencing will help to prevent diseases and overcome them. Whole exome sequencing will tell us how to educate patients. Personal genomics data is definitely going to be used much sooner than many think. In the next decade, it's going to happen. Most healthy people in the Western Hemisphere are going to use personal genomic data. Prices of gene sequencing will go down to a few hundred dollars, making it affordable for everyone.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e You published a very interesting paper that looked at 25 healthy people. It turns out that 24% of them—almost 1 in 4—have \"management changing\" DNA mutations. These mutations could predispose them to increased risk of cancer and heart disease. 80% of people tested harbored 1 to 3 different mutations. These mutations required alterations in the dosages of medications approved by the US FDA. Could you please tell us about gene sequencing to find cancer mutations in healthy people?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e I was surprised. I did not expect so much knowledge from this DNA genome sequencing. It's going to change my clinical judgment. Our early cancer detection methods will be changed not only for me but for my entire team. And indeed, we did. We found someone who is prone to develop breast cancer because she had a BRCA mutation, but clinical history did not tell us about breast cancer risk.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e We had a daughter and her mother. The mother has a tendency to develop colon polyps. Whenever I did a colonoscopy, I found polyps. Then we found a gene that predisposed her to colon polyps and colon cancer. It showed us matching between the genotype and the phenotype. The daughter did not have this gene. We told the daughter this, so we don't have to do a new colonoscopy every 1-2 years because she does not carry the gene that her mother carries.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e You can have it both ways. All this information was just from whole exome sequencing. I think the fidelity of sequencing was not that great. In the future, we will improve whole genome sequencing quality. I'm sure we can gain much more information about early cancer detection. But there are a lot of cancer-causing genes that we still do not know about.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e We don’t know their functions. We still do not exactly know what is meaningful among all these genes. It is much more complicated. We do the whole exome sequencing, which is only about 1% of all the DNA bases. There is a lot of DNA between the exons. I don't believe in the term \"garbage DNA.\" Everything has a meaning. But at the same time, it's very interesting that interpretation of the genome is also very important.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e Of course, there are a lot of gray areas in whole genome sequencing to find cancer risks. But some of the genes have well-known mutations that can predispose people to cancer. Therefore, we shouldn't pursue an \"ostrich strategy\" for cancer risk detection. We should really know what's in the genes. A mutation that is found is a clear-cut answer for cancer risk. Then it requires manual curation of the genome as was done in your paper. It requires some altered behavior with cancer risk mitigation. I absolutely agree!\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852069970076,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"do-cancer-screening-once-every-year-how-to-avoid-cancer-4","title":"Do cancer screening once every year. How to avoid cancer. 4","description":"\u003ch1\u003eAnnual Cancer Screening: Early Detection and Prevention Strategies\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#importance-of-annual-cancer-screening\"\u003eImportance of Annual Cancer Screening\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#integrated-cancer-prevention-centers-approach\"\u003eIntegrated Cancer Prevention Center's Approach\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#benefits-of-early-cancer-detection\"\u003eBenefits of Early Cancer Detection\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#personalized-screening-programs\"\u003ePersonalized Screening Programs\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#evidence-based-medicine-in-cancer-prevention\"\u003eEvidence-Based Medicine in Cancer Prevention\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#global-cancer-statistics-and-israels-success\"\u003eGlobal Cancer Statistics and Israel's Success\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#future-of-cancer-screening\"\u003eFuture of Cancer Screening\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"importance-of-annual-cancer-screening\"\u003eImportance of Annual Cancer Screening\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, stresses the critical role of annual cancer screening in early detection and prevention. He likens regular health checkups to maintaining a new car, emphasizing that even when everything seems fine, regular checkups are essential to catch potential issues early. This proactive approach can lead to early intervention and significantly improve treatment outcomes.\u003c\/p\u003e\n\n\u003ch2 id=\"integrated-cancer-prevention-centers-approach\"\u003eIntegrated Cancer Prevention Center's Approach\u003c\/h2\u003e\n\u003cp\u003eThe Integrated Cancer Prevention Center, led by Dr. Arber, offers a unique \"one-stop shop\" for cancer prevention and detection. This center is the only one of its kind globally, providing comprehensive screening services within four hours. By coordinating various cancer tests, the center ensures efficient and effective early cancer detection, significantly reducing mortality rates among its patients.\u003c\/p\u003e\n\n\u003ch2 id=\"benefits-of-early-cancer-detection\"\u003eBenefits of Early Cancer Detection\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD highlights the substantial benefits of early cancer detection, noting that finding cancer at an early stage can lead to a near 100% cure rate. Early detection allows for less invasive treatments and prevents cancer from progressing to more advanced stages. This approach is particularly effective for cancers like melanoma, where early removal can prevent metastasis.\u003c\/p\u003e\n\n\u003ch2 id=\"personalized-screening-programs\"\u003ePersonalized Screening Programs\u003c\/h2\u003e\n\u003cp\u003eDr. Arber advocates for personalized cancer screening programs that consider individual genetics and family history. Such tailored approaches ensure that high-yield diagnostic tests are used effectively, improving the chances of early detection. This personalized strategy contrasts with mass screening, which may not be cost-effective or necessary for all cancers.\u003c\/p\u003e\n\n\u003ch2 id=\"evidence-based-medicine-in-cancer-prevention\"\u003eEvidence-Based Medicine in Cancer Prevention\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD emphasizes the importance of evidence-based medicine in cancer prevention. He notes that not all screening tests are suitable for early cancer detection, and only those with proven efficacy should be used. This approach ensures that resources are used efficiently and that patients receive the most accurate and beneficial screenings.\u003c\/p\u003e\n\n\u003ch2 id=\"global-cancer-statistics-and-israels-success\"\u003eGlobal Cancer Statistics and Israel's Success\u003c\/h2\u003e\n\u003cp\u003eDr. Arber shares global cancer statistics, highlighting Israel's success in reducing cancer mortality rates. While the worldwide cancer mortality rate is around 60%, Israel's rate is significantly lower at 39%. At the Integrated Cancer Prevention Center, the mortality rate is even lower at 15%, demonstrating the effectiveness of their early detection and prevention strategies.\u003c\/p\u003e\n\n\u003ch2 id=\"future-of-cancer-screening\"\u003eFuture of Cancer Screening\u003c\/h2\u003e\n\u003cp\u003eDr. Arber envisions a future where comprehensive cancer screening centers are more widely available. He advocates for the establishment of similar centers in other locations, emphasizing the importance of early detection and prevention in reducing cancer mortality. By adopting a holistic approach to cancer screening, healthcare systems can improve patient outcomes and save lives.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e You lead the integrated cancer prevention center. You also published a very interesting paper that screened 300 individuals for 11 different cancers. You actually found a high rate of tumors. It was a 2 to 3 times higher cancer rate than in the general population. There was a presence of both malignant and benign tumors. Could you please talk about that research? What are your views on having screening programs for cancer prevention?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e This was outlined in your cancer research article. This was our first cancer research paper on early cancer prevention. We had another paper where we summed up the result of the first 1,000 cancer screening patients. Now 20,000 patients attended this unique Integrated Cancer Prevention Center. That is actually the only one in the world that is doing a one-stop shop for cancer prevention and detection.\u003c\/p\u003e\n\n\u003cp\u003eThe best therapy for cancer is early detection and prevention. Sometimes there is a cancer, especially when there are symptoms. I do not say that there is nothing to do. But in most cancer cases, we can delay cancer progression. But a real cure usually is not achievable. If you find cancer at an early stage, you can cure cancer. You find a smaller melanoma early. You take it out in five minutes. That's it!\u003c\/p\u003e\n\n\u003cp\u003eSometimes you wait another few months. Then melanoma's depth is 0.1 millimeters and there are metastases everywhere. The key point is cancer early detection and cancer prevention. This is what we are doing here in my cancer prevention center. Within four hours, we have all the physicians and all the equipment and all the staff to diagnose a patient.\u003c\/p\u003e\n\n\u003cp\u003eWe have the cancer detection blood tests. Obviously, we are in a tertiary big excellent hospital. We are able to provide these services. People are coming and going into different cancer-testing stations. This is not simple. But we are able to computerize it. We direct patients to each cancer testing station in synchronous ways and in harmony. Then we are able to detect early cancer.\u003c\/p\u003e\n\n\u003cp\u003eSurprisingly, we were able to find tumors in about 13% of our cancer screening program attendees. But almost all of the cancers were at a very early stage. I can tell you some statistics which are quite strong. It's not coming just from Israel, it's worldwide. Mortality from cancer is overall about 60% from all the millions of cancers found around the world.\u003c\/p\u003e\n\n\u003cp\u003eIn Israel, there are about 28,000 new cancer cases per year, and 11,000 people dying from cancer, which turns into about 39% cancer mortality. Maybe this is another testament to the good medicine in Israel. This statistic on cancer in Israel is better than average worldwide. In my cancer prevention center, the mortality from cancer is only 15%. This again gives us some kind of indication that what we're doing is good.\u003c\/p\u003e\n\n\u003cp\u003eSometimes you are able to detect cancer at an early stage. Then the cancer cure rate is close to 100%. I think cancer prevention is always difficult for people to understand. Because it's difficult to understand something that did not happen. We prevented an event that did not happen. It's like having a car. When you have a brand new car, you still need to do this annual checkup test. The car feels fine, it's brand new. But you still do check-up tests.\u003c\/p\u003e\n\n\u003cp\u003eThat is my advice to people. Treat yourself at least as good as you treat your car. Once a year you are entitled to have a check-up. And everything is fine. Don't feel that you wasted your time and money. It's worth it. It can give you a big return on your health investment. I think it's certainly true. But it's also important to do the right test for early cancer detection.\u003c\/p\u003e\n\n\u003cp\u003eBecause a lot of the generally available screening tests that are done during the checkups are not intended for the early diagnosis of heart disease and cancer. Or they don't work well in a very high percentage of cases. Knowing the personal genetics and studying the family history is probably the most important disease prevention strategy. We have to do some high-yield cancer diagnostic tests. Obviously, we only advocate evidence-based medicine.\u003c\/p\u003e\n\n\u003cp\u003eThere is a difference between screening and personal case findings. Thyroid cancer is a good example. It is not recommended to do screening for thyroid cancer of the entire population. But the patients come to me because they attended a cancer prevention center screening program. Then just in two minutes to palpate the thyroid gland. If it is needed, we do a thyroid ultrasound. It is an office procedure.\u003c\/p\u003e\n\n\u003cp\u003eMass screening is something completely different. It's not cost-effective. It is not worth bringing everyone for a thyroid ultrasound. But you came to a screening program for a different reason. Thyroid screening is easy to do. This integration does not exist usually. Because every cancer center has its own program for every cancer. But this is a mistake because it's impossible to predict where to screen.\u003c\/p\u003e\n\n\u003cp\u003eThe example with the car is relevant. You don't go to one place to check the engine. Then to a different place to check the electric wiring. Then to another place to check the tires. You do an entire car check at one place. It is usually a certified place. This is exactly what I'm aiming for and advocating to do for cancer screening. One stage, one-stop shop for cancer screening. It is in a good tertiary hospital. Then this is a way to go for early cancer detection. It is something that is possible to open in other places.\u003c\/p\u003e\n\n\u003cp\u003eThank you, that's very important. It’s very important for early cancer screening.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852070002844,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"cancer-prevention-by-medications-aspirin-and-cox-2-inhibitors-delay-cancers-and-alzheimer-s-disease-5","title":"Cancer prevention by medications. Aspirin and COX-2 inhibitors delay cancers and Alzheimer’s disease. 5","description":"\u003ch1\u003eExploring Aspirin and COX-2 Inhibitors in Cancer Prevention\u003c\/h1\u003e\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#aspirins-role-in-cancer-prevention\"\u003eAspirin's Role in Cancer Prevention\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#mechanisms-of-aspirin-in-cancer-prevention\"\u003eMechanisms of Aspirin in Cancer Prevention\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#cox-2-inhibitors-and-colon-cancer-prevention\"\u003eCOX-2 Inhibitors and Colon Cancer Prevention\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#managing-side-effects-of-aspirin-and-cox-2-inhibitors\"\u003eManaging Side Effects of Aspirin and COX-2 Inhibitors\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#personalized-medicine-in-chemoprevention\"\u003ePersonalized Medicine in Chemoprevention\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 id=\"aspirins-role-in-cancer-prevention\"\u003eAspirin's Role in Cancer Prevention\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, highlights aspirin's potential as a \"magic bullet\" for preventing major health issues, including cancer. Aspirin has been extensively studied for its ability to reduce the risk of gastrointestinal cancers, particularly colorectal cancer. Its long history and well-documented efficacy make it a promising option for cancer prevention when used appropriately.\u003c\/p\u003e\n\u003ch2 id=\"mechanisms-of-aspirin-in-cancer-prevention\"\u003eMechanisms of Aspirin in Cancer Prevention\u003c\/h2\u003e\n\u003cp\u003eAspirin's cancer-preventive effects are attributed to its anti-inflammatory properties and ability to inhibit platelet aggregation. Dr. Nadir Arber, MD explains that aspirin can interfere with cancer cell proliferation and reduce the risk of metastasis. Despite some controversy, the evidence supporting aspirin's role in cancer prevention is substantial, provided it is used under medical guidance.\u003c\/p\u003e\n\u003ch2 id=\"cox-2-inhibitors-and-colon-cancer-prevention\"\u003eCOX-2 Inhibitors and Colon Cancer Prevention\u003c\/h2\u003e\n\u003cp\u003eCOX-2 inhibitors, such as those developed by Merck and Pfizer, have shown promise in reducing colon polyps, which can develop into colon cancer. Dr. Arber led a significant international clinical trial demonstrating a 50% reduction in colon polyps with COX-2 inhibitors. However, concerns about cardiovascular toxicity have limited their widespread use for cancer prevention.\u003c\/p\u003e\n\u003ch2 id=\"managing-side-effects-of-aspirin-and-cox-2-inhibitors\"\u003eManaging Side Effects of Aspirin and COX-2 Inhibitors\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD emphasizes the importance of managing potential side effects, such as gastrointestinal bleeding associated with aspirin use. Addressing Helicobacter pylori infections can mitigate these risks. While COX-2 inhibitors have been linked to cardiovascular issues, careful patient selection and monitoring can help minimize adverse effects.\u003c\/p\u003e\n\u003ch2 id=\"personalized-medicine-in-chemoprevention\"\u003ePersonalized Medicine in Chemoprevention\u003c\/h2\u003e\n\u003cp\u003eDr. Arber advocates for a personalized approach to chemoprevention, considering genetic factors that may influence a patient's response to aspirin and COX-2 inhibitors. By tailoring treatment to individual genetic profiles, healthcare providers can optimize the benefits of these medications while minimizing risks, paving the way for more effective cancer prevention strategies.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Aspirin might be a magic bullet to prevent diseases. Today, there are three major catastrophes: ischemic heart disease, cancer, and Alzheimer's disease. Most probably, aspirin can prevent or delay all three major health catastrophes. Let's talk about the chemoprevention of cancer. How can we use medications to lower the risks of cancer? How can we use medicines to lower the chances of cancer returning if it has already been diagnosed and treated?\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e Aspirin for cancer prevention is not controversial. There is a long history and a lot of data about aspirin in cancer prevention. But aspirin must be used in the correct way. It can prevent not only colon cancer but many other cancers. Aspirin was first marketed in 1897, more than 120 years ago, and is still prescribed. I think that aspirin might be the magic bullet for cancer prevention. We know a lot about aspirin's efficacy and toxicity, so I feel safe about it.\u003c\/p\u003e\n\u003cp\u003eWhen a patient comes to me, they often say, \"We would like to live longer and better.\" This is a big mistake during clinical trials for cancer chemoprevention and early detection. They use one organ as the target of a clinical cancer prevention trial. This is a mistake because you should look for overall morbidity and mortality, not just one specific organ.\u003c\/p\u003e\n\u003cp\u003eI'm going to tell you about a big clinical trial where I was a principal investigator. We used COX-2 inhibitors to prevent colon cancer and had amazing results. Aspirin might be a magic bullet to prevent many types of cancer. We know the profile of aspirin side effects is low. Even if there is major bleeding, we know as gastroenterologists how to prevent it. But bleeding due to aspirin is quite rare, especially if we treat Helicobacter pylori.\u003c\/p\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003cstrong\u003eDr. Nadir Arber, MD: \u003c\/strong\u003eHelicobacter pylori is an important risk factor. It can increase the risks of side effects, but it can be easily identified by a diagnostic test. Helicobacter pylori can also cause gastric cancer. I think aspirin should definitely be taken for cancer prevention. I personally take it, and I think this is the way to go. It's true that the genetic profile is also important to reduce aspirin risks.\u003c\/p\u003e\n\u003cp\u003eWe also published a paper about genetic influence on cancer prevention. We can predict the response to non-steroidal anti-inflammatory COX-2 inhibitors based on data from our genome. Now we are trying to validate it in a large number of samples. This is going to be the way forward. Somebody will be prescribed aspirin or a novel medication, and we'll make sure that the patient doesn't carry a mutation for high side effects risks.\u003c\/p\u003e\n\u003cp\u003eIn 1999, Merck and Pfizer came to the market with a new medication: COX-2 inhibitors. There are two COX enzymes in our body. COX-1 is the housekeeping gene. It keeps the integrity of the gastrointestinal mucosa. COX-2 is not expressed in normal mucosa but is upregulated as a consequence of inflammatory or neoplastic cancer-inducing stimuli.\u003c\/p\u003e\n\u003cp\u003eMerck and Pfizer came out with COX-2 inhibitors that inhibit only COX-2. They did not inhibit COX-1. This should be the preferred medication because it does not damage the normal gastric mucosa. At that time, I approached Merck and Pfizer. I told them that whenever you want a new medication, first you look for toxicity. If the drug is not toxic, then you look for efficacy.\u003c\/p\u003e\n\u003cp\u003eNow you have a perfect medication. It's not toxic and very effective in controlling pain and inflammation. Why don't we try to find new indications? Let's see if COX-2 inhibitors can also prevent cancer. Merck said, \"Excellent idea, we'll do it by ourselves.\" But Pfizer let me and Professor Bernard Levine do it. We did an international multicenter clinical trial with 1561 patients from five continents and 107 medical centers.\u003c\/p\u003e\n\u003cp\u003eWe gave this medication, COX-2 inhibitor, to patients with colon polyps. We were able to show that after 3 and 5 years, we reduced the numbers of colon polyps by roughly 50%, especially advanced adenomas. Advanced adenomas are more prone to develop into colon cancer. There were two other parallel clinical trials at the same time, and they were stopped due to unforeseen cardiovascular toxicity.\u003c\/p\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003cstrong\u003eDr. Nadir Arber, MD: \u003c\/strong\u003eEveryone had concerns about GI toxicity, but they found some cardiovascular toxicity. This is strange because the number of patients was very low. We had about 19 and 31 with heart toxicity of COX-2 inhibitors. It's very low. Side effects became evident after a year or 1.5 years, only in patients with some risk factors, like ischemic heart disease.\u003c\/p\u003e\n\u003cp\u003eWith these patients, you should be more careful and conservative. But other patients did well, especially those with high risk for colon cancer. COX-2 inhibitor is an ideal medication to prevent colorectal cancer in high-risk patients. But the cancer prevention indication of COX-2 inhibitors was put on hold, not for medical or scientific reasons. Unfortunately, we can't use this effective medication anymore for cancer prevention. There are not many other chemopreventive medications in wide use to prevent colon cancer. It's probably for liability reasons. They were worried that somebody might sue them.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Chemoprevention of cancer is certainly a very important topic.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852070035612,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"chemoprevention-of-cancer-curcumin-statins-dfmo-6","title":"Chemoprevention of cancer. Curcumin, statins, DFMO. 6","description":"\u003ch1\u003eExploring Chemoprevention: Curcumin, Statins, and DFMO in Cancer Risk Reduction\u003c\/h1\u003e\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#curcumin-green-tea-and-selenium-in-cancer-prevention\"\u003eCurcumin, Green Tea, and Selenium in Cancer Prevention\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#dfmo-and-its-role-in-cancer-prevention\"\u003eDFMO and Its Role in Cancer Prevention\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#statins-for-cancer-risk-reduction\"\u003eStatins for Cancer Risk Reduction\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#criteria-for-effective-chemoprevention\"\u003eCriteria for Effective Chemoprevention\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#combination-therapy-in-cancer-prevention\"\u003eCombination Therapy in Cancer Prevention\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 id=\"curcumin-green-tea-and-selenium-in-cancer-prevention\"\u003eCurcumin, Green Tea, and Selenium in Cancer Prevention\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, emphasizes the potential of curcumin, especially when combined with green tea and selenium, in cancer prevention. This combination acts as a natural COX-2 inhibitor and targets inflammation, which is crucial in preventing colorectal cancer. Dr. Nadir Arber, MD notes the high consumption of curcumin in India and its correlation with lower colorectal cancer rates, suggesting a promising avenue for further research.\u003c\/p\u003e\n\u003ch2 id=\"dfmo-and-its-role-in-cancer-prevention\"\u003eDFMO and Its Role in Cancer Prevention\u003c\/h2\u003e\n\u003cp\u003eDFMO, or Di-Fluoro-Methyl-Ornithine, has been studied for its potential in cancer prevention. Dr. Anton Titov, MD, discusses with Dr. Arber the clinical trials that explored DFMO's efficacy. Despite its potential, DFMO presents challenges such as ototoxicity and cost, making it less practical for widespread use. Dr. Nadir Arber, MD highlights the importance of considering side effects and practicality in chemoprevention strategies.\u003c\/p\u003e\n\u003ch2 id=\"statins-for-cancer-risk-reduction\"\u003eStatins for Cancer Risk Reduction\u003c\/h2\u003e\n\u003cp\u003eStatins, widely used for cardiovascular disease prevention, have shown mixed results in cancer risk reduction. Dr. Nadir Arber, MD, discusses the evidence from clinical trials, noting that while some trials suggest a reduction in gastrointestinal cancer risk, others do not support this finding. Dr. Arber advises caution in advocating statins solely for cancer prevention, emphasizing the need for more conclusive evidence.\u003c\/p\u003e\n\u003ch2 id=\"criteria-for-effective-chemoprevention\"\u003eCriteria for Effective Chemoprevention\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, outlines five key criteria for effective chemoprevention: oral administration, once-daily dosing, efficacy, low toxicity, and affordability. These criteria ensure that chemopreventive agents are practical and accessible for widespread use. Dr. Arber compares these criteria to the contraceptive pill, highlighting the importance of compliance and practicality in preventive medicine.\u003c\/p\u003e\n\u003ch2 id=\"combination-therapy-in-cancer-prevention\"\u003eCombination Therapy in Cancer Prevention\u003c\/h2\u003e\n\u003cp\u003eCombination therapy is a promising approach in cancer prevention, according to Dr. Nadir Arber, MD. By using multiple agents, it is possible to lower medication concentrations, minimize toxicity, and enhance efficacy. Dr. Arber believes that combination therapy represents the future of both cancer prevention and treatment, aligning with current trends in medical practice.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Let's talk about chemoprevention of cancer. How can we use medications to lower the risks of cancer? How can we use medicines to lower the chances of cancer returning if it has already been diagnosed and treated?\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e We have several ways of cancer chemoprevention in my lab. We developed a mixture of curcumin, green tea, and selenium, and we put it in one tablet. It’s very effective and acts as a strong natural COX-2 inhibitor to prevent cancers. Curcumin and green tea can treat all kinds of inflammation. However, for this kind of research, you need a lot of money, and it's difficult to achieve it within the framework of academia. Everything we've discussed was done without the contribution and support from the medical industry; it was part of our academic work.\u003c\/p\u003e\n\u003cp\u003eWe were able to pursue this very promising cancer chemoprevention method. This is definitely something that should be explored more. Curcumin is a very interesting substance because turmeric acts on NFKB and many other factors in the body. Turmeric can also halt the progress of hematological cancers. In India, curcumin consumption is high, and the rates of colorectal cancer are lower. Of course, there are more factors involved in the lower colon cancer incidence in India, but this is very fascinating!\u003c\/p\u003e\n\u003cp\u003eCurcumin is fascinating. We showed that curcumin has synergistic effects when combined with green tea and selenium. We wrote a patent on it. It has a synergistic, amazing effect, working on NFKB and COX-2. It is very promising for colorectal cancer prevention, and there are no side effects!\u003c\/p\u003e\n\u003cp\u003eSometimes we continue discussing chemoprevention of cancer using medicinal substances. We know that for reducing the risk of cancers, one compound is DFMO, which is Di-Fluoro-Methyl-Ornithine.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e What is DFMO, and how can it lower the risks of certain cancers? What is the potential mechanism?\u003c\/p\u003e\n\u003cp\u003eThis was a good clinical trial. What I like about this clinical trial is that it used combination therapy to prevent cancers. I strongly believe in combination therapy to prevent and treat cancer. It is the way to go in medicine. Now everything is combination therapy because this strategy can lower the concentrations of the medications, minimize toxicity, and increase efficacy.\u003c\/p\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003cstrong\u003eDr. Nadir Arber, MD: \u003c\/strong\u003eI don't think DFMO is potentially good for inhibiting cancer growth, but also DFMO is not that practical. This fact was buried inside the article. There could be a lot of hearing loss with DFMO use. When looking for medications to prevent cancer, you have to consider five major criteria. The medication has to be given by mouth, at most once a day, should be effective, have low toxicity, and be cheap. An example is a contraception pill for preventing pregnancy. You need something like that.\u003c\/p\u003e\n\u003cp\u003eDFMO was not that cheap and had side effects, especially hearing loss. Its ototoxicity is quite toxic. DFMO did not fulfill all criteria. When looking for chemoprevention of cancer, these are the criteria that we should look for the medication to fulfill. Obtain a medical second opinion on cancer, then it could achieve worldwide compliance.\u003c\/p\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003cstrong\u003eDr. Nadir Arber, MD: \u003c\/strong\u003eStatins are clearly used with great efficacy to reduce risks of cardiovascular disease. But it was noticed in several clinical trials that statins can reduce risks of various cancers, including gastrointestinal cancers. In some clinical trials, the evidence was quite clear. In other clinical trials, evidence for cancer prevention by statins was not shown.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e What do you think about the use of statins in reducing the risks of cancer?\u003c\/p\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003cstrong\u003eDr. Nadir Arber, MD: \u003c\/strong\u003eStatins might be another \"magic bullet\" of the century, but still, just in preventing heart disease. For preventing cancer, the data on statins is not sufficient. It's not good enough that we can advocate statins for this indication, only for preventing cancer. It's true that there are some common risk factors for ischemic heart disease and cancer, like obesity, sedentary lifestyle, and hyperlipidemia. Statins just for prevention of colon cancer are not sufficient. I cannot advocate statins for colon cancer prevention.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852070232220,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"cancer-gene-therapy-viruses-and-hiv-enzymes-against-tumors-7","title":"Cancer gene therapy. Viruses and HIV enzymes against tumors. 7","description":"\u003ch1\u003eInnovative Gene Therapy for Colorectal Cancer: Viral Vectors and Precision Medicine\u003c\/h1\u003e\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#gene-therapy-for-colorectal-cancer\"\u003eGene Therapy for Colorectal Cancer\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#trojan-horse-strategy-in-cancer-treatment\"\u003eTrojan Horse Strategy in Cancer Treatment\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#viral-vectors-and-lethal-genes\"\u003eViral Vectors and Lethal Genes\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#precision-medicine-platform-for-cancer\"\u003ePrecision Medicine Platform for Cancer\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#hiv-enzymes-in-cancer-therapy\"\u003eHIV Enzymes in Cancer Therapy\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#future-of-cancer-gene-therapy\"\u003eFuture of Cancer Gene Therapy\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 id=\"gene-therapy-for-colorectal-cancer\"\u003eGene Therapy for Colorectal Cancer\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, is pioneering gene therapy for colorectal cancer using viral vectors. This experimental treatment is aimed at terminally ill patients, offering a last resort when other therapies have failed. The approach involves delivering therapeutic genes directly to cancer cells, providing a targeted and potentially more effective treatment option.\u003c\/p\u003e\n\u003ch2 id=\"trojan-horse-strategy-in-cancer-treatment\"\u003eTrojan Horse Strategy in Cancer Treatment\u003c\/h2\u003e\n\u003cp\u003eDr. Arber describes the \"Trojan horse strategy\" as a novel method to combat cancer. This technique exploits cancer's own growth pathways to introduce lethal genes into malignant cells. By targeting pathways unique to cancer cells, this strategy aims to halt tumor growth while minimizing damage to healthy tissue.\u003c\/p\u003e\n\u003ch2 id=\"viral-vectors-and-lethal-genes\"\u003eViral Vectors and Lethal Genes\u003c\/h2\u003e\n\u003cp\u003eViral vectors are used to deliver lethal genes specifically to cancer cells. Dr. Nadir Arber, MD explains that these vectors are engineered to express antibodies that recognize cancer-specific markers, such as CD24. This ensures that the therapeutic genes are activated only within cancer cells, sparing normal cells from harm.\u003c\/p\u003e\n\u003ch2 id=\"precision-medicine-platform-for-cancer\"\u003ePrecision Medicine Platform for Cancer\u003c\/h2\u003e\n\u003cp\u003eThis gene therapy approach represents a precision medicine platform that can be tailored to individual patients and tumor types. Dr. Anton Titov, MD, emphasizes the adaptability of this strategy, which allows for customization based on the genetic profile of the cancer, potentially improving treatment outcomes.\u003c\/p\u003e\n\u003ch2 id=\"hiv-enzymes-in-cancer-therapy\"\u003eHIV Enzymes in Cancer Therapy\u003c\/h2\u003e\n\u003cp\u003eDr. Arber is also exploring the use of HIV enzymes, specifically integrase, in cancer therapy. This innovative approach involves using the enzyme to create DNA breaks in cancer cells, triggering an immune response that leads to cell death. This method leverages the body's natural defenses to selectively target and destroy cancer cells.\u003c\/p\u003e\n\u003ch2 id=\"future-of-cancer-gene-therapy\"\u003eFuture of Cancer Gene Therapy\u003c\/h2\u003e\n\u003cp\u003eThe potential of gene therapy to revolutionize cancer treatment is significant. Dr. Nadir Arber, MD, and Dr. Anton Titov, MD, discuss the promise of these cutting-edge therapies to change the landscape of oncology. By harnessing the power of precision medicine, gene therapy offers new hope for patients facing difficult prognoses.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Gene therapy as a magic bullet against cancer captures the imagination. But progress has been slow. Leading cancer expert and researcher shares new ideas on subverting viruses to treat tumors.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e You work also on the gene therapy for treating colorectal cancers. You use viral vectors. Could you discuss your gene therapy work in colorectal cancer?\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e Yes, you just have to emphasize that this is still experimental. This week we are going to do gene therapy on the first colon cancer patients. We're going to give gene therapy for terminally ill cancer patients. It's like mercy therapy. We are going for the last resort of mercy because some colon cancer patients are otherwise going to die.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e The patient has nothing to lose. It's a lot of hope. But gene therapy for colon cancer expectations are very much conservative. This is, again, we're trying to think outside of the box.\u003c\/p\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003cstrong\u003eDr. Nadir Arber, MD: \u003c\/strong\u003eSometimes you have normal cells turn into malignant cells. They usually have some mutations. One mutation is KRAS. Cancer cells constantly divide and become cancer. It's not controlled divisions, very basically.\u003c\/p\u003e\n\u003cp\u003eWith chemotherapy or additional cancer therapy, we are trying to stop these active molecular pathways. They turn normal cells into malignant cells. Usually, cancer therapy leads to tumor growth arrest. Cancer cells stop growing because this active cancer growth pathway was shut down.\u003c\/p\u003e\n\u003cp\u003eThen after a while, the cancer finds some other growth-enabling pathways. Cancer growth bypasses this molecular pathway stop that was put into cancer. Now cancer resumes activity via other different molecular pathways. Usually, we have seen in a clinic. After cancer growth started again, then all of a sudden there is a rapid deterioration. The colon cancer patient dies quickly.\u003c\/p\u003e\n\u003cp\u003eWhat we tried in my lab is to use a different cancer treatment. I call it the Trojan horse strategy. Instead of inhibiting these active cancer growth pathways that exist only in cancer cells, we are using cancer growth molecular pathways to specifically kill colorectal cancers.\u003c\/p\u003e\n\u003cp\u003eWhat you use is the strategy that has five components. First, you have to identify these active cancer molecular pathways. Then you have to identify where the cancer pathway attaches to the nucleus. It is the DNA responsive elements. Sometimes cancer growth message comes from the membrane into the cytoplasm. Then the cancer message goes into the nucleus. It is telling the cells to divide.\u003c\/p\u003e\n\u003cp\u003eWe can hook to it, you can identify it, and we can hook a lethal gene to the message. It is going to be activated only in the cancer cells and not in the normal cells. In order to improve the strategy, we are using usually viruses to deliver a lethal gene construct into the cancer cells.\u003c\/p\u003e\n\u003cp\u003eWe want to selectively bring the gene therapy only to cancer cells. We are expressing on the top of the viruses specific antibodies to CD24. It is, as we spoke before, expressed in malignant cells but not in normal cells. The final component is that we are expressing very lethal genes that are based on the active cancer growth pathway.\u003c\/p\u003e\n\u003cp\u003eWe also have the antidote that is regulated by tumor suppressor genes. They are expressed in the normal cells but not in the malignant cells. We can keep the balance of just killing the colorectal cancer cells. As we know, there is also some \"leak\" in any biological system. We can express antitoxins in the normal cells. In that way, we can use even higher doses of gene therapy to selectively kill colorectal cancer cells. But at the same time, we make sure that healthy cells are going to stay alive.\u003c\/p\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003cstrong\u003eDr. Nadir Arber, MD: \u003c\/strong\u003eThis is very promising gene colorectal cancer therapy. What is good about it? This is a gene therapy platform for many types of cancer. It's not just for any specific cancer. Because using this gene therapy strategy, you can change every part of it. You can adapt cancer gene therapy to the person or to the tumor. This is precision medicine at its best. It is very promising.\u003c\/p\u003e\n\u003cp\u003eWe are looking into the future. This may change the landscape of cancer therapy. And that's clearly the goal of every clinician and clinician-scientist. Absolutely!\u003c\/p\u003e\n\u003cp\u003eAnother cancer therapy clinical trial that we are doing now. It's taken a new medication that is used to treat HIV patients. It's using the integrase of the HIV virus. We are using this technology to treat cancer. It is a cancer therapy clinical trial we are starting now. It looks very promising.\u003c\/p\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003cstrong\u003eDr. Nadir Arber, MD: \u003c\/strong\u003eThis is how we are using some viruses that were developed in my lab as cancer therapy. We specifically target cancer cells, and only the cancer cells. Viruses bring this integrase enzyme. It is causing cuts in the DNA. When there are a lot of cuts in the DNA, the immune system is going to recognize these cells as cancer cells. Immune cells will execute the program of cell death, apoptosis. That selectively kills cancer cells.\u003c\/p\u003e\n\u003cp\u003eThis is a fascinating new cancer therapy. That is thinking \"outside of the box.\" Cancer gene therapy might give another hope for cancer therapy. This is certainly interesting. Because cancer gene therapy utilizes true precision medicine. Yes, that's the way!\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852070264988,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"how-good-is-optical-colonoscopy-for-colon-cancer-screening-only-70-effective-8","title":"How good is optical colonoscopy for colon cancer screening? Only 70% effective? 8","description":"\u003ch1\u003eAdvancements in Colon Cancer Screening: Beyond Optical Colonoscopy\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#optical-colonoscopy-effectiveness\"\u003eOptical Colonoscopy Effectiveness\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#emerging-screening-technologies\"\u003eEmerging Screening Technologies\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#capsule-endoscopy-innovation\"\u003eCapsule Endoscopy Innovation\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#blood-tests-for-early-detection\"\u003eBlood Tests for Early Detection\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#future-directions-in-screening\"\u003eFuture Directions in Screening\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"optical-colonoscopy-effectiveness\"\u003eOptical Colonoscopy Effectiveness\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, explains that while optical colonoscopy is often viewed as the gold standard for colorectal cancer screening, its effectiveness may be limited. Studies suggest it detects only 60-70% of right-sided colon cancers. This discrepancy highlights the need for improved screening methods to ensure comprehensive cancer detection.\u003c\/p\u003e\n\n\u003ch2 id=\"emerging-screening-technologies\"\u003eEmerging Screening Technologies\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, discusses the potential of new technologies like CT colonography and capsule endoscopy. These methods offer less invasive alternatives to traditional colonoscopy, potentially increasing patient compliance and screening accuracy. As these technologies advance, they may play a significant role in future colorectal cancer screening protocols.\u003c\/p\u003e\n\n\u003ch2 id=\"capsule-endoscopy-innovation\"\u003eCapsule Endoscopy Innovation\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, is involved in developing a novel \"swallow and forget\" capsule endoscopy. This prep-less technology allows patients to swallow a capsule that scans the bowel for abnormalities without the need for bowel cleansing. This method could revolutionize colorectal cancer screening by simplifying the process and improving patient experience.\u003c\/p\u003e\n\n\u003ch2 id=\"blood-tests-for-early-detection\"\u003eBlood Tests for Early Detection\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, highlights ongoing research into blood tests for early cancer detection. Collaborations with international labs, including those at Johns Hopkins, aim to validate these tests through multicenter clinical trials. Successful development of such tests could enable earlier detection of colon cancer and potentially other cancers, improving patient outcomes.\u003c\/p\u003e\n\n\u003ch2 id=\"future-directions-in-screening\"\u003eFuture Directions in Screening\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, envisions a future where screening resources are optimized by targeting high-risk patients with the most effective tests. By reducing unnecessary colonoscopies and focusing on those with a higher likelihood of cancer, healthcare systems can improve efficiency and patient compliance. These advancements promise to enhance early detection and prevention strategies for colorectal cancer.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Colonoscopy is said to be a \"gold standard\" for colon cancer detection. But there is data that optical colonoscopy detects only 60-70% of right-sided colon cancers. Maybe it’s time to focus on CT colonography? Or \"swallow and forget\" camera technologies?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e Optical colonoscopy is considered the golden standard in colorectal cancer screening. But it's very interesting that sometimes a certain number of right-sided colon cancers are missed. People say this. A 90% colorectal cancer reduction with doing optical colonoscopy. In reality, it is actually closer to 60 to 70% colon cancer reduction in some published clinical trials.\u003c\/p\u003e\n\n\u003cp\u003eWhat is the best way to screen for colorectal cancer today? What are the new methods of colorectal cancer screening? What are you working on? What colon cancer screening methods are coming to clinical practice?\u003c\/p\u003e\n\n\u003cp\u003eI think in 2020 and 2021, still optical colonoscopy is the way to go. What we have to do is to try to better pinpoint and choose the patients that have a significantly increased risk of colorectal cancer. For that, we are trying to develop new cancer screening tests. It's amazing that about 80% of these new cancer screening technologies are coming from Israel. I am very proud of it. I'm basically also involved in a few new colorectal cancer detection methods.\u003c\/p\u003e\n\n\u003cp\u003eWe are doing one clinical trial, which is amazing and very promising with colorectal cancer checkup. It's another Israeli startup. This is a technology that I call \"swallow and forget.\" It's a prep-less cancer screening by capsule endoscopy. You just swallow it. There is no need for bowel cleansing preparations, no need to do anything. It just has a small source of energy which is transmitted into the mucosa. It does back scattering and the absorptions. The capsule can tell if there is normal bowel mucosa or if there is some polyp or colon cancer.\u003c\/p\u003e\n\n\u003cp\u003eWe have published two papers and now we are doing in Israel a multi-center clinical trial to find out the efficacy of colorectal cancer screening. It will be followed by an international clinical trial. This is colon cancer screening technology that is going to be amazing. Still, the cost might be the issue.\u003c\/p\u003e\n\n\u003cp\u003eAnother thing that I alluded to in the beginning of our interview is a blood test for early colon cancer detection. In my lab and two labs in America and other centers across the world, we work intensely on early cancer screening tests. Two of the laboratories are from Johns Hopkins and one laboratory is from Australia. But definitely, blood cancer screening tests have to be validated in international multicenter clinical trials. But again, this is the way to go.\u003c\/p\u003e\n\n\u003cp\u003eYou have to have a colon cancer test. But if it's possible to have a test to detect all cancers, it's even better. And then only patients in whom we know that there is a very high likelihood of finding cancer, or colon cancer, will be sent to have colonoscopy. In this way, we can use the resources better and also the compliance from the patients will be better. Because currently, we are doing a lot of colonoscopies which are normal.\u003c\/p\u003e\n\n\u003cp\u003eSometimes you can find a way not to do colonoscopy because cancer risk is not high. Then we can achieve much better results and even increase our ability to prevent colon cancer early in the preclinical stage.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852070297756,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"whole-genome-sequencing-can-predict-cancer-risks-clinical-case-9","title":"Whole genome sequencing can predict cancer risks. Clinical case. 9","description":"\u003ch1\u003eWhole Genome Sequencing in Cancer Risk Prediction and Prevention\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#genetic-testing-and-cancer-risk\"\u003eGenetic Testing and Cancer Risk\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#brca-mutations-a-case-study\"\u003eBRCA Mutations: A Case Study\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#precision-medicine-in-cancer-prevention\"\u003ePrecision Medicine in Cancer Prevention\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#importance-of-regular-health-checks\"\u003eImportance of Regular Health Checks\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#integrated-cancer-prevention-center\"\u003eIntegrated Cancer Prevention Center\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"genetic-testing-and-cancer-risk\"\u003eGenetic Testing and Cancer Risk\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, explains that whole genome sequencing and whole exome sequencing are powerful tools in identifying cancer risks that are not apparent from a patient's family history or standard screening tests. These advanced genetic tests can reveal mutations, such as BRCA, that significantly increase cancer risk, allowing for proactive measures in cancer prevention and treatment.\u003c\/p\u003e\n\n\u003ch2 id=\"brca-mutations-a-case-study\"\u003eBRCA Mutations: A Case Study\u003c\/h2\u003e\n\u003cp\u003eDr. Arber shares a clinical case where whole genome sequencing identified BRCA mutations in a patient without a family history of breast cancer. This discovery led to early-stage detection of breast cancer through mammography, resulting in successful treatment. The case highlights the importance of genetic testing in uncovering hidden cancer risks and saving lives.\u003c\/p\u003e\n\n\u003ch2 id=\"precision-medicine-in-cancer-prevention\"\u003ePrecision Medicine in Cancer Prevention\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, discusses how precision medicine can be used to prevent cancer by tailoring medication choices based on an individual's genetic profile. By understanding the likelihood of efficacy and toxicity of medications, patients can make informed decisions about their treatment options, balancing cancer risk with potential side effects.\u003c\/p\u003e\n\n\u003ch2 id=\"importance-of-regular-health-checks\"\u003eImportance of Regular Health Checks\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, emphasizes the importance of regular health checks, even for healthy individuals, to detect early signs of cancer and other diseases. He compares healthy individuals to new cars that require annual check-ups to ensure optimal functioning and prevent future issues. This proactive approach can lead to longer, healthier lives.\u003c\/p\u003e\n\n\u003ch2 id=\"integrated-cancer-prevention-center\"\u003eIntegrated Cancer Prevention Center\u003c\/h2\u003e\n\u003cp\u003eDr. Nadir Arber, MD, describes the integrated cancer prevention center he has established, which focuses on early detection and prevention of cancer and cardiovascular diseases. By offering comprehensive health assessments, the center aims to identify smoldering diseases in patients who feel well, ultimately improving health outcomes and extending life expectancy.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Mutations that increase cancer risks often cannot be deduced from a patient’s family history or screening tests. This includes breast cancer and BRCA mutations. Whole Exome Sequencing or Next Generation Sequencing can help find hidden disease risks. Genome sequencing predicts individual response to medications.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e We spoke a lot today about new methods of cancer prevention and screening. Is there a clinical case that you could discuss? It illustrates some of the topics in cancer prevention, screening, and treatment that we discussed today.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e We touched upon an important cancer screening topic. We discussed the Whole Genome Sequencing or Whole Exome Sequencing to detect risks of cancer. We found some new significant mutations. We were not able to guess these cancer-causing mutations based on the personal or family history of these patients.\u003c\/p\u003e\n\n\u003cp\u003eActually, the life of this patient and her family member were saved. This is when we found BRCA mutations in a patient without any history of breast cancer. Especially breast cancer. Sometimes the mutation comes from a father. In males with BRCA mutation, breast cancer risk is significantly higher, but it's not that high. Sometimes a male relative doesn't have breast cancer despite the BRCA mutation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e His daughters are not aware of the BRCA mutation for increased breast cancer risk. And we were able to find it.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Nadir Arber, MD:\u003c\/strong\u003e We did a mammography, and we found breast cancer at an early stage. They were cured. We also spoke about how to use precision medicine to prevent cancer early. We talked about how to prescribe aspirin or non-steroidal anti-inflammatory medications to prevent cancer.\u003c\/p\u003e\n\n\u003cp\u003eAnother clinical trial that we have done is when you're able to guess based on the genome of this person the likelihood of having efficacy and toxicity of medication. We were able to tell patients that taking this medication depends on your risk and your willingness to accept this kind of toxicity. If you have a very high risk of developing cancer, then you will be more willing to accept toxicity.\u003c\/p\u003e\n\n\u003cp\u003eSometimes you have a low risk for cancer. Obtain a medical second opinion on cancer. Then you are more reluctant to risk having toxicity from a medication. This is another way how we can combine future genetic testing with clinical implications to reduce cancer.\u003c\/p\u003e\n\n\u003cp\u003eFinally, the most important is to check healthy people. Healthy people are like new cars. They should be checked annually at facilities like I have established here. We have the integrated cancer prevention center. Now we're widening it. We add another program to check for cardiovascular risks. Cancer and heart disease are two major killers.\u003c\/p\u003e\n\n\u003cp\u003eOnce people are here, we do some tests to detect when a patient is fine and feeling well. But we are trying to find all kinds of smoldering disease. This is a way to go. This way we'll be able to improve our life. At the same time, we make people live longer. It's the best time and the cheapest way to visit a physician when you are completely healthy!\u003c\/p\u003e\n\n\u003cp\u003eExactly! I also give this talk in China. I don't know if it's true or not, but it's good. The Chinese told me that they are paying the physicians as long as they are feeling well. If they become sick, then the physician failed. Obtain a medical second opinion on cancer. Then people stop paying! I don't know if it's true or not. But this makes a lot of sense.\u003c\/p\u003e\n\n\u003cp\u003eThat is a story that I was once told about the old Chinese village. A doctor will go around each house and outside of the house there'll be some place where people put money and the physician would take it. And if there is no money, then the person became ill and therefore the physician should treat the patient. It's certainly a beautiful story that illustrates the true attitude to medicine. I agree!\u003c\/p\u003e\n\n\u003cp\u003eThank you very much, Professor Nadir Arber! We're going to look forward to reading more of your research. We will read about the development of various cancer prevention methods that you are working on. We will publicize them as much as possible to people. Thank you!\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852070330524,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"dr-kevin-barrows-integrative-medicine-expert-biography-0","title":"Dr. Kevin Barrows. Integrative medicine expert. Biography. 0","description":"\u003ch1\u003eIntegrative Medicine and Mindfulness in Healthcare\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#dr-kevin-barrows-md-career-path\"\u003eDr. Kevin Barrows, MD' Career Path\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#mind-body-medicine-focus\"\u003eMind-Body Medicine Focus\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#mindfulness-program-at-osher-center\"\u003eMindfulness Program at Osher Center\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#education-and-training\"\u003eEducation and Training\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#certification-and-expertise\"\u003eCertification and Expertise\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"dr-kevin-barrows-md-career-path\"\u003eDr. Kevin Barrows, MD' Career Path\u003c\/h2\u003e\n\u003cp\u003eDr. Kevin Barrows, MD, has built a distinguished career in integrative medicine, focusing on the intersection of mindfulness and healthcare. As Director of the Mindfulness Program at the Osher Center for Integrative Medicine, Dr. Barrows has pioneered programs that integrate mindfulness practices into clinical settings. His role as a Clinical Professor at UCSF further underscores his commitment to educating the next generation of healthcare professionals.\u003c\/p\u003e\n\n\u003ch2 id=\"mind-body-medicine-focus\"\u003eMind-Body Medicine Focus\u003c\/h2\u003e\n\u003cp\u003eDr. Barrows' primary clinical interest lies in Mind-Body Medicine, a field that explores the connection between mental and physical health. By applying mindfulness techniques, Dr. Barrows helps patients manage stress, improve mental clarity, and enhance overall well-being. His work demonstrates the profound impact that mindfulness can have on patient care and recovery.\u003c\/p\u003e\n\n\u003ch2 id=\"mindfulness-program-at-osher-center\"\u003eMindfulness Program at Osher Center\u003c\/h2\u003e\n\u003cp\u003eAs the Founder and Director of the Mindfulness Program at the Osher Center, Dr. Barrows has developed comprehensive mindfulness initiatives aimed at improving patient outcomes. These programs are designed to integrate seamlessly into healthcare settings, providing patients with tools to manage their health through mindfulness practices.\u003c\/p\u003e\n\n\u003ch2 id=\"education-and-training\"\u003eEducation and Training\u003c\/h2\u003e\n\u003cp\u003eDr. Barrows graduated from the UCSF School of Medicine in 1993 and completed a family medicine residency in 1996. His pursuit of integrative medicine led him to a two-year fellowship at the University of Arizona, where he honed his expertise in combining traditional and holistic approaches to healthcare.\u003c\/p\u003e\n\n\u003ch2 id=\"certification-and-expertise\"\u003eCertification and Expertise\u003c\/h2\u003e\n\u003cp\u003eIn 2004, Dr. Barrows received certification from the American Board of Holistic Medicine, solidifying his expertise in integrative and holistic health practices. This certification underscores his dedication to providing comprehensive care that addresses both the mind and body, enhancing the quality of life for his patients.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Hello from San Francisco, California! We are with Dr. Kevin Barrows, MD, who is the Director of the Mindfulness Program at Osher Center for Integrative Medicine, and Clinical Professor at University of California San Francisco. Dr. Barrows graduated from UCSF School of Medicine in 1993 and completed a family medicine residency in 1996. He also completed a two-year fellowship in Integrative Medicine at the University of Arizona. Dr. Barrows received a certification through the American Board of Holistic Medicine in 2004.\u003c\/p\u003e\n\n\u003cp\u003eDr. Barrows's primary clinical interest is in Mind-Body Medicine, with a special focus on the application of Mindfulness practice in health care settings. He is the Founder and Director of Mindfulness programs at the Osher Center for Integrative Medicine at UCSF.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Dr. Barrows, hello and welcome! Thank you!\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852070396060,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"what-is-integrative-medicine-1","title":"What is integrative medicine? 1","description":"\u003ch1\u003eIntegrative Medicine: Principles and Applications\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#definition-of-integrative-medicine\"\u003eDefinition of Integrative Medicine\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#five-categories-of-integrative-medicine\"\u003eFive Categories of Integrative Medicine\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#evidence-based-approach-in-integrative-medicine\"\u003eEvidence-Based Approach in Integrative Medicine\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#foundational-health-practices-in-integrative-medicine\"\u003eFoundational Health Practices in Integrative Medicine\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#innate-healing-principle-in-integrative-medicine\"\u003eInnate Healing Principle in Integrative Medicine\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#applications-of-integrative-medicine\"\u003eApplications of Integrative Medicine\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"definition-of-integrative-medicine\"\u003eDefinition of Integrative Medicine\u003c\/h2\u003e\n\u003cp\u003eIntegrative medicine combines conventional medical treatments with complementary therapies to provide holistic patient care. Dr. Kevin Barrows, MD, emphasizes that integrative medicine seeks to integrate pharmaceutical and surgical treatments with therapies such as acupuncture, herbal medicine, and manual therapies. This approach aims to enhance patient outcomes by addressing the physical, emotional, and spiritual aspects of health.\u003c\/p\u003e\n\n\u003ch2 id=\"five-categories-of-integrative-medicine\"\u003eFive Categories of Integrative Medicine\u003c\/h2\u003e\n\u003cp\u003eDr. Kevin Barrows, MD, categorizes integrative medicine into five main areas: Mind-Body medicine, Energy medicine, Manual medicine, Biological therapies, and Whole systems. Mind-Body medicine includes practices like meditation and biofeedback. Energy medicine involves manipulating the bioelectric field for health benefits. Manual medicine encompasses therapies like chiropractic and massage. Biological therapies use natural substances like herbs and supplements. Whole systems include traditional practices like Chinese and Ayurvedic medicine.\u003c\/p\u003e\n\n\u003ch2 id=\"evidence-based-approach-in-integrative-medicine\"\u003eEvidence-Based Approach in Integrative Medicine\u003c\/h2\u003e\n\u003cp\u003eIntegrative medicine prioritizes evidence-based treatments, similar to conventional medicine. Dr. Kevin Barrows, MD, highlights the importance of scientific testing and clinical trials to validate the efficacy of therapies. However, integrative medicine also considers historical and traditional use as a form of evidence, recognizing the value of long-standing practices in systems like Chinese medicine.\u003c\/p\u003e\n\n\u003ch2 id=\"foundational-health-practices-in-integrative-medicine\"\u003eFoundational Health Practices in Integrative Medicine\u003c\/h2\u003e\n\u003cp\u003eFoundational health practices are crucial in integrative medicine, according to Dr. Kevin Barrows, MD. These include nutrition, exercise, sleep, and stress management. Integrative medicine places extra emphasis on these areas, ensuring that basic health needs are met before introducing pharmaceuticals or natural medicines. This holistic approach supports overall well-being and enhances the body's natural healing processes.\u003c\/p\u003e\n\n\u003ch2 id=\"innate-healing-principle-in-integrative-medicine\"\u003eInnate Healing Principle in Integrative Medicine\u003c\/h2\u003e\n\u003cp\u003eThe concept of innate healing is central to integrative medicine. Dr. Kevin Barrows, MD, explains that all living beings have a natural tendency to heal and maintain balance. Integrative medicine focuses on identifying and removing obstacles that prevent the body from healing itself. This philosophical difference from conventional medicine underscores the holistic nature of integrative care.\u003c\/p\u003e\n\n\u003ch2 id=\"applications-of-integrative-medicine\"\u003eApplications of Integrative Medicine\u003c\/h2\u003e\n\u003cp\u003eIntegrative medicine can be applied to various health conditions, including cancer and irritable bowel syndrome. Dr. Kevin Barrows, MD, discusses how integrative approaches can complement conventional treatments, offering patients a comprehensive care plan. By incorporating therapies like mindfulness and acupuncture, integrative medicine addresses the multifaceted needs of patients, promoting healing and improving quality of life.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e What is integrative medicine? Sometimes integrative medical treatment works best. What are the most effective holistic medical treatments? How to use holistic integrative medicine properly? Foundational practices of integrative medicine. Innate healing principle. How to apply integrative medicine for cancer. How to use integrative medicine for irritable bowel syndrome.\u003c\/p\u003e\n\n\u003cp\u003eIntegrative medicine is a term being used more often now. Different patients assign different meanings to this term. What is integrative medicine?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Kevin Barrows, MD:\u003c\/strong\u003e The word \"integrative\" comes from the idea of integrating conventional medicine, pharmaceutical treatment, and surgical operations with complementary therapies. These medical practices come in many different categories, such as acupuncture, botanical medicines, herbal medicines, and manual therapies.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Could you please provide more details on the integrative medicine concept? How does integrative medicine fit into general traditional allopathic medicine?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Kevin Barrows, MD:\u003c\/strong\u003e Integrative medicine integrates conventional allopathic medicine in the West with some complementary therapies that might have origins in other cultures and distant times. It's useful to categorize those therapies into five categories. One category is mind-body medicine, which includes meditation, hypnosis, and biofeedback. Another is energy medicine, based on the principle that there's a bioelectric field emanated by all living beings, including humans, which can be manipulated for health benefits.\u003c\/p\u003e\n\n\u003cp\u003eManual medicine involves the practitioner putting their hands on the patient to achieve a therapeutic outcome, such as chiropractic, osteopathic, or massage therapies. Biological therapies are similar to the pharmaceutical model, involving herbs, supplements, natural medicines, probiotics, fish oil, and plant medicines to produce therapeutic biochemical effects. The last category includes whole systems like Chinese medicine, Ayurvedic medicine from India, and homeopathic medicine, which might employ many different kinds of complementary therapies under one system.\u003c\/p\u003e\n\n\u003cp\u003eIntegrative medicine borrows from these five categories and integrates them with patients' conventional care. It also includes foundational tenets shared with conventional medicine, such as being evidence-based. We prefer therapies tested scientifically and treatments with clinical trials showing efficacy. However, we have a broad definition of evidence, considering long-standing traditional use as a form of evidence, even if it hasn't been tested in a randomized control trial.\u003c\/p\u003e\n\n\u003cp\u003eIntegrative medicine places great emphasis on foundational health practices like nutrition, exercise, sleep, and stress management. We always start there, ensuring basic health practices are attended to before introducing pharmaceuticals or natural medicines. This approach ensures the body and mind have what they need to be healthy.\u003c\/p\u003e\n\n\u003cp\u003eThere is also a subtle philosophical difference between integrative and conventional medicine: the principle of innate healing. All living things have a natural tendency to heal, and integrative medicine emphasizes this concept. When a patient is ill, we first consider why they are not getting better on their own, as their body is a natural healing system. This philosophical difference characterizes integrative medicine.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852070461596,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"what-is-mind-body-medicine-2","title":"What is Mind-Body medicine? 2","description":"\u003ch1\u003eUnderstanding Mind-Body Medicine: Applications and Benefits\u003c\/h1\u003e\n\n\u003ch2\u003eJump To Section\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#concept-of-mind-body-medicine\"\u003eConcept of Mind-Body Medicine\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#mind-body-connection-in-health\"\u003eMind-Body Connection in Health\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#therapies-in-mind-body-medicine\"\u003eTherapies in Mind-Body Medicine\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#applications-in-medical-conditions\"\u003eApplications in Medical Conditions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#scientific-research-supporting-mind-body-medicine\"\u003eScientific Research Supporting Mind-Body Medicine\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#potential-of-mind-body-medicine\"\u003ePotential of Mind-Body Medicine\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"concept-of-mind-body-medicine\"\u003eConcept of Mind-Body Medicine\u003c\/h2\u003e\n\u003cp\u003eDr. Kevin Barrows, MD, defines Mind-Body Medicine as the processes of the mind that influence the health of the body. He emphasizes that this definition is imperfect because it suggests a separation between mind and body. Instead, Mind-Body Medicine views them as interconnected, where any action affecting one will impact the other.\u003c\/p\u003e\n\n\u003ch2 id=\"mind-body-connection-in-health\"\u003eMind-Body Connection in Health\u003c\/h2\u003e\n\u003cp\u003eDr. Kevin Barrows, MD, explains that the mind and body are not separate entities. The mind can affect the body, and vice versa. For example, aerobic exercise can enhance mood, while certain medications like interferon for chronic hepatitis can cause depression. This highlights the chemical and psychological interplay in health.\u003c\/p\u003e\n\n\u003ch2 id=\"therapies-in-mind-body-medicine\"\u003eTherapies in Mind-Body Medicine\u003c\/h2\u003e\n\u003cp\u003eMind-Body Medicine includes therapies such as meditation, hypnosis, biofeedback, guided imagery, tai chi, and yoga. Dr. Kevin Barrows, MD, notes these practices as powerful tools for healing, often underutilized in conventional medicine. They offer a holistic approach to health by addressing both mental and physical aspects.\u003c\/p\u003e\n\n\u003ch2 id=\"applications-in-medical-conditions\"\u003eApplications in Medical Conditions\u003c\/h2\u003e\n\u003cp\u003eDr. Kevin Barrows, MD, discusses the use of Mind-Body Medicine in treating migraines, irritable bowel syndrome, and pain-related diseases. He highlights its effectiveness in mental health conditions like depression and anxiety, where the brain's perception of pain and mood can be significantly altered through these practices.\u003c\/p\u003e\n\n\u003ch2 id=\"scientific-research-supporting-mind-body-medicine\"\u003eScientific Research Supporting Mind-Body Medicine\u003c\/h2\u003e\n\u003cp\u003eThere is substantial Western scientific research supporting the mind-body connection. Dr. Barrows points to studies showing how physical activities and certain medications impact mental health, reinforcing the idea that mind and body are deeply intertwined in health outcomes.\u003c\/p\u003e\n\n\u003ch2 id=\"potential-of-mind-body-medicine\"\u003ePotential of Mind-Body Medicine\u003c\/h2\u003e\n\u003cp\u003eDr. Barrows believes Mind-Body Medicine is a frontier with vast untapped healing potential. He suggests that the mind's power may play a role in seemingly miraculous recoveries, where patients defy medical expectations. This potential makes Mind-Body Medicine a valuable field for further exploration and application in healthcare.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e What is Mind-Body Medicine? What is the best way to apply Mind-Body Medicine?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Kevin Barrows, MD:\u003c\/strong\u003e We can start to define Mind-Body Medicine as processes of the mind that influence the health of the body. That's an imperfect definition of Mind-Body Medicine, but we can start there. The reason I say this definition is imperfect is that we are saying processes of the mind influence the body, which implies a subtle duality. This duality suggests that the mind and the body are separate, with the mind affecting the body. The fundamental principle of Mind-Body Medicine is that they're connected. There is one patient, and anything that you might do to the mind or body is going to affect both.\u003c\/p\u003e\n\n\u003cp\u003eFurthermore, it's not just the mind affecting the body; the body can affect the mind. We have some great Western scientific research on the mind and body connection. We know that aerobic exercise enhances mood, and we know certain therapeutic agents we use, like interferon for chronic hepatitis, have a high incidence of depression as a side effect. This is a chemical medicine that we are giving, and it's affecting the mind.\u003c\/p\u003e\n\n\u003cp\u003eExamples of Mind-Body Medicine therapies include meditation, hypnosis, biofeedback, guided imagery, tai chi, and yoga. Mind-Body Medicine is a very useful field and maybe the biggest untapped source of healing power in many cases. It's a kind of frontier that is not fully explored. I often think about miracle cures, like when a doctor thought a patient was going to die, and then three months later, they were well. I often wonder whether the power of the mind is playing a role there. That is the Mind-Body Medicine phenomenon.\u003c\/p\u003e\n\n\u003cp\u003eI find it really useful in certain cases. In most cases, Mind-Body Medicine can be useful, but I would say in particular in diseases like migraine, irritable bowel syndrome, and pain diseases. The brain can really alter our perception of pain. Certainly, Mind-Body Medicine is helpful in mental health diseases, depression, and anxiety.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e What is Mind-Body Medicine? Introduction and examples of use in cancer treatment and autoimmune disease. How to use Mind-Body Medicine in daily life.\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852070494364,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}]}],"url":"https:\/\/diagnosticdetectives.com\/collections\/all.oembed?page=33","provider":"DiagnosticDetectives.Com","version":"1.0","type":"link"}